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ABSTRACT.
The transforming growth factors Beta (TGFp) comprise three closely-related polypeptides 
with non-overlapping functions in vivo. On a mixed genetic background, a proportion of 
mice homozygous null and heterozygous for a targeted disruption in their TGFpl gene 
die pre-natally with defects in yolk sac haematopoiesis and vasculogenesis (Dickson et 
al., 1995). In this project, the variable penetrance of lethality in TGFpi knockouts was 
investigated. The TGFpi null allele was bred to 93.75% purity in different inbred strains 
of mice, and the gross morphology and histology of TGFpl+/- intercross litters from 
these backgrounds was examined at different pre- and post-natal stages. Molecular 
aspects of the abnormal mid-gestation phenotype were analysed.
The lethal phenotype of the TGFpl knockout was clearly strain-dependent - and the 
variable expressivity and penetrance of the observed phenotypes in TGFpl+/- and 
TGFpl-/- conceptuses suggested three critical stages when TGFpl is essential: a) pre- 
organogenesis; b) in the establishment of a stable extra-embryonic vasculature and during 
haemoglobinisation of primitive eiythroid precursors; c) post-natally as an 
immunomodulator. This study shows that a combination of genetic and environmental 
factors interact to produce the TGFp 1 knockout phenotypes.
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SUMMARY.
The transforming growth factors type Beta (TGFp) are proteins with widespread and 
well-documented expression patterns in vivo. There are three isoforms of TGFp found in 
vertebrates; TGFps 1, 2 and 3. in vitro, the TGFps have been reported to be both growth 
inhibitory and stimulatory, depending on the target cell type. All three isoforms are 
expressed in the developing embryo, and are thought to play important roles during 
embryogenesis.
Two groups have generated transgenic mice with a targeted disruption of the TGFpi gene 
(Shull et al., 1992 & Kulkarni et al., 1993). The cause of death of the homozygous 
TGFpl null animals was characterised by Dickson et al. (1995), working on a mixed 
genetic background (50% NIH/ Ola, 37.5% C57BL/ 6J/ Ola, 12.5% 129/ Sv): Dr. 
Dickson found that 50% of TGFpl-/- and 25% of TGFP1+/- embryos died in utero due 
to defective extra-embryonic haematopoiesis and vasculogenesis. This is in concordance 
with previous reports that in the murine embryo, TGFpl RNA expression is first detected 
in the haemangioblasts of the yolk sac at approximately 7.0dpc (Akhurst et al., 1990). 
The haemangioblasts are located in the blood islands and give rise to vascular endothelial 
and primitive haematopoietic cells. TGFpl expression persists in the descendant cells of 
these lineages (Akhurst et al., 1990). All TGFpi-/- animals which survived to birth died 
at around three weeks of age due to a wasting syndrome involving a multifocal, mixed 
inflammatory cell response and tissue necrosis.
This project was undertaken in order to characterise any strain-specific differences in the 
onset and manifestation of the abnormal TGFpi knockout phenotype. The TGFpl null 
allele was bred to 93.75% purity on inbred NIH/ Ola (NIH), 129/ Sv/ Ola (129) and 
C57BL/ 6J/ Ola (C57) genetic backgrounds. Defined intercrosses of these strains; i.e. FI 
(reciprocal NIH x C57) and F2 (FI x FI), were also used in this study. In order to 
objectively and accurately assess the gross morphology of conceptuses at 8.0-10.5dpc, a 
scoring system was developed to specifically and precisely stage the embryo and yolk sac 
using developmental landmarks. This system also incorporated a means of quantifying the 
abnormalities typically found in mid-gestation TGFpl knockout conceptuses; and 
therefore enabled the comparison of the precise developmental age and severity of defects 
observed in conceptuses of different genotypes from different genetic backgrounds. 
Thus, in the course of this project; >100, 9.5dpc and 11.5dpc conceptuses from 
TGFpl+/- intercross litters of each strain were morphologically scored and genotyped by
PCR. In addition, the genotype ratios of animals generated from reciprocal TGFpl+/- x 
TGFpl+/+, and TGFpi+/- intercrosses at 3 weeks of age and 1 day old were studied.
It was found that 89% of C57 TGFpl-/- embryos died before 9.5dpc due to an unknown 
cause. The majority of NIH TGFpl-/- animals survived to birth, but died at around 3 
weeks of age with a multi-focal immune reaction. The majority of FI, F2 and 129 animals 
died during mid-gestation (10.5dpc-12.0dpc) with defects of the extra-embryonic 
vascular system. This phenotype typically comprised a combination of the following 
abnormalities: An inadequate or disorganised yolk sac vasculature, yolk sac anaemia, 
haemmorhages in the yolk sac or embryo, defects of the allantois and/ or chorion. Thus, 
the TGFpi knockout phenotype was shown to have a strain-specific expressivity and 
penetrance.
A number of histological and molecular aspects of the TGFp 1 knockout phenotype were 
investigated at mid-gestation. When examined histologically, the yolk sac from abnormal 
TGFp 1 knockout conceptuses appeared to have weak contacts between the endoderm and 
mesothelium, leading to the shearing of tissue layers, dilated endothelial tubes and 
exovasation of primitive erythroid cells. Immunohistochemistry revealed a down- 
regulation in the number of perivascular pericytes in the affected yolk sacs. The apparent 
anaemia of some mutant yolk sacs may have been due to defective haemoglobinisation of 
the primitive red blood cells, assessed in this study using May-Grunwald Giemsa staining 
of yolk sac blood smears; however, haemorrhages observed in the yolk sac and/ or 
embryo could also have contributed to the anaemic phenotype.
The effect of the parental origin of alleles of the TGFpl modifier gene (Bonyadi et al., 
1997) upon death in utero was studied in >260 F2 conceptuses at 9.5dpc using a PCR 
marker polymorphic for the chromosomal location of the modifier gene between NIH and 
C57-derived alleles. TGFpl+/- and -/- embryos with two C57-derived modifier gene 
alleles were more likely to die in early/ mid-gestation, compared to littermates. 
Interestingly, it was found that an NIH allele at this locus could contribute to the survival 
of C57 TGFpl-/- embryos to 9.5dpc.
Thus, it appears that TGFp 1 is crucial for three stages of murine development: Prior to 
9.5dpc; during the establishment of a functional extra-embryonic circulatory system at 
mid-gestation; and as an immunomodulator at around 3 weeks of age. A variety of genetic 
and environmental factors interact to produce the observed TGFp 1 knockout phenotype.
ABBREVIATIONS.
Units.
aa = amino acid 
bp = base pairs 
0 C = degrees Celsius 
cm = centimetre 
cpm = counts per minute 
dpc = days post coitum 
dpp = days post partum 
g = gram 
kb = Kilobase 
kDa = kiloDalton 
L = litre 
M = molar 
mg = milligram 
ml = millilitre 
mM = millimolar 
ng = nanogram 
nm = nanometre 
OD = optical density 
rpm = revolutions per minute 
V = volts 
jitCi = microCurie 
jig = microgram 
pi = microlitre 
pm = micrometre
Proteins.
p-LAP = TGFP latency associated peptide
BMP = bone morphogenetic protein
CDMP = cartilidge-derived morphogenetic protein
dpp = decapentaplegic
DVR = decapentaplegic -Vg-related group
Chemicals and Reagents.
BSA = bovine serum albumin 
cDNA = complementary DNA 
DAB = 3,3’- diaminobenzidine 
DEPC = diethylpyrocarbonate 
DIG = digoxigenin 
DNA = deoxyribonucleic acid 
dNTP = deoxynucleoide triphosphates 
DTT = dithiothreitol 
EDTA = ethylenediamininetetra acetic acid 
ET = Embryo Transfer Freezing medium 
EtBr = ethidium bromide 
mRNA = messenger RNA 
PBS = phosphate buffered saline 
PFA = paraformaldehyde 
RNA = ribonucleic acid 
SDS = sodium dodecyl sulphate 
TE = Tris-EDTA 
TESPA = 3-amino propyltriethoxysilane 
UTP = Uridine 5’- Triphosphate
Proteins (continued).
ECM = extracellular matrix 
EGF = epidermal growth factor 
FGF = fibroblast growth factor 
FN = fibronectin
FSH = follicle stimulating hormone 
GDF-9 = growth/ differentiation factor 9 
GDNF = glial-derived neurotrophic factor 
LTBP = latency associated TGFP binding protein 
MIS = Mullerian inhibitory substance 
TGFp = transforming growth factor type Beta 
VEGF = vascular endothelial growth factor 
Vg-1 = vegetal-1 
Vgr-1 =Vg-1 related
Other
C57 = C57BL/ 6J/ Ola 
EC = endothelial cells
FI = Generated by reciprocal C57 x NIH intercrosses. 
F2 = Generated by FI intercrosses.
HSC = haematopoietic stem cells
NIH = NIH/ Ola
PCR = polymerase chain reaction
RFC = microvascular endothelial cells
RFLP = restriction fragment length polymorphism
UV = ultraviolet
+/+ = homozygous wild type
+/- = heterozygous
-/- = homozygous null
129= 129/ Sv/ Ola
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Chapter 1
INTRODUCTION. 
1.1 Cellular Interactions and Pattern Formation in 
Embryogenesis.
Mammalian prenatal development has been studied for centuries. Prior to the advent of 
molecular biology a variety of elegant descriptive and grafting studies enabled the 
postulation of key theories regarding cell fate, morphogen gradients and the inductive 
ability of certain tissues. However, it is only due to investigations on a molecular level 
that the precise mechanism of some of the interactions observed during embryogenesis 
have been elucidated.
In the last few decades a multitude of proteins which are active during mammalian 
embryogenesis have been identified. The sequences of many of the genes which encode 
these proteins are highly conserved across divergent species, indicating common 
evolutionary origins. This has proved to be a useful tool in the investigation of the 
structural and functional homology and analogy of many developmental systems.
Genes and gene products are typically classified by their degree of relatedness to each 
other on various structural levels. The transforming growth factor type Beta (TGFp) 
superfamily is one such discrete group of highly conserved proteins with disparate 
functions. The TGFp superfamily is reviewed below.
1.2 The Transforming Growth Factor Beta 
Superfamily.
The TGFp supeifamily comprises a large family of secreted signalling proteins which 
have many different functions in vivo and in vitro. All are known to play a role or roles 
during developmental processes. Members of the superfamily are found in a wide variety
1
of species including Drosophila, C. elegans and man, and exhibit between approximately 
40-80% homology at the amino acid (aa) level. All of the family members are initially 
synthesised as a large precursor protein which must be cleaved at an R-X-X-R site 
(where R = arginine and X can be any amino acid) to release a mature peptide. The 
mechanisms of this process are covered in detail later in this chapter. It is the structure of 
the mature region which is the most highly conserved within the superfamily; there is up 
to 100% aa identity of this region between homologues of different species.
Cysteine residues in the mature peptide are conserved between all superfamily members. 
One of these residues is involved in an intermolecular disulphide bond linking the 
biologically active homo- orhetero-dimericform of the molecule, the others are involved 
in the formation of an intramolecular ‘cysteine knot’, a common structural motif within 
the superfamily (McDonald & Hendrickson, 1992).
The TGFp superfamily can be subdivided into smaller, more related groups: The TGFps, 
the activins and the DVR (<decapentaplegic Vg-related) group. Other newer unclassiflable 
superfamily members also exist; for example lefty (Meno et al., 1996 & Colligton et al., 
1996). The superfamily members described in detail below may share receptors. For an 
overview of the degree of relatedness between the members of the TGFp superfamily, 
see Figure 1.
1.2.1 The Transform ing Growth Factors Beta.
The first member of the TGFp superfamily to be identified was human TGFpl (Assoian 
et al., 1983; Frolick et al., 1983 & Roberts et a l, 1983). It was cloned in 1985 by 
Derynck et al. Further biochemical purification and molecular cloning has led to the 
identification of three distinct TGFps in mammals, designated TGFpi, TGFp2 and 
TGFp3. Work done in vitro and in vivo on all 3 TGFp isoforms has revealed a great 
diversity of function. They are able to stimulate or inhibit cell proliferation and 
differentiation or alter the cellular phenotype. The potency of each isoform depends upon 
the cell type and environment (Miyazono, 1993; Akhurst, 1994 & Cui & Akhurst, 1996 
for review articles).
All three TGFp genes share common structural features: All contain 7 exons, with 
conserved splice site junctions. The proteins are synthesized as pre-pro-TGFps; the 
length of which varies between isoforms, i.e. TGFpl is 390 aa and TGFps 2 and 3 are 
412aa. These are large precursor molecules with a short N-terminal signal peptide, the
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latter enables the protein to be released from the cell (see Figure 2). The precursor 
proteins usually exist as homodimers bound by disulphide bonds, however, heterodimers 
between TGFps 1 and 2 (Cheiftez etal, 1988), and TGFps 2 and 3 (Ogawa et al, 1992) 
have been characterised. The mature bioactive form of TGFp is released by proteolytic 
cleavage of the pre-pro TGFp at an arginine - rich sequence 112aa from the C-terminal. 
However, the N-terminal fragment remains non-covalently associated with the mature 
dimer and is termed the latency-associated peptide (P-LAP). The P-LAP maintains the 
TGFp in a latent state, forming the small latent complex.
Although certain features of the p-LAPs of the different TGFp isoforms are conserved 
for functional and structural reasons; the sequence of the p-LAPs is dissimilar. P2-LAP 
lacks an RGD integrin-binding motif, which p i and P3 p-LAPs possess. This has been 
postulated to provide a functional distinction for TGFp2. All 3 p-LAPS are capable of 
binding to each of the mature isoform homodimers and in most biological assays each 
isoform is interchangeable (Roberts & Spom, 1990). Thus, although the P-LAP may not 
be directly responsible for functional differences between TGFP2 and TGFps 1 and 3, it 
may play a part in modulating the affinity of the latent TGFp2 complex for the extra­
cellular matrix (ECM).
In humans, little similarity has been found between the promoters characterised for each 
TGFp gene (Kim e ta l., 1989; Lafyatis etal., 1990; Noma etal., 1991). Each has distinct 
regulatory elements, suggesting, as expected, that each isoform can be independently 
regulated in response to diverse stimuli. With the gene promoters, as with the mature 
TGFps, there is a high degree of interspecies homology. This is consistent with 
observation that the localisation and function of the TGFp isoforms is comparable across 
a variety of species. For example, mature human TGFpi is identical to mature avian, 
bovine, simian and porcine TGFpl (Derynck etal., 1985, 1987; Sharpies et al., 1987; 
vanObberghen-Schillinge ta l,  1987 & Jakowlew etal., 1988) and differs from murine 
TGFpl by one amino acid (Derynck etal., 1986). However, there may be different inter­
specific roles for the regulation and function of TGFp isoforms during embryogenesis. 
Evidence presented by Potts and Runyan shows that TGFp3 plays a key role in avian 
heart development (Runyan et al., 1992). Work done on murine cardiac development 
(Millan et a l, 1991 & Dickson et al., 1993) suggests that TGFp2 may replace it in the 
developing mouse heart.
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Figure 1. The Transforming Growth Factor Beta Superfamily.
The diagram shows the inter-relationship of the members of the TGFp, Activin, 
DVR and unclassified subgroups of the TGFp superfamily. Length of the branches 
does not indicate the degree of inter-relatedness.
20-23aa N-Terminal Signal Sequence
'y 7 Mature TGFp (112aa)
250-3 lOaa Latency Associated Peptide (p-L A P)
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C) LARGE LATENT 
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Latency Associated Binding Protein (LTBP)
D) ACTIVE TGFp
Figure 2. D iagram m atic R epresentation o f the D ifferent Forms o f TGFp.
TGFp is translated into a precursor molecule, known as pre-pro TGFp (A). Two of these 
monomers associate via disulphide bonds (S) and the mature dimeric TGFp is formed by 
proteolytic cleavage at an arginine-rich region; i.e. the mature regions of the molecules are 
separated from their latency associated peptides (P-LA P). The cleaved p~LAP can remain 
covalently associated with the TGFp dimer and, by this, will continue to confer latency. 
This is called the small latent TGFp complex (B). The large latent complex (C) contains 
the small latent complex plus the latency associated binding protein (LTBP). The LTBP 
binds to the p -L A P  via disulphide bonds. The mature form of TGFp is activated only on 
release from the p -L A P  (D). The activation process of TGFp may involve the interaction 
of mannose-6-phosphate (P*) with the cell surface and plasmin.
1.2.2 The A ctivins.
Activins function as dimers, of which there are 2 distinct monomeric fonns: Pa and 
Pb- The Pb subunit also forms part of the inhibin heterodimer. Thus, 3 types of 
activin have been isolated, activin A (papa), activin B (pbPb) and activin AB (papb)* 
All are capable of inducing mesoderm in animal cap explants from the Xenopus 
embryo (Nakamura et al., 1992) and inducing the release of follicle stimulating 
hormone (FSH) (Mason et a l, 1985). Extensive studies in the mouse have shown that 
both activin subunits are expressed zygotically before implantation (Albano et a l,
1993) and expressed in several tissue types during post-implantation development. 
During gastrulation and early post-implantation development the activins are expressed 
exclusively in the decidua. By 10.5 days post conception (dpc), activin A has localised 
in mesenchymal tissues of the embryo and activin B is expressed in the central 
nervous system as well as the gastric epithelium. pa and Pb subunits are coincidentally 
expressed in, among other tissues, the blood vessels and intervertebral disc anlagen 
(Feijen e ta l ,  1994).
Knockout mice, i.e. animals lacking the activin genes, have been generated. Animals 
without the pb subunit developed to term and only exhibited defects in eyelid 
formation and female reproductive ability, thus proving that activin B is not essential 
for mesoderm formation (Vassalli et a l,  1994). It must be remembered that mutants 
involving the activin pb subunit also affect the formation of inhibin. pa homozygous 
null mutations die within 24 hours of birth with severe craniofacial malformations, 
however, the mesoderm had developed normally (Matzuk et a l, 1995a). Mice lacking 
both activin subunits exhibit the sum of defects from the individual mutants (Matzuk et 
a l,  1995b).
Since these phenoytypes do not involve gross disturbances in mesoderm formation, it 
has been postulated that maternal decidual activin plays a role in rescuing the 
homozygous null conceptuses (Smith, 1995). Letterio et a l, (1994) showed that 
TGFpl protein can cross the placenta. However, since the activin A knockout is lethal 
it would be impossible to test this theory properly for the activins without using 
inducible knockouts (see Introduction 1.5.3).
A number of activin receptors have been cloned and characterised. All are 
serine/threonine kinase receptors and fall into two classes, type I or type II. These 
receptors form a heterodimeric complex to signal. To date, only the knockout of
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activin receptor IIA (ActRcIIA) has been published. Surprisingly, the majority of 
homozygous mutants developed normally, although some exhibited skeletal 
abnormalities. General defects included a decrease in the level of FSH and reduced 
reproductive capabilities (Matzuk et a i ,  1995b). This result suggests that there are 
several activin type II receptors mediating different cellular responses i.e. ActRcIIA 
governs activin’s role in FSH induction, but not mesoderm induction. Preliminary 
reports of activin type IA and IB receptor knockouts show early post implantation loss 
in both mutants, as do double knockouts for ActRcIIA and ActRcIIB (Gu et al., 1996; 
Oh et al., 1996). The data suggests a complex interaction of combinations of receptors 
and ligands necessary for the multifarious effects of activin.
1.2.3 The Decapentaplegic-Vg Related Group (DVR group).
The DVR subfamily are classified together because they are more similar to one 
another than to the TGFps and activins (see Figure 1). The group comprises the 
Xenopus gene Vg-1 and its mammalian homologue Vgr-1, the D rosophila  gene 
decapentaplegic (dpp) and the bone morphogenetic proteins (BMPs). This subgroup is 
rapidly expanding.
The details of the dpp signalling pathway are emerging: one, type II and two, type I 
serine/threonine kinase receptors have been characterised; punt, saxophone and thick 
veins respectively. Both receptor types are required for dpp-related signalling (Ruberte 
et a l , 1995). Downstream signalling elements in the TGFp signalling pathway will be 
discussed later in this chapter.
1.2.3.1 The Bone Morphogenetic Proteins (BMPs).
The BMPs were first described by Urist in 1965. Urist found that by implanting 
extracts of demineralised bone into ectopic sites in rodents, new bone formed. The 
inductive proteinacious factor(s) involved were named bone morphogenetic protein 
(BMP). Subsequently, a family of BMPs have been cloned which fall into a number 
of subfamilies. BMP-1 is not a member of the TGFP superfamily and closely 
resembles the Drosophila tolloid protein. Mature BMPs 2 and 4 are classified with 
dpp. BMP-3 and BMPs 5-8 are also in distinct subgroups (see Reddi, 1992 for a 
review article) (see Figure 1).
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In vertebrates, BMPs are expressed in many embryonic tissues and organs. This is 
reflected in the variety of phenotypes reported in the knockouts of BMPs which have 
been characterised: The majority of BMP-4 homozygous mutants die at the egg 
cylinder stage. The conceptuses which survive to mid-gestation are developmentally 
retarded and die with truncated posterior structures and a haematopoietic deficiency in 
the yolk sac (Winnier et al., 1995). BMP-2 mutants die at 9.5dpc with defects of 
cardiac and amnion/ chorion formation (Zhang & Bradley, 1996) and BMP-7 
homozygous mutants die shortly after birth with renal failure. They also suffer 
micropthalmia and polydactyly (Dudley et al., 1995).
Recent work suggests that different members of the BMP family interact with their 
receptors using different mechanisms to those utilised by the rest of the TGFp 
superfamily, and that a number of BMP receptors remain unidentified (Neuhaus et al., 
1996). Binding studies have shown that the type I activin-like kinase receptor 3 (ALK- 
3) and ALK-6 can bind BMPs 2 ,4  and 7, thus they have been designated BMPR-1A 
and BMPR-1B respectively (ten Dijke e ta l., 1994). Interestingly, BMPR-1A deficient 
embryos die at gastrulation without forming any mesoderm (Mishina et al, 1995). A 
type II receptor, BMPR-II has been cloned (Rosenweig et al., 1995).
1.3 Activation and Signalling of the TGF|3s.
1.3.1 TGFp Latency.
As previously described, the TGFps are synthesised as large pre-pro (precursor) 
molecules which are proteolytically cleaved to give the mature peptide and a P-LAP 
fragment. The p-LAP remains non-covalently associated with the mature peptide, 
forming the small latent complex (see Figure 2). Thus, all 3 TGFp isoforms are 
secreted as biologically inactive complexes which must be activated in order to interact 
with TGFp receptors.
Fractions of latent TGFp have been found to contain additional high molecular weight 
proteins, which are associated with the p-LAP. The best characterised of these is latent 
TGFp binding protein (LTBP), which is found bound to the p-LAP by a disulphide 
bond (Miyazono et a l,  1988). Binding studies have shown that the LTBP cannot 
confer latency alone; in fact, the P-LAP is sufficient to confer TGFp latency and 
thereby control the bioactvity of TGFp (Kanzaki et al., 1990 & Miyazono et al., 1993)
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(see Figure 2). A second LTBP, LTBP-2 has also been described (Moren et a l ,
1994).
The LTBP amino acid (aa) sequence contains repeat motifs which are present in 
fibrillin, an ECM protein. It also contains an RGD motif and a potential p2-laminin 
binding domain (Kanzaki et al., 1990 & Maslen et a l , 1991). Protein studies have 
confirmed that LTBP-1-associated TGFp is found in the ECM of fibroblasts and can 
be released by the addition of plasmin (Taipale et a l , 1994). More recently, Ghosh & 
Brauer (1995) showed that latent TGFp is present in much of the embryonic cardiac 
ECM, whilst the distribution of active TGFp is much more restricted. Thus, the role 
of the LTBP appears to be to direct the latent TGFp to the cell surface where it can 
either be stored, or processed to the active form. Dallas et a l  (1995) have also 
proposed a role for LTBP-1 as means of storing latent TGFp in the ECM of bone 
where LTBP-1 may be involved in the formation of the ECM of bone. This work also 
supported previous assertions that plasmin was the key regulator of both free and 
matrix-bound latent TGFp activation.
1.3.2 TGFp Receptors.
The nomenclature of the TGFp receptors is based upon their sizes as elucidated in 
chemical crosslinking studies using radio-iodinatedTGFp. Thus, Type I receptors are 
approximately 53 kDa, Type II receptors between 70-85 kDa and Type III receptors 
between 200-400 kDa . The first TGFp superfamily receptor to be cloned was an 
activin type II receptor, ActRIIA (Matthews and Vale, 1993) (see Massague et a l , 
1993 & Kingsley etal., 1994, for review articles).
Sequence comparison between the TGFp supeifamily type I and II receptors cloned 
subsequently showed that these receptors represent subfamilies of novel serine/ 
threonine kinase signalling molecules. Each comprises an extracellular domain, a 
transmembrane region and an intracellular kinase domain. Type II receptors contain a 
serine/ threonine- rich C-terminal tail not present in type I receptors. Unique to the 
type I receptors is a 30 aa conserved region; namely, the GS domain, which is located 
immediately N-terminal to the kinase domain. This region is involved in type I 
receptor activation (Wrana et a l, 1994a, b) (see Massague et a l, 1992 & Kingsley et 
a l, 1994 for review articles).
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In a pattern echoed throughout the TGFp superfamily, a number of receptors have 
been cloned for TGFp: One type II receptor; TpR-II (Lin et a l ,  1992) and two type I 
receptors; TpR-I and TSR-1 also known as ALKs 5 and 1 respectively (Franzen et a l,  
1993 & Bassing et a l ,  1994). TpR-1 appears to be a definitive TGFp type I receptor 
whereas TSR-1 interacts with both activin and TGFp type II receptors (Carcamo et 
a l ,  1994). Thus, the initiation of the TGFp signal is complex. It involves a system 
which has the ability to induce an array of diverse cellular effects using receptors 
which may overlap with other TGFp superfamily signal pathways.
TpR-II is a constitutively active serine/ threonine kinase whose activity is not 
increased by ligand binding. Ligand binding to TPR-EI induces recruitment of TPR-I 
into a stable complex and, once this complex is formed, TpR-II phosphorylates TpR-I 
at serine/ threonine residues in the GS domain and a signal is induced (Wrana et a l ,  
1994a). This heteromeric complex is required for a TGFp Signal i.e. the kinase 
activity of both TpR-II and TpR-I is necessary for TGFP signalling, and a 
constitutively active TpRI can generate certain cellular responses in the absence of 
TpR-H (Weiser et a l ,  1995 & Carcamo et a l ,  1995). Thus TPR-I is effectively a cell- 
surface component of the downstream TGFp signalling pathway. Naturally-occuring 
kinase-deficient receptor Is can compensate for their defects by dimerising in complex 
with a TpR-II and co-operatively interact in the induction of a TGFP signal (Weis- 
Garcia et a l ,  1996). This may provide a means of producing the diverse cellular 
effects induced by TGFp. Indeed, there is other evidence that members of the TGFp 
superfamily can form homo- and hetero-dimers and it may be these different 
combinations which drive the formation of specific receptor combinations and elicit 
different cellular responses (Kingsley, 1994).
Both type III receptors; betaglycan and endoglin, are thought to play a role in the 
presentation of TGFp to TpR-II. Transient complexes between TpR-II and TpR-III 
have been detected on the cell-surface after the addition of TGFp (Lopez-Castillas et 
a l ,  1993 & Zhang et a l ,  1996). Betaglycan is a membrane-bound proteoglycan with a 
short cytoplasmic tail and no apparent signalling motif (Lopez-Castillas et al, 1991 & 
Wang et a l ,  1991). It is found in many cell-types excluding haematopoietic and 
endothelial cells (Ohta et a l ,  1987) and also exists in a free-floating form. This can 
still bind TGFp, but cannot present it to the receptors (Lopez-Castillas et a l ,  1994). 
Thus, betaglycan may play a role in controlling excess ligand. Endoglin is a 180 kDa 
homodimeric membrane glycoprotein. It is only found on vascular endothelial cells 
and erythroid precursors (Buhring et a l ,  1991) and does not exist in a free-floating
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form (Cheifetz et al., 1992). The type III receptors also exhibit different binding 
affinities for the TGFp isoforms. Betaglycan can bind all 3 TGFp isoforms with 
varying affinities (Mitchell et al., 1992), whereas endoglin only binds TGFpi and 3 
(Cheifetz et al., 1992).
Thus, the variations of affinity in ligand-receptor interaction may assist in the 
modulation of the effects of the different TGFps: TGFps 1 and 3 bind TpR-II with 
high affinity, however, TGFp2 does not bind well to either TpR-II or TpR-I, despite 
all 3 isoforms having similar effectiveness. However, TpR-II has been shown to be 
necessary for TGFP2 function (Wrana et al., 1992). It appears that type III receptors 
may control the cell’s responsiveness to TGFp2. Endoglin binds TGFp2 with a lower 
affinity than it binds TGFpl and 3, which may be why certain types of haematopoietic 
and endothelial cells are less responsive to TGFp2 (Ohta et al., 1987; Ottman & 
Pelus., 1988; Merwin etal., 1991 & Qian et al., 1992).
It is possible that betaglycan acts as a modulator of TGFP2. TGFp2 will not bind to 
TpR-II when the receptor exists in a free, soluble form; whereas at the cell-surface, in 
transfected COS cells the binding of TGFP2 to TpR-II was increased 10-100 fold by 
the presence of betaglycan (Lin etal., 1995). It has been observed that a small subset 
of TGFp receptors display a similar affinity for all TGFp isoforms (Cheifetz et al., 
1990 & Zhou et al., 1995). It is not known whether these molecules are acting in 
concert with binding proteins, such as a type III receptor or a similar molecule, or if 
they represent a unique, unknown type of TGFp receptor.
1.3.3 TGFp Receptor Signalling.
The TGFp family transduce their signals via a heteromeric complex of a type I and a 
type II serine/ threonine kinase receptors. This is generally the same throughout the 
TGFp superfamily: Activins, BMPs and TGFps have all been shown to require both 
receptor types in order to signal. However, there are differences in receptor-ligand 
interaction between the subgroups. Whereas in the TGFp and activin signalling 
pathway only the type II receptor binds ligand and recruits a type I receptor into a 
stable heteromeric complex, all BMP receptors show weak binding of ligand, 
however, a high affinity binding of BMP is observed when both receptor types are 
present. There is also a degree of type I receptor subunit promiscuity within the TGFp 
superfamily; i.e. the type II receptors are able to interact with a number of type I 
receptors, for example, TSR-1 has been reported to bind both activin and TGFp and
9
ActR-I can signal with both BMP-7 and activin (ten Dijke et a l ,  1996 for a reveiw 
article).
Several molecules thought to play downstream roles in TGFp receptor activation and 
signalling have been identified. FKBP-12 and farnesyl protein transferase A were both 
isolated using a yeast two-hybrid system with an intracellular TGFp type I receptor as 
“bait”. The exact function of these molecules is unknown. Both fail to interact with a 
kinase-defective type I receptor, although no ligand dependence has been 
demonstrated in the ability of either to phosphorylate or associate with the receptor 
(Wang et a l ,  1994 & Kawabata et al., 1995). Using a TpR-II intracellular domain as 
“bait”, TpR interacting protein-1 (TRIP-1) was isolated. The interaction and 
phosphorylation of TRIP-1 is dependent on TpR-II kinase activity, but independent of 
ligand and TpR-I (Chen et a l ,  1995). Similarly, the exact function of TRIP-1 is 
unknown.
As previously mentioned, the Drosophila type I and II receptors are saxophone, thick 
veins and punt. They interact with the Drosophila BMP-2 and 4 homologue dpp. A 
genetic screen for enhancers of weak dpp  alleles led to the identification and 
characterisation of mothers against decapentaplegic (mad), a downstream component 
required for dpp signalling (Raftery et a l ,  1995 & Sekelsky et a l ,  1995).
In C. elegans, daf-4 has been characterised as a serine/ threonine kinase BMP 
receptor homologue, able to bind ligand and signal without interacting with a receptor 
I (Estevez et al., 1993). The sma-2, 3 and 4 genes were identified as downstream 
elements in the daf-4 pathway and found to be structurally related to the Drosophila 
mad gene (Savage et al., 1996). Thus far, four vertebrate homolgues of mad have 
been identified; these have been named Smad-1 to Smad-4 (Zhang et al., 1996). 
Smads from different species show a high level of sequence conservation; for 
example, human and Xenopus Smad-1 are 95% identical.
Experimental evidence has shown that different Smads  can induce different 
intracellular responses, and overexpression of specific Smads can mimic the effect of 
different TGFp superfamily ligands. For example, overexpresion of Smad-1 induces 
BMP-2 and 4 effects, Smad-2 induces activin-like effects and Smad-3 induces TGFp- 
like effects (Graff et a l ,  1996; Liu et a l ,  1995; Thomsen et a l ,  1996 & Zhang et a l,  
1996). Smad-4 is different in structure to the other Smads, and may be involved co­
operatively in signal transduction. Thus, overexpression of a truncated Smad-3 and
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Smad-4 but not Smad-2, inhibits a TGFp intracellular response (Zhang et al., 1996). 
Hence, it has been postulated that the signal from a TGFp superfamily receptor I can 
be transmitted via a single Smad and this process may involve functional interactions 
with Smad-4.
The precise roles of the Smad family remain unclear, but they may be involved in the 
transcriptional upregulation or activation of other downstream genes in the TGFp 
family signalling pathways. Vertebrate homologues of the Drosophila transcription 
factors schnurri, sal and salr which act downstream from dpp, may be involved in this 
interaction (Arora et al., 1995; Greider et al., 1995 & de Celis et al., 1996).
1.4 TGFpi and Embryogenesis.
The distribution of TGFp 1 RNA and protein throughout murine embryogenesis has 
been well documented. Transcripts are found from the 4-cell embryo stage onwards 
by reverse transcription PCR, but are undetectable by in-situ hybridisation until 
7.5dpc when they are found in the developing blood islands (Rappolee et al., 1988). 
Thereafter, TGFpi localises to the developing endothelial and haematopoietic cells in 
the yolk sac, allantois and embryo proper, the pro-angiogenic progenitors of the 
cardiogenic mesoderm and the endocardium (Lenhert & Akhurst, 1988 & Akhurst et 
al., 1990).
1.4.1 TGFp and Preimplantation Development.
Spatial and temporal patterns of TGFp during preimplantation development suggest 
that it may play a role in implantation, decidualization and placentation. Successful 
implantation requires a series of complex co-ordinated interactions between the 
maternal and embryonic tissues involving many cellular processes. Maternal tolerance 
to the conceptus must be established to prevent rejection of the developing embryo. 
Cell migration, proliferation and differentiation, ECM remodelling and neo- 
vascularisation must also take place to create a suitable environment for gestation.
TGFpl RNA and protein studies have shown that during the preimplantation period 
TGFpi is localised intracellularly in the maternal uterine luminal and glandular 
epithelium. It is diffusely expressed extracellularly throughout the decidualizing 
uterine stroma after the initiation of implantation at 4.5dpc (Tamada et al., 1990). This
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pattern continues in the deciduum through mid-gestation with the highest level of 
TGFpi expression occurring proximal to the uterine wall (Akhurst et a l ,  1990).
During the preimplantation period TGFp2 is localised in the maternal uterine luminal 
and glandular epithelium, the myometrium and vascular smooth muscle. Post­
implantation, TGFp2 immunoreactivity is observed in the deciduum as well as the 
myometrium and epithelium (Das et a l ,  1992). TGFP3 protein is found in the 
myometrium and vascular smooth muscle at the peri-implantation stage (Das et at.,
1992).
Type I and II TGFp receptors and TSR-1 are present in the uterine and decidual tissue 
(Roelen et a l ,  1994). Thus, these tissues can respond to TGFp in an autocrine 
manner.
All three TGFp isoforms have been detected in the 1-cell, then the 4-cell embryo 
suggesting that the embryo begins to produce TGFp as soon as the genome is 
activated (Rappolee et al., 1988 & Paria et a l ,  1992). It is not known precisely 
whether preimplanation embryos can respond to TGFp. In vitro culture of individual 
2-cell embryos to blastocyst stage is significantly enhanced by the addition of TGFp 1 
(Paria & Dey, 1990). In addition, specific binding of radiolabelled TGFpi and 2 to 
blastocysts has been demonstrated, and distinct roles for TGFp isoforms in blastocyst 
dormancy and activation proposed (Paria et a l ,  1992). However, Roelen et a l,  
(1994) presented data that the TGFp type I and II receptors were undetectable in the 
embryo until after gastrulation and therefore concluded that embryonic TGFp acts in a 
paracrine fashion upon maternal tissue, regulating implantation and maintaining 
pregnancy. Thus, there may be specific, as yet undetected TGFp receptors functioning 
in early embryogenesis.
1.4.2 TGFp and Yolk-Sac Developm ent.
1.4.2.1 Normal D evelopm ent of Extra-Em bryonic Tissue.
During murine embryogenesis; the extra-embryonic tissues serve several essential 
functions. They provide a well-regulated environment for embryonic development 
prior to the formation of the chorio-allantoic junction at around lO.Odpc and protect the 
developing embryo. The extra-embryonic tissues are consituted of; the placenta - 
derived from trophoblast, mesoderm and endoderm; the parietal yolk sac - derived
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from parietal endoderm and trophoblast; the visceral yolk sac - derived from visceral 
endoderm and mesoderm; and the amnion which is derived from mesoderm and 
ectoderm.
The visceral yolk sac, hereafter referred to as the yolk sac, starts to form as the inner 
cell mass (ICM) of the blastocyst differentiates into layers of primitive ectoderm and 
endoderm. The primitive endoderm does not contribute to the definitive endoderm of 
the adult mouse but only to the visceral and parietal extraembryonic endoderm. Cells 
from the primitive endoderm migrate along the inner surface of the trophectoderm. 
This layer becomes the parietal endoderm and secretes the Reichert’s membrane which 
is thought to act as a passive filter between the maternal and foetal environment.
The remainder of the endoderm forms a visceral endoderm layer wrapped around the 
egg cylinder. As gestation progresses mesodermal cells generated from the posterior 
primitive streak of the embryo migrate onto the inner surface of the visceral endoderm 
and the yolk sac is formed from regions where mesoderm is adjacent to the visceral 
endoderm. It is these mesodermal cells which give rise to the first haematopoietic 
tissue, i.e. the blood islands of the yolk sac.
The amnion begins as a roof over the primitive, unturned 8-8.5dpc embryo. It 
expands rapidly with the turning of the embryo and, by 9.5dpc exists as a thin 
membrane lying between the embryo and the yolk sac
The allantois is a major component of the maternal and foetal relationship during 
gestation. At 8.0-8.5dpc the allantois is a finger-like projection of mesodermal cells 
from the posterior margin of the embryonic ectoderm which expands upwards from 
the amniotic cavity into the exocoelomic cavity. Between 8.5 and 8.75dpc the allantois 
begins to fuse with the chorion. The chorion lies in direct contact with the 
ectoplacental cone and is covered by a layer of mesodermal cells which contribute to 
the placenta. By 9.0dpc, a primitive placenta has been formed as a result of the fusion 
of the allantois, chorion and ectoplacental cone. The primitive vasculature of the 
allantois connects with the vasculature in the chorion and the umbilical vessels appear. 
At around lO.Odpc the ectoplacental cone becomes the labyrinthine part of the placenta 
and the embryo begins to receive nutrients from the mother. Prior to this, the embryo 
was reliant upon the yolk sac for nourishment. (Yang etal., 1995).
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Figure 3. A Diagram m atic R epresentation o f Blood Island Form ation in the 
M urine Yolk Sac.
Between 7.0 and 8.0dpc, the blood islands develop in the yolk sac. They are distinct 
regions of mesodermal proliferation induced by the endoderm. The blood islands contain 
the haemangioblast progenitor cells which give rise to both the endothelial and 
haematopoietic cell lineages in the yolk sac. By 8.0dpc, the outermost haemangioblasts 
have flattened and become a layer of endothelial cells. The inner haemangioblasts remain 
rounded and form erythroid precursors. Between 8.5 and 9.0dpc, the endothelial cells 
begin to anastomose, forming the basis of the developing vascular plexus in the yolk sac 
(Martin etal., 1995).
See Slack, 1983 and Hogan et al., 1994 for a detailed overview of murine 
development.
1.4.2.2 The Role of TGF(3 in Yolk-Sac Development.
At 7.0-8.0dpc in the murine yolk sac, the blood islands are induced by the endoderm. 
The blood islands are functionally distinct regions of mesodermal proliferation which 
contain the haemangioblasts, the progenitors of endothelial and haematopoietic cell 
lineages (Miura & Wilt, 1969; Pardanaud et al., 1989 & Martin et al., 1995). The first 
expression of TGFpi mRNA occurs in the blood islands of the 7.5dpc conceptus 
(Akhurst et al., 1990). In the blood islands, outer haemangioblasts differentiate into a 
layer of endothelial cells which anastamose to form blood vessels during 
vasculogenesis. The primitive erythroid cells are generated from the inner 
haemangioblasts (see Figure 3). The TGFpi gene continues to be expressed in both 
lineages in the yolk sac and allantois as the extra-embryonic vascular plexus develops 
(Akhurst et al., 1990).
The vascular plexus is formed by a combination of the distinct processes of 
vasculogenesis and angiogenesis. The former is defined as the the in situ 
differentiation of mesodermally-derived precursors and the assembly of these 
differentiating endothelial cells into discrete blood vessels, and only occurs during 
early embryogenesis: Whereas the latter is the sprouting of new vessels by the 
proliferation and migration of endothelial cells from pre-existing blood vessels, and is 
essential throughout embryogenesis as well as adulthood. Vasculogenesis results in 
the formation of the primordia of the heart and large vessels, as well as the capillary 
network found throughout the yolk sac and embryo during development (Suri et al., 
1996).
It is generally thought that TGFp is growth inhibitory to endothelial cells in culture 
(Heimark et al., 1986 & Muller et al., 1987). In vitro studies have been used to 
examine the effect of TGFP on vascular endothelial cells. Both TGFps 1 and 2 inhibit 
the proliferation and migration of bovine vascular endothelial cells in culture, although 
TGFpi is almost 100 times as potent as TGFp2 (Baird & Durkin, 1986; Frater- 
Schroder et al., 1986 & Jennings et al., 1988). When microvascular endothelial cells 
(RFCs) are seeded within a 2D collagen gel, TGFpi inhibits cell proliferation and 
induces a  smooth-muscle actin expression. However, when RFCs are seeded into a
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3D collagen gel, TGFpi induces the formation of capilliary tubes and the upregulation 
of cell adhesion molecules, ECM proteins and receptors. The cells no longer express 
a  smooth-muscle actin. Interestingly, in the 3D culture system, cells could not be 
inhibited by TGFpi (Madri et al., 1988; Merwin et a l,  1990 & Madri et al., 1992).
a  smooth-muscle actin is known to be a marker for perivascular pericytes (Herman et 
al., 1985). Pericytes are found in close association with endothelial cells (EC) within 
the microvascular basement membrane but their exact function is unclear. They have 
been attributed roles in the maintenance of microvascular integrity and the regulation of 
the growth, migration and differentiation of EC during angiogenesis. These effects are 
mediated by TGFpi in vitro (Sato & Rifkin, 1989 & Antonelli-Orlidge etal., 1989). 
TGFpi is reported to induce the expression of a  smooth-muscle actin in pericytes in 
culture (Verbeek etal., 1994). Latent TGFpi is produced by both endothelial cells and 
pericytes in vitro, however, it only becomes activated when EC and pericytes are 
cocultured. The group also found that removing TGFpi with antibodies inhibits EC 
migration (Sato & Rifkin, 1989).
Thus, in the light of the defective extra-embryonic vascular phenotype of the mid­
gestation TGFpi-/- conceptuses, TGFpi has been proposed to play an autocrine role 
in the vasculogenesis and angiogenesis of the yolk sac (Dickson e ta l,  1995).
1.4 .3  TGFp and Haematopoiesis.
1.4.3.1 Norm al H aematopoiesis in Developm ent.
Blood is comprised of cells of many lineages i.e. erythrocytes, neutrophils, 
monocytes/ macrophages, platelets, mast cells, B-lymphoid and T-lymphoid cells. 
These are all derived from haematopoietic stem cells (HSCs). Each lineage is produced 
continuously throughout the lifespan of the individual and relies upon the proliferative 
expansion of progenitor cells and the progressive commitment of progenitors to single 
lineage differentiation (for an overview, see Dzierzak & Medvinsky, 1995; Orkin,
1995).
Haematopoiesis occurs in waves. In murine embryogenesis, primitive haematopoiesis 
begins in the yolk-sac from precursors initially observed at 7dpc (Moore & Metcalf, 
1970). By 8.0dpc, the first blood cells to arise, that is, nucleated, primitive red blood 
cells are visible in the yolk sac. However, these cells do not enter the primitive
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circulation until 8.5dpc. At 8.5-9.0dpc definitive haematopoiesis begins, and HSCs 
are detectable in the aortic/ gonadal/ mesonephros (AGM) region of the embryo 
proper. Until recently, the foetal liver was presumed to be the site of initiation of 
definitive murine haematopoiesis. However; mature, progenitor and stem-cell 
haematopoietic activity is only detectable in the foetal liver after 10.5dpc; and this may 
be directly related to the earlier onset of haematopoietic activity in the yolk sac and 
AGM region. Therefore, it is probable that the HSCs of mice (and possibly man) 
which populate the adult, arise in the AGM region (Medvinsky et al., 1993). Yolk sac 
HSCs may contribute transiently to embryonic haematopoiesis, but their exact role is 
unclear (Godin et al., 1995). It has been shown that primitive and definitive 
erythrocytes arise from different types of precursor cells which have distinct 
morphological and biochemical characteristics. By 14.0dpc erythroid cells from 
definitive precurors comprise the majority of circulating red blood cells (Nakano et al.,
1996). In adults, definitive haematopoiesis is maintained in the spleen and bone 
marrow.
There are clear molecular and developmental distinctions between primitive and 
definitive haematopoiesis. Gene-targeted c-myb-/- mice and mice deficient in the 
retinoblastoma (Rb-/-) gene die with anaemia at 15.0-16.0dpc during definitive 
haematopoiesis.These mice exhibit normal primitive haematopoiesis in the yolk-sac, 
but are severely anaemic by 15.0dpc. This is due to a proliferative defect of definitive 
haematopoietic progenitors in c-myb-/- embryos and abnormalities in the 
haematopoietic microenvironment in Rb-/- embryos (Mucenski et al., 1991 & Clarke 
et al., 1992). GATA-2 knock out mice die at 10.5-11.5dpc with severe anaemia due to 
defects in primitive haematopoiesis (Tsai et al., 1994). It was inferred that GATA-2 
controls the proliferation and/or maintenance of early progenitors or stem cells.
1.4.3.2 The Role o f  TGFp in Haematopoiesis.
The initial embryonic localization of TGFp 1 RNA transcripts is within the blood- 
islands of the yolk-sac. The blood-islands contain mesodermal haemangioblasts, the 
progenitors of the endothelial and haematopoietic lineages (Sabin, 1920; Wilt, 1965; 
Miura & Wilt, 1969) (see Figure 3). The cellular descendants of both of these lineages 
have been shown to express TGFpi RNA and protein (Akhurst et al., 1990). Later in 
development, during definitive haematopoieis, TGFpi RNA is detectable in foetal 
blood cells in the developing liver.
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TGFpi has been reported as having many and varied effects on haematopoietic cell 
lines in culture and in vivo. It appears to be bi-functional, ie. either growth stimulatory 
or inhibitory depending on the target cells and the cytokines present. In general, the 
sensitivity of progenitor cells to the inhibitory effects of TGFpi is thought to be 
inversely correlated with maturity, i.e. immature progenitors are profoundly inhibited 
by TGFp whereas more mature progenitors may be stimulated by TGFpi (Ohta et a l , 
1987; Keller et al., 1990; Sing et a l ,  1988 & Keller et a l ,  1991). For example, 
repeated injections of TGFpi given to adult mice resulted in a reversible 95% 
reduction in red cell counts and a 50-400% increase in circulating white cells. The 
reduction in erythroid production was due to suppression of differentiation of early 
erythroid precursors, not the lysis of existing cells (Carlino et a l ,  1992). TGFpi can 
also induce the accumulation of haemoglobin in K-562 cells, a multipotential human 
haematopoietic cell line (Chen e ta l ,  1989).
It is not known precisely what the relevance of these results is in terms of murine 
primitive haematopoiesis. Directly, it is possible that growth inhibition of erythroid 
precursors may mask less profound effects. Indirectly, it may also be the case that 
ablation of TGFpi causes specific abnormalities in the correct formation of the blood- 
islands which result in defective haematopoiesis.
1.4.4 TGFp and the Extra-Cellular Matrix (ECM).
The ECM provides a complex and dynamic support for tissue structure. It is required 
in cell migration which is essential during the processes of vasculogenesis, 
angiogeneis and haematopoiesis.
TGFP is known to modulate ECM deposition by promoting its formation and 
controlling its degradation. TGFp is known to stimulate the deposition of, among 
others: Fibronectins, collagens I, II, IV and V, thrombospondin, chondroitin/ 
dermatin sulphate proteoglycans, laminin and tenascin. Tenascin distribution is 
restricted in the embryo, and correlates with the expression of TGFp 1. TGFp 1 is 
known to activate the transcription of tenascin, and may play a role in its induction 
(Chiquet-Ehrismann et a l ,  1988 & Akhurst, 1990). TGFp also decreases the 
synthesis and secretion of several ECM-degrading proteases such as plasminogen 
activator (PA), elastase and collagenase. However, this process is controlled by the 
upregulation of a number of protease inhibitors by TGFp; plasminogen activator
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inhibitor-1 (PAI-I) and tissue inhibitor of metalloproteinases (TIMP) (see Roberts & 
Sporn, 1990).
Specifically, TGFpi has been shown to induce the expression of fibronectin by 
microvascular endothelial cells in 2D and 3D culture systems. Interestingly, the 
synthesis of PAI-1 and PA were both increased but only briefly, early in the 
angiogenic process in 3D culture (Sankar et al., 1996). The seemingly contradictory 
nature of TGFpi function in the ECM may be attributable to the culture conditions, 
differention state of the cells and the cell types used.
TGFps 1 and 2 are able to selectively upregulate the expression of integrins. Integrins 
are the cell-surface receptors of ECM proteins; thus TGFpi can regulate cellular 
phenotype and behaviour by modulating the interaction of the cell with the ECM 
(Ignotz & Massague, 1987 & Roberts et al., 1988), as well as by altering the 
composition of the ECM.
1.4.5 TGFp and the Immune System.
The in vitro and in vivo response of cells to TGFp have shown that it acts as a potent 
modulator of the immune system, generally functioning as an immunosupressor (for 
review articles see Roberts & Sporn, 1990; Cui & Akhurst, 1996). Interestingly, all 
TGFpi-/- mice which survive to birth die at around 3 weeks of age due to a massive 
multi-focal immune disorder (see Introduction 1.6.1).
During inflammation TGFp acts as a chemoattractant, stimulating monocyte migration 
and macrophage production (Wahl et al., 1987). At higher concentrations TGFp can 
induce monocyte cytokine expression (McCartney-Francis, 1989). TGFp can also 
modulate macrophage function - by inhibiting the cells’ ability to release hydrogen 
peroxide it removes their capacity to kill cells, whilst retaining the cells’ ability to 
produce growth factors (Tsunawaki et al., 1988). After initiation of an inflammatory 
response, TGFp exhibits inhibitory effects by preventing the adhesion of neutrophils 
and T-lymphocytes to the endothelium (Gamble & Vadas, 1991).
Analysis of the immunomodulatory properties of the structure of TGFp isoforms has 
lead to the conclusion that each isoform has a distinct influence on the immune 
response. Based on 3D protein analysis, it has been postulated that TGFpi would 
possess an immunosuppressive and stimulative ability, whereas TGFP2 would be a
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strong immunosuppressor and TGFp3 would be immunostimulative (Weiczorek et 
al., 1995). For example, TGFpi has been suggested as a potential immunosupressor 
in the therapy of the human autoimmune disease multiple schlerosis (MS): The 
administration of TGFpi to mice with experimental allergic encephalomyelitis (EAE), 
a mouse model of MS, has been found to ameliorate the symptoms and reduce 
nervous system damage (Racke et al., 1991). TGFp2 has been cited as an 
immunosupressor in glioblastoma tumourigenesis (De Martin et al., 1987).
1.4.6 TGFp and Cardiogenesis.
Cardiogenesis is an extremely complex morphogenetic process: In the mouse; 
progenitor, cardiac mesoderm cells arise at gastrulation. The primitive, layered heart 
tube is formed at 7-7.5dpc by the rapid spread of angiogenic and promyogenic clusters 
located in the mesoderm. The heart tube consists of an acellular jelly separating 2 
concentric tubes of endocardium and myocardium. Between 7.5-1 l.Odpc septation 
and valve formation take place and a recognisable 4-chambered contractile organ is 
formed.
In in vitro studies of cardiac culture systems, in contrast to the usual growth inhibitoiy 
effects, TGFps 1 and 2 are both able to induce differentiation of cardiac muscle 
(Parker et al., 1991 & Muslin & Williams, 1991). The addition of TGFpi or 2 to ES 
cells in culture can induce the formation of cardiac and skeletal muscle. TGFp2 can 
also increase the beating rate of the cardiac muscle (Slager et a l , 1992).
As previously described, expression studies have shown that TGFps 1 and 2 RNA are 
both detectable in the developing murine cardiac mesoderm from 7.0dpc onwards. By 
8.0dpc TGFpi expression has localised to the endocardium, while TGFp2 is detected 
in the myocardium. This distinct pattern continues, but by 8.5-9.5dpc the expression 
of both isoforms is restricted to the outflow tract (OFT) and atrioventricular (AV) 
regions. This is the period when endothelial cells from the AV canal and OFT become 
capable of mesenchymal transformation and migrate into the underlying cardiac jelly 
leading to septation and formation of valves (Akhurst et al., 1990; Dickson et al.,
1993). It has been postulated that TGFps 1 and 2 form a co-operative signal which 
induces the formation of cushion tissue: Autocrine TGFpi modulates the ECM to 
allow migration of enothelial cells into the cardiac jelly forming cardiac cushion tissue; 
whilst a paracrine TGFp2 signal emanates from the myocardium and induces an 
endothelial-mesenchymal transition in the cardiac cushion tissue, enabling valve
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formation and septation (Runyan & Markwald, 1983; Akhurst et a l , 1990 & Dickson 
et al., 1993).
Expression of all 3 TGFP isoforms becomes restricted later in cardiac development. 
TGFp3 is expressed transiently at the base of the valves at 14.5-16.5dpc in 
mesenchymal condensations (Millan et al., 1991). TGFp2 is undetectable in the heart 
after 17.5dpc whereas TGFpi continues to be expressed in the endocardium until 7 
days post partum (dpp) (Pelton et a l ,  1991 & Millan et a l ,  1991). In the adult mouse, 
TGFpi is expressed in the myocardium and can control the expression of a number of 
cardiac-specific genes (Roberts e ta l ,  1981 & Parker et a l ,  1990). The expression of 
TGFpi is upregulated in response to mechanical load, infarction and adrenergic 
agonists (Thompson et a l ,  1988, 1989 & Bhambi & Eghbali, 1991). Thus, all 3 
isoforms of TGFp appear to be involved in many aspects of cardiogenesis, however 
TGFpi also has a key role in the maintenance of the normal adult heart.
1.5 Generation of Mutants in the Analysis of 
Gene Function.
1.5.1 Introduction.
Despite a wealth of information regarding the distribution of a protein and/ or its 
mRNA during development and during different situations in the adult animal, the 
exact function of a gene can only be assumed. However, the relative ease of genetic 
manipulation of the mouse allows the researcher to modify the genome by ablating or 
modifying target genes. The production of single, then double and triple knock-outs 
(as well as ‘knock-ups’; whereby the expression level of a gene is upregulated, and 
‘knock-ins’; when the targeted sequence of a gene is replaced by that of another) and 
the advent of tissue-specific and inducible mutations are powerful tools in the study of 
mammalian gene expression and can provide a complementary approach to more 
longstanding molecular techniques (see Brown & Jones, 1996; Barinager 1994 & 
Takahashi et a l, 1994 for review articles).
The mouse was the mammal of choice studied by early geneticists because of its small 
size, ease of maintenance, resistance to infection, large litter size and rapid generation 
time. Also, natural variants and mice with spontaneous mutations mainly affecting 
coat-colour and behaviour were well-characterised and readily available from mouse 
breeders. Examples of these; the albino and pink-eyed dilute mutants, were used in the
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first experiments demonstrating Mendelian inheritance and linkage by J.B.S. Haldane 
and his contemporaries in the early twentieth century. These spontaneous mutants and 
variants also proved valuable in more recent studies. For example, the Dominant white 
spotting (W) and Steel (SI) pigmentation mutants were found to be caused by 
mutations in genes encoding a transmembrane tyrosine kinase receptor, c-kit (Chabot 
etal., 1988 & Geissler etal., 1988) and its ligand, Steel factor (Anderson et al., 1990 
& Zsebo eta l,  1990), respectively. These proteins play a major role in the growth and 
survival of melanocytes, primordial germ cells and haematopoietic cells.
1.5.2 The Use of ‘Forward G enetics’.
More recently, geneticists have employed artificial means of generating murine 
mutants for research. Large numbers of mice are subjected to a mutagenesis study i.e. 
systematically exposed to potent mutagens such as x-rays and chlorambucil, both 
known to produce large deletions; or to the alkylating agent N-ethyl-N-nitrosourea 
(ENU) best for producing point mutations. The mice and their progeny are then 
screened for interesting phenotypic defects and the causative lesions examined. This 
process is known as ‘forward genetics’ i.e. working from phenotype to gene.
An example of a successful ENU mutagenesis project is the investigation of the 
circadian rhythm ‘Clock’ mutation in mice (Vitatema, et al., 1994). Over 300 
C57BL/6J mice were treated with ENU and their wheel-running patterns analysed. 
Normal mice have a set circadian pattern of exercise. One mouse which exhibited 
abnormal wheel-running patterns was isolated and analysed. From the homozygous 
mutant progeny of this founder, it was clear that the mutation regulated the length of 
the circadian period and the persistence of circadian rhythm. The Clock mutation was 
rapidly mapped by linkage analysis.
1.5.3 The Use of ‘Reverse G enetics’.
The relative ease with which the mouse genome can be manipulated has permitted the 
use of transgenic animals as a means of studying gene expression: That is, 
transmissable mutations can be produced in the mouse genome by the replacement of a 
gene of choice with a segment of exogenous DNA. The DNA introduced into the 
genome may be an entire cloned gene, a cDNA, or a region of a gene which has been 
mutated in vitro. The biological consequences of these induced mutations are of great
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interest to the researcher; thus ‘reverse genetics’, working from the targeted mutation 
of a gene to the resulting phenotype, has become commonplace within the last six 
years.
Since the TGFpi knockout mice used in this project were generated by gene transfer 
into embryonic stem (ES) cells this method of gene manipulation in vivo will be 
described in detail below:
ES cells are totipotent. They are derived from the inner cell mass (ICM) of the 
blastocyst and can re-integrate into the ICM of another blastocyst. ES cells can be 
maintained in an undifferentiated state in vitro, hence, while in culture, modified DNA 
can be transfected into the cells. Once genetically modified, the ES cell is injected into 
the ICM of another blastocyst which is then transferred to the uterus of a pseudo­
pregnant host mother and allowed to develop to term. If the exogenous DNA has 
integrated into the genome, the resulting offspring will be chimeric, and, if the 
chimeras contain the mutation in their germ line, the mutation will be transmitted to the 
next generation. The phenotype of heterozygous and homozygous mutant progeny 
should provide evidence for the function of the gene in vivo. Also, where questions of 
functional redundancy between co-expressed proteins have arisen, the problem can be 
addressed by intercrossing single knockouts to create double and triple knockouts (see 
Melton, 1994 & Hogan etal., 1994 for an overview of transgenic mouse production).
Random integration of the exogenous DNA into the genome in transgenic mouse 
production may cause additional unquantifiable phenotypic effects, thus a process of 
gene targeting via homologous recombination is employed. However, the incidence of 
random integration is still very high. To identify recombinants, a neo cassette is 
included in the targeted cDNA. This will provide resistance to neomycin to any cell 
with intergration and expression of the transgene. To differentiate between random 
and homologous recombination events, the herpes simplex virus thymidine kinase 
(HSV-TK) gene is placed at one or both ends of the targeted cDNA construct. The 
HSV-TK gene is removed if the cDNA integrates at its homologous site, and therefore 
is continuously expressed if the construct has integrated randomly. HSV-TK makes 
the cell sensitive to the drug gancyclovir; thus, only homologous recombinants will 
survive exposure to gancyclovir (Frohmann & Martin, 1989) (see Figure 4 for a 
schematic example).
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Figure 4. T argeted D isruption of Exon 1 o f the TGFp G ene.
A schematic representation of the targeting vector, the wild type TG Fpi allele and the 
predicted disrupted TGFp 1 allele are shown above. The black boxes show exons, the open 
boxes indicate introns and promoterless regions. The neomycin (Neo) resistance/ HSV-TK 
(TK) sensitivity selection system was used to isolate the ES cells which contained the 
transgene in the desired selection site (see Introduction 1.5.3).
95, 96, 97 and 98 indicate the nested set of PCR primers used routinely to amplify the 
TGFp 1 wild-type allele, whereas TGF 0 and PGK -1 are the PCR primers used to amplify 
the TGFp 1 null allele. Their annealing sites are indicated by arrows. The difference in the 
size of the Sac I (S) and Hind III (H) fragments in the wild type and targeted alleles are 
shown by double-headed arrows.
A major disadvantage of creating knockout mice in the above manner is that the protein 
is removed completely from the animal from the outset of development. If the mutation 
is lethal any study of the knockout at later stages of development is precluded. Thus, 
methods for controlled expression of transgenes have been developed. For example, if 
transgenic mice carrying the PI bacteriophage Cre recombinase under the control of a 
tissue-specific regulatory element are crossed with a line of mice in which loxP 
recombination sites have been inserted in the genome; such as either side of the 
targeted gene. The Cre lines up the loxP sites and removes the intervening DNA 
leaving one loxP site behind (Lasko et al., 1992)(see Figure 5). Lasko et al. (1992) 
generated mice which carried a lens-specific aA-crystallin promoter followed by a 
stop codon flanked with loxP sites, this was followed by a SV40 T antigen coding 
sequence. When these animals were mated with Cre mice, the stop codon was excised 
and the dormant T antigen was activated, resulting in mice with lens tumours. A 
similar method involving yeast FLP recombinase which recognises FRP sites has also 
been described ( 0 ’Gorman e/a/., 1991).
Both the Cre/ loxP and the FLP/ FRP systems are useful in creating tissue-specific 
mutations. However, there is no temporal control over the expression of the modified 
gene. A system has been developed whereby a transgene may be switched on 
throughout the animal at any developmental stage for a controlled period. The 
exogenous DNA is introduced into the mouse genome under the control of the 
repressor of the tetracycline -resistance operon from E. coli {tet). The tet transgenic is 
mated with a mouse containing the activating domain of viral protein VP16 of herpes 
simplex virus tetracycline-controlled tetracycline trans-activator protein (tTa). In the 
resulting double transgenics, the tTa binds to the tet operator sequences in the absence 
of tetracycline, thereby activating transcription of the gene. However, transcription is 
not permitted in the presence of tetracycline since, in this circumstance, the tTa does 
not bind to the tet operator sequence (Furth et al. , 1994). Thus tetracycline must be 
routinely administered to the double transgenics in order to repress transcription of the 
exogenous sequence. Tetracycline is not toxic at the concentration required for control 
of transcription, but may require titration to adequately repress the expression of the 
transgene (G. O’Neill, pers. comm.). Therefore, the use of a tetracycline-responsive 
binary system, either systemically, or with a Cre/ loxP or FLP/ FRP tissue-specific 
system could answer many of the unanswered questions of mouse genetics.
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Cre is a recombinase from E. coli which recognises loxP sites in the genome. By mating 
transgenic mice which carry the Cre gene with mice that have loxP sequences, the 
Cre/loxP system can be used as a control switch in gene induction and ablation. A) 
shows an example of Cre being used to excise a /avP-flanked sequence from the genome. 
In B) expression of the gene is permitted by the excision of the stop codon via the 
Cre//a*P system.
X and Y are random sites within the genome.
1.6 TGFp Knockout Mice.
1.6.1 TG Fpi K nockout Mice.
Two independent groups have generated TGFpi knockout mice. The endogenous 
TGFp gene was disrupted by the insertion of a neo-cassette into exon 6 (Shull et al., 
1992), and exon 1 (Kulkami et al., 1993) (see Figure 4). Lines of mice able to 
transmit a copy of the TGFpi knockout allele were bred from chimeric founder 
animals. Both groups reported that a proportion of TGFp homozygous null (TGFpi 
-/-) animals were bom and survived to 3 weeks of age. These animals were 
indistinguishable from their littermates until 10-14 days post-partum (dpp), whereafter 
they became noticeably runted and displayed a hunched posture and dishevelled coat.
1-2 weeks later these mice were severely wasted and died. Post-mortem investigations 
revealed no major malformations. However, Shull et al. (1992) reported that the 
TGFpi-/- animals had fewer Peyer’s patches and smaller spleens compared to 
TGFpi+/+ littermates. Histological analysis by both groups revealed that the cause of 
death appeared to be an infiltration of lymphocytes and macrophages resulting in 
secondary necrosis in many organs, including the heart, lungs and stomach. Since no 
evidence was found of pathogens it was concluded that death resulted from an 
autoimmune disorder. This was in concordance with previous work which had 
suggested that TGFpi was a negative regulator of the immune system (Racke et al., 
1991).
Further investigation (Geiser etal., 1993) showed that there was an increase in major 
histocompatability (MHC) Type II gene expression in infiltrated TGFpi-/- tissues 
prior to the inflammatory response. MHC Type II molecules are expressed on a 
limited number of cells involved in antigen presention to T-helper cells. In 
autoimmune diseases immune activity is directed against cells inappropriately 
expressing MHC class II molecules. These results suggest that TGFpi may 
downregulate the expression of MHC Type II molecules in vivo.
Dickson et al. (1995), described the TGFpi knockout phenotype at mid-gestation. 
The knockout allele (Kulkami et al., 1993) was bred onto a mixed genetic background 
(12.5% 129/Sv/ Ola, 33.5% C57BL/6J/ Ola, 50% NIH/ Ola) and the resulting 
embryonic phenotype characterised. The results were as follows: All of the severe 
abnormalities observed in TGFpl+/- and TGFpi-/- conceptuses at 9.5dpc were
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restricted to extra-embryonic tissue and involved defects of vasculogenesis and/or 
haematopoiesis. Any embryonic defects observed were thought to be secondary 
effects of the yolk sac phenotype. Genotype and phenotype analysis at different 
developmental stages led to the conclusion that 50% TGFpi-/- and 25% TGFpl+/- 
embryos died at around 10.5dpc as a result of yolk sac insufficiency. All of the 
TGFpi-/- animals which survived to birth died at 3 weeks post-partum due to a 
massive inflammatory reaction. Reciprocal TGFpl+/- x TGFpi+/+ crosses showed a 
statistically significant 20% loss of TGFp 1+/- pups when the mother was TGFpl+/-. 
However, this loss was rectified when 2-cell stage preimplantation embryos from 
TGFpl+/- intercrosses were transferred into wild-type pseudo-pregnant females. It 
was therefore concluded that the maternal genotype influenced the ability of a TGFpi 
knockout conceptus to survive in utero (Dickson etal., 1996).
Further evidence that the maternal environment influences the TGFpi-/- phenotype 
exists. It is known that murine maternal circulating TGFP 1 can cross the placenta, and 
is also detectable in milk. Letterio et al. (1994) reported that TGFpi protein was 
detectable by immunohistochemistry in TGFpi-/- embryos from TGFpl+/- 
intercrosses in utero, but was not present in TGFpi-/- conceptuses from a TGFpi-/- 
mother. Thus, on some genetic backgrounds maternal sources of TGFpi are sufficient 
to support the TGFpi-/- animal through development to weaning. In the 2 reported 
cases of a litter being bom to a surviving TGFp 1-/- mother (crossed with a TGFp 1+/- 
stud), the resulting TGFpi-/- phenotype increased in penetrance and severity (Letterio 
etal., 1994 & Dickson etal., 1995). The embryos died at around 9.5dpc with cardiac 
as well as extraembryonic defects. It is unclear whether the reported cardiac 
abnormalities were a primary effect of a reduction in TGFpi, or a secondary effect of 
yolk-sac insufficiency.
1.6.2 TGFP3 Knockout Mice.
Two independent groups have generated TGFP3 knockout mice by the targeted 
disruption of exon 6 of the gene (Proetzel etal., 1995 & Kaartinen et al., 1995). Both 
groups report that the expected numbers of TGFp3-/- animals were bom. These pups 
were noted to be unable to suckle at 4 hours post-partum. They rapidly become 
cyanotic and dehydrated and died within 24 hours of birth. Post-mortem analysis 
revealed the cause of death to be defective development of the palate and delayed 
pulmonary development. Proetzel etal. (1995) also presented evidence that there was 
a variable expressivity of the cleft palate phenotype in the three inbred strains studied.
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The most severe cleft palate phenotypes were observed on a C57BL/6J genetic 
background.
Mammalian palatogenesis occurs between 14.5 and 18.5dpc. The developing palatal 
shelves must elevate and the medial edge epithelium (MEE) of both adhere. The 
resulting epithelial seam is eliminated forming a seamless mesenchymal shelf 
separating the oral and nasal cavities (Ferguson, 1988). Previously, expression 
studies have suggested a crucial role for TGFp3 during palatogenesis, specifically in 
the MEE (Fitzpatrick et al., 1990 & Pelton et al., 1990). In vitro organ culture studies 
have shown that TGFps 1 and 2 accelerate palatal shelf fusion, but antibodies to 
TGFp3 block the fusion process altogether (Brunet et al., 1995). The defects seen in 
the TGFp3-/- neonates appears to be due to inadequate fusion between the palatal 
shelves. However it is not known whether this is due insufficient expression of ECM 
molecules or defects in epithelial-mesenchymal transition. It is noteworthy that the 
phenotypes of the TGFpi and TGFp3 knockout animals indicate no overlap in their 
essential function.
1.6.3 TJ3R-II Knockout Mice.
Recently, Oshima et al., (1996) reported the phenotype of TpR-II knockout mice on 
an unspecified genetic background. A truncation mutation was introduced by 
homologous recombination upstream of the TPR-II cytoplasmic serine/ threonine 
kinase domain. This design allowed normal ligand-binding, but prevented signal 
transduction.
When TpR-II+/- mice were intercrossed, no TpR-II-/- pups survived to birth. No 
TpR-n+/- conceptuses were affected. Upon gross morphological inspection, 8.5dpc 
TPR-II-/- conceptuses were identical to their littermates, however, by 9.5dpc the TpR-
II-/- yolk sacs exhibited severe anaemia. No live TpR-II-/- embryos were observed at 
13.5dpc. Histological analysis of the 9.5dpc TPR-H-/- yolk sacs revealed detatchment 
of tissue layers resulting in distended capilliary vessel formation. This was noted to be 
similar to the vascular phenotype seen by histology in TGFpi knockout conceptuses 
at 9.5dpc by Dickson et al., 1995.
In order to assess the developmental potential of TpR-II cells, Oshima et al. (1996) 
also generated eight chimeric mice from a TpR-II-/- ES cell line. The extent of 
chimerism was estimated by coat colour contribution and thought to be <5%,
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suggesting that high-contribution chimeras died in utero. The chimeras were 
indistinguishable from normal littermates at birth, but exhibited a severe wasting 
phenotype at 2 weeks post-partum similar to TGF(3l-/- animals which survive to birth 
(Shull et al., 1991; Kulkarni et a l ,  1992). A number of different congenital 
abnormalities were observed i.e. anopthalmia, cystic kidney, and hydrocephalus, 
however, it was impossible to determine the cell lineages to which the TpR-II-/- cells 
had contributed.
Unexpectedly, the phenotype of the TpR-II-/- embryos is strikingly similar to the 
reported TGFpl knockout phenotype. This implies that the earliest developmental 
stage where signalling via TpR-II is essential is 8.5-9.0dpc for haematopoiesis and 
vasculogenesis. Inducible TGFp and TpR-I and II knockouts as well as an 
investigation of the phenotype of TpR-II-/- mice on other pure inbred strains are 
required to fully eludcidate the role of each TGFpl isoform and receptor in 
development.
1.7 Inbred Mouse Strains.
An inbred strain of mice is defined as one which has been maintained for more than 20 
generations of brother-to-sister matings and is essentially homozygous at all genetic 
loci, except for mutations arising spontaneously (Altman & Katz 1979 & Morse, 
1981). There are more than 400 inbred strains available today and most can be 
obtained commercially. A standardised nomenclature refers to strain, substrain and 
history^and the different characteristics of each strain such as littersize and tumour- 
susceptibility are well documented.
Inbred mouse strains have rapidly become an important tool in the elucidation and 
mapping of modifier genes in disease models. Previously, several groups have noted 
strain-specific differences in severity and penetrance of mutant phenotypes (see 
Discussion for a detailed appraisal); for example, the TGFp3 knockout (Introduction 
1.6.2). Sufficient differences exist between inbred strains to enable the researcher to 
use mapping resources such as RFLPs and microsatellites in concert with statistical 
tools to investigate inter-strain polymorphisms with respect to specific knockout 
phenotypes and thus begin to dissect the genetic and environmental components of 
strain-specific phenotypes, for example, to identify modifier genes (Bonyadi et al.,
1997).
27
1.8 Project Aims
1.8.1 A Strain-Specific Phenotype in TG Fpi-/- Mice?
Previously, this group had characterised the phenotype of mixed genetic background 
TGFp 1 knockout mice and identified the cause of pre-natal lethality as defects in extra- 
embryonic vasculogenesis and haematopoiesis (Kulkami et al., 1993 & Dickson et al., 
1995). Since the penetrance of the pre-natal lethal phenotype reported in this study 
was at odds with that published initially (Shull et al., 1992 & Kulkami et al., 1993), 
the primary aim of this project was to analyse the expressivity and penetrance of the 
pre-natal phenotype associated with the TGFpi null allele on defined genetic 
backgrounds. To this end the TGFpl null allele was bred through 4 generations of 
mice onto 3 different genetic backgrounds ie. NIH/ Ola (NIH), C57BL/6J/01a (C57) 
and 129/ Sv/ Ola (129) by F. Cousins. Defined intercrosses of those backgrounds i.e. 
FI (reciprocal NIH x C57) and F2 (FI x FI) were used as tools to better define the 
genetic and epigenetic factors acting.
In order to clarify the onset of pre-natal lethality; embryos from TGFpl+/- 
intercrosses were scored at 9.5 and 11.5dpc using an objective scoring system and 
genotyped by PCR. The relationship between genotype and phenotype on each genetic 
background was analysed statistically and put in context with genotype data collected 
from neonates and mice at weaning. Histological, molecular and immunohistochemical 
attempts to define the cause of pre-natal death were made.
1 .8 .2  The Role of a Strain-Specific TG Fpi M odifier in Pre- 
Natal Lethality.
Bonyadi et al (1997, in press) have shown that around 80% of the genetic variation 
seen between NIH and C57 mice in the TGFpi knockout phenotype is due to the 
action of a strain-specific modifier gene. That is, TGFpl-/- animals homozygous for 
NIH derived alleles at this locus tend to survive to 3 weeks of age, whereas TGFp 1 -/- 
embryos homozygous for C57 derived alleles at this locus die pre-natally. Since the 
data used in this study was generated using post-natal TGFpl-/- animals, it was 
decided to investigate the associations between phenotype, genotype and strain- 
specific alleles of the modifier gene at 9.5dpc.
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>260 9.5dpc F2 conceptuses were objectively morphologically scored, TGFpl 
genotyped by PCR and screened for the origin of the modifier gene alleles (C57 and/ 
or NIH) using microsatellite-based PCR primers. If there was no association between 
TGFpi genotype, the modifier genotype and severity of phenotype, there would be no 
deviation from the expected 1 : 2 : 1  ratio of normal embryos when the TGFpl 
genotype ratio and screening data were correlated and analysed using a %2 ‘goodness 
of fit’ statistical test.
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Chapter 2 
MATERIALS AND METHODS.
All solutions used in the preparation and manipulation of nucleic acids were made using 
deionised water purified by a Millipore Milli-Q reagent grade water purification system then 
autoclaved. Glassware and plasticware for use with DNA was washed and autoclaved. 
Gloves were worn at all times. Sterile, disposable microfuge tubes and pipette tips were 
used in all experiments.
All glassware for handling RNA was washed thoroughly, rinsed in Milli-Q water and baked 
for a minimum of four hours at 180°C. Plasticware was submerged in Milli-Q water, 
treated with 0.01% Diethylpyrocarbonate (DEPC) in water for a minimum of 4 hours then 
autoclaved. Solutions for use with RNA were made exclusively for this purpose. They, 
with the exception of organic solvents and Tris based solutions, were Millipore-filtered and 
treated with 0.01% DEPC for a minimum of four hours, then sterilised by autoclaving.
2.1 Mouse Husbandry.
2.1.1 Introduction.
The TGFpl null allele was originally generated on a 129/Sv/Ev background (Kulkami et 
a l,  1993). Previously, the TGFpi knockout mice were bred by this group to produce a 
mixed genetic background (50% NIH/Ola, 37.5% C57BL/6J/01a, 12.5% 129/Sv/Ola) 
(Dickson etal., 1995). For the purposes of this study the TGFpl knockout allele had been 
bred through four generations, i.e. to 93.75% purity onto either inbred NIH/ Ola (NIH), 
inbred C57BL/ 6J/ Ola (C57), or inbred 129/ Sv/ Ola (129) strains. All mice were obtained 
from Harlan Olac Ltd. UK.
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FI mice were generated by reciprocal intercrossing of NIH and C57 mice heterozygous for 
the TGFp 1 knockout allele. F2 mice were generated by intercrossing FI mice heterozygous 
for the TGFp 1 null allele.
2.1.2 Collection o f  Em bryos.
Embryos were harvested from natural timed pregnancies. Noon on the day of the vaginal 
plug was regarded as 0.5dpc. Pregnant females were sacrificed by cervical dislocation. A 
ventral incision in the body wall was made and the uterus dissected out into chilled Embryo 
Transfer Freezing (ET) Medium (Gibco BRL) by either D. Duggan, F. Cousins or S. 
Rusholme. Embryos for scoring, and those used for whole mount in-situ hybridisation, 
were dissected from the uterus and decidua in ET medium using watchmakers forceps and 
assessed using a modified version of Brown and Fabros’ morphological scoring system 
(1981); see Tables 1 and 2. Embryos for genotyping were washed in fresh ET Medium to 
remove any residual maternal tissue. Genotyping was performed by PCR using genomic 
DNA extracted from a whole conceptus or halved embryo. Embryos genotyped by 
radioactive in-situ hybridisation were dissected free of the uterus only.
2.1.3 Collection and Screening of Pups.
Pups were harvested on the day of birth and sacrificed by decapitation by D. Duggan. 
Genotyping was done by PCR using genomic DNA extracted from washed tail tissue.
2.1.4 Screening Adult Animals.
Tail biopsies were performed on anaesthetised 3 week old mice at weaning by D. Duggan 
and F. Cousins. 0.5cm of tail tissue was removed using a hot, sterile scalpel blade. 
Genomic DNA was isolated for the purpose of genotyping by PCR.
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Tables 1 and 2. An Objective Morphological Scoring system for Mid-Gestation 
Conceptuses.
These tables detail a modified version of a morphological scoring system  
devised by Brown and Fabro (1981). It has been expanded specifically in 
the range of 0-41 somites in order to characterise fully and as objectively as 
possible the variation of the precise developmental stage of 9.5dpc  
conceptuses used in this study. Scoring using Table 1 provides ‘score 1% a 
detailed analysis of key features, and therefore should enable the user to 
gauge accurately the precise developmental stage of a conceptus. Table 2 
was devised as a means to objectively and quantitatively assess the range of 
defects commonly occurring in TGFpi knockout mice, and provides ‘score 
2 \  Defects noted not encompassed by Table 2 were also recorded. Prior to 
genotyping, representative conceptuses from each litter were photographed. 
Scores 1 and 2 were used as a tool to compare the relative developmental 
stage and phenotype of all conceptuses studied (see Results).
Table 2.
0 IB 2B 3B
YS VESSELS NORMAL MAIN VESSELS PRESENT BUT NO BRANCHING
INADEQUATE MAIN VESSELS AND/OR PERSISTENT BLOOD ISLANDS
AVASCULAR YOLK SAC
ANAEMIA NORMAL EMBRYO ANAEMIC +/++/+++
YOLK SAC ANAEMIC +/++/+++ EMBRYO AND YOLK SAC TOTALLY ANAEMIC +/++/+++
BLOODLEAKAGE NORMAL FAINT LEAK IN YOLK SAC OR EMBRYO
HAEMORRHAGE LN YOLKSAC OR EMBRYO
HAEMORRHAGE IN YOLK SAC AND EMBRYO
ALLANTOIS NORMAL ALLANTOIS EMPTY, OR CONTAINING CLOTS OR LUMPS
ALLANTOIS ABNORMAL AND /OR CHORION SWOLLEN
FAILURE TO MAKE A CHORIO-ALLANTOIC CONNECTION
NECROSIS NORMAL EMBRYONIC HEART NOT BEATING EMBRYO STARTING TO APPEAR NECROTIC
EMBRYO AND YOLK SACDISINTEGRATING
IMMATURITY NORMAL 0.25 DPC RETARDED 0.5DFC RETARDED 0.75DPC+ RETARDED
HEARTDEFECTS NORMAL
PERICARDIUMSWOLLEN PERICARDIALHAEMORRHAGE
PERICARDIUM SWOLLEN WITH HAEMORRHAGE
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2.2 General DNA and RNA Methods
2.2.1 Ethanol Precipitation of DNA and RNA.
Both DNA and RNA samples were precipitated by the addition of sodium acetate pH5.5 to 
a final concentration of 3mM plus 2 volumes of 100% ethanol for DNA, 3 volumes for 
RNA. Tubes were shaken and left at -20°C for at least 1 hour or incubated on dry ice for 20 
minutes. The nucleic acid was pelleted by centrifugation in a benchtop microfuge for 20 
minutes. The pellet was washed twice in 70% Ethanol and air-dried, then completely 
resuspended in a suitable volume of Tris-EDTA (TE) (lOmM Tris HCL pH 8.0, ImM 
EDTA).
2.2 .2  Agarose Gel E lectrophoresis.
A 0.8-2.0% agarose solution was made up in 1 x TAE buffer (0.04M Tris-acetate, ImM 
EDTA pH 8.0) and dissolved in a microwave; Ethidium Bromide (EtBr) was added to a 
final concentration of 0.5pg/ml. The agarose mixture was poured into a horizontal gel 
mould and allowed to set at room temperature in a fume hood. DNA samples were mixed 
with 10% volume of gel-loading buffer (50% glycerol, 1% bromophenol blue, lOmM 
sodium phosphate pH7.0) and loaded into wells. Gels were run at approximately TVI cm 
inter-electrode distance in TAE buffer containing 0.5|ig/ml EtBr. An appropriate size 
marker (Gibco) was run alongside the PCR samples, the bands were visualised on a UV 
transilluminator and photographed.
2.2.3 Interm ediate M elting Temperature Agarose Gel 
Electrophoresis.
A high-resolution gel was required to distinguish between products from the screening 
PCR for D5MU268.4% Metaphor (Flowgen) intermediate melting point agarose was added 
to an appropriate volume of chilled 1 x TAE buffer whilst the solution was stirred. The 
mixture was tared on a balance then heated at 70% power in a microwave for several 20 
second bursts. The solution was mixed gently between bursts. Once the agarose was 
completely melted and the solution cooled to approximately 60°C, hot distilled water was 
added to return the mixture to its initial weight. 0.5pg/ml EtBr was added and the agarose 
solution poured into a gel casting kit to a depth of 3-5mm. The gel was allowed to set at 
room temperature, then chilled at 4°C for a minimum of 30 minutes.
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Gels were run in 1 x TAE buffer containing 0.5p g/ml EtBr at a 6V/ cm interelectrode 
distance until the loading buffer dye front had travelled at least 60% of the gel.
2.2 .4  Restriction E ndonuclease Digests of Plasmid DNA.
An appropriate amount of DNA, not exceeding 200pg/ml, was incubated with the required 
restriction enzyme(s) (Pharmacia) and OnePhorAll buffer (Pharmacia) at a concentration of 
at least 2 units/p, g DNA according to the manufacturer’s instructions. An aliquot of the 
completed digest was analysed with respect to an uncut sample by agarose gel 
electrophoresis, as previously described, lpg/ml 1Kb ladder was run alongside the samples 
to confirm the band sizes.
2.2.5 Spectrophotometric Q uantitation of DNA.
lp l of DNA solution was placed in a cuvette containing 999pl ddH20 and the absorbance 
measured at a wavelength of 260nm. The machine was first zeroed with a ddH20 blank.
The following were used to calculate the concentration of DNA in the sample: A solution 
containing 50pg/ml of double stranded DNA has an absorbance of 1 at a wavelength of 
260nm. The optical density of a pure preparation of DNA has a E26C/E28O ratio ^ 1.8. 
Oligonucleotide solutions have an absorbance of 1 corresponding to 33p g/ml at 260nm.
2.3 Isolation of DNA.
2.3.1 Transfection of P lasm id into Bacterial Cells.
lOOpl competent DH5a E.Coli cells (Stratagene) were transfected by the addition of 20- 
50ng plasmid DNA in a 1.5 ml Eppendorf tube. The mixture was incubated on ice for 30 
minutes, then heat-shocked for 3 minutes at 42°C. The cells were allowed to recover for 5 
minutes at room temperature before adding 800pl L-broth (1% bactotryptone, 0.5% yeast 
extract (Difco) and 0.5% NaCl in water at pH 7.5) and incubating at 37°C for 45 minutes. 
The cells were then briefly pelleted for 20 seconds in a microfuge, and all but lOOpl of the 
supernatant poured off. The pellet was resuspended in the residual amount of L-broth and 
spread evenly onto L-agar plates (1.5% agar in L-broth) containing 50mg/ml ampicillin 
(Sigma) and allowed to dry. The plates were inverted and incubated at37°C overnight.
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2.3.2 Small Scale Extraction of Plasm id DNA.
A single bacterial colony was picked using sterile technique and used to inoculate 5 ml of L- 
Broth containing 50mg/ml ampicillin. This was cultured overnight at 37°C in an orbital 
shaker at 225 rpm. 1.5 ml of the overnight culture was microcentrifuged for 5 minutes, the 
supernatant discarded and the pellet resuspended in lOOpl of Solution 1 (50mM glucose, 
25mM Tris-HCl, lOmM EDTA pH8.0). 200ml of fresh Solution 2 (0.4M NaOH, 196SDS) 
was added and inverted gently until the mixture cleared. The lysed cells were incubated on 
ice for 5 minutes. The solution was neutralised by the addition of 150ml Solution 3 (3M 
KOAc pH4.8), the tubes mixed gently, and then placed on ice for 30 minutes to precipitate 
the protein. The samples were microcentrifuged for 2-3 minutes before removing and 
retaining the supernatant. An equal volume of isopropanol was added to the solution and the 
tubes vortexed, then centrifuged at 14,000 rpm to precipitate and pellet the DNA. The 
supernatant was removed and the pellet resuspended in 50pl TE plus 50pg/ml RNase A. 
This was incubated at37°C. After 30 minutes an equal volume of Tris-equilibrated phenol 
pH8.0 was added to the sample, mixed thoroughly and centrifuged for 5 minutes in a 
microcentrifuge. The aqueous phase was retained and added to an equal volume of 49 : 1 
chloroform : isoamyl alcohol. This was mixed and microcentrifuged for 5 minutes and the 
aqueous phase removed to a fresh tube and ethanol precipitated as previously described.
The DNA was checked by a diagnostic restriction enzyme digest and its concentration was 
assessed using spectrophotometry.
2.3.3 Large Scale Preparation of Plasmid DNA.
Large scale extraction of plasmid DNA was carried out by a modifed alkali-lysis method as 
described in Sambrook etal., 1989.
The bacteria containing the plasmid of interest was used to inoculate a subculture, i.e. 5ml 
of L-broth containing 50mg/ml ampicillin. This was cultured overnight at 37°C with orbital 
shaking at 225 rpm. The 5ml culture was used to inoculate 500 ml of L-broth in a 2 litre 
flask with 5Qmg/ ml ampicillin. The large scale culture was incubated overnight at 37°C 
with vigorous shaking (225rpm).
Mature bacterial cells were harvested by centrifugation (3,000 rpm, 10 minutes at 4°C) in a 
Sorvall RC-5B centrifuge with a GS-3 rotor. The supernatant was discarded and the pellet 
resuspended gently in Solution 1 (2ml/50ml culture) containing lOmg/ml freshly added
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lysozyme (Sigma). The cell suspension was vortexed and incubated on ice for 5 minutes. 
Fresh Solution 2 was added (4ml/50ml culture) and inverted gently until the mixture 
cleared. The lysed cells were incubated on ice for 5 minutes. The solution was neutralised 
by the addition of Solution 3 (6ml/50ml culture) and the mixture inverted gently until a 
heavy white precipitate was formed, then incubated on ice for 30 minutes. This was 
centrifuged at 3,000 rpm for 10 minutes at 4°C to pellet the precipitated bacterial 
chromosomal DNA and protein. The supernatant was filtered through sterile gauze into a 
fresh 50ml screw-capped Sorvall polypropylene tube and the plasmid DNA was precipitated 
by the addition of 0.6 volumes of isopropanol. The sample was mixed thoroughly and the 
DNA was pelleted by centrifugation (Sorvall RC-5B centrifuge in a GSA rotor) at 10,000 
rpm for 10 minutes at room temperature. The supernatant was discarded and the DNA 
resuspended in 10 ml 1 x TE; 50pg/ml RNAse A was added and the samples incubated at 
37°C for 30 minutes. The DNA was phenol-chloroform, then chloroform extracted and 
preciptated with ethanol, as previously described.
The pellet was resuspended in 500pl 1 x TE and the concentration determined by 
spectrophotometry. Diagnostic restriction digests were used to confirm the identity of the 
plasmid and insert.
2.3.4 E xtraction  of Genomic DNA from Tail Biopsies.
Tail tissue was placed in 200pl Tail Lysis Buffer (lOOmM Tris-HCl pH8.5, 0.2% SDS, 
5mM EDTA, 200mM NaCl) with 100p,g/ml proteinase K (Sigma) and incubated at 55°C 
until the tissue was fully digested. Tubes were shaken and centrifuged for 10 minutes in a 
bench-top microcentrifuge to pellet the tail debris. The cell lysate was poured off into 1 
volume of isopropanol, inverted and allowed to stand at room temperature for 15 minutes. 
Precipitated DNA was picked up using a clean pippette tip and placed in a fresh tube. The 
DNA was air dried and completely resuspended in 50pl of TE (lOmM Tris pH8.0, ImM 
EDTA).
The DNA solution was heated to 94°C for 10 minutes then chilled on ice and stored at 4°C 
before genotyping by PCR.
2.3.5 Extraction of Genomic DNA from Conceptuses.
Conceptus tissue was placed in 200pl Tail Lysis Buffer with lOOpg/ml proteinase K and 
incubated at 55°C until the tissue was fully digested. Tubes were shaken and an equal
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volume of phenol (Sigma) was added and mixed. This was microcentifuged in a bench-top 
centrifuge for 10 minutes whereupon the upper phase was removed to a fresh tube and an 
equal volume of 49: 1 chloroform : isoamyl alcohol added and the mixture vortexed for 10 
seconds. This was centrifuged for 5 minutes prior to the transfer of the upper phase to a 
fresh tube. The DNA was ethanol precipitated.
Genomic DNA from tails, pups and embryos was resuspended in 50pl sterile TE.
2.4 Genotyping and Screening by PCR.
2.4.1 Genotyping by PCR.
The genotype of embyos, pups and adult mice was determined by PCR analysis. All DNA 
used for PCR had previously been heated to 94°C for 10 minutes then chilled on ice and 
stored at 4°C before genotyping and/or screening.
3 pairs of primers were used simultaneously: Nested primers; 95, 96, 97 and 98 
complementary to the first exon and the first intron of the TGFpi genomic sequence 
amplified the wild-type TGFpl allele; and 2 oligonucleotide primers; TGF 0 and PGK-1 
complementary to the deleted portion of the first exon of the TGFpl and the Neomycin 
cassette amplified the null TGFpl allele (see Table 3 and Figure 6). Oligonucleotide primers 
were manufactured on an Applied Biosystems 391 DNA Synthesizer by E.O’Hare.
150-200pg of DNA and 1 unit Tfl (taq) polymerase (Cambio) were added to 25fxl of 
premix containing 1 x PCR buffer (Cambio), 1.5mM MgCl2 (Cambio) and 5mM dNTPs 
(Boehringer Mannheim). A layer of mineral oil (Sigma) was placed over the top of the 
reaction to prevent evaporation. PCR was carried out on a Perkin Elmer Cetus DNA 
Thermocycler. The protocol used consisted of cycles of the following sequential steps: 
Denaturation (95°C for 1 minute), annealing (61°C for 1.5 minutes), elongation (72°C 
for 2 minutes). An additional elongation step (72°C for 15 minutes) was implemented after 
completion of 28-33 cycles. 15pl of each PCR reaction was analysed by agarose gel 
electrophoresis on a 1.5% gel.
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Figure 6 - G enotype A nalysis o f TG Fpl K nockout Anim als by PCR.
DNA extracted from TGFp 1 knockout embryos or tails was genotyped by PCR. Lanes 1, 
2 and 3 each represent a separate PCR reaction. The premix used for TGFP 1 genotyping 
contained 6 primers; a nested set of 4 to amplify the TGFp 1 wild type allele (625bp), and 
a pair of primers to amplify the null allele (375bp). Thus, in the above panel, lane 1 is a 
sample from a T G Fpl-/-, lane 2 from a TGFp 1+/- and lane 3 from a T G Fpl+ /+  animal. 
In all genotyping PCR reactions a negative (no DNA) and positive (non-transgenic DNA) 
control was assessed alongside the experimental PCR reactions.
L = 1 kb ladder. 
X = 50 bp ladder
95 5’-GAG AGT AAG CCC ACT AGA G-3’
96 5’-CGT GCG CCT GTC GCT TTC TG-3’
97 5 ’-GCG GAC TAC TAT GCT AAA G-3’
98 5’-GGT CAC CCG CGT GCT AAT GG-3’
TGF 0 5 ’-AGG GAG CTG GTG AAA CGG AA-3’
PGK-1 5’-TCC ATC TGC ACG AGA CTA GT-3’
Table 3. Oligonucleotides for Genotyping TGFpi Transgenic Mice by PCR.
In order to genotype TGFpl+/+, +/- and -/- animals by PCR, genomic DNA 
from whole conceptuses, half-embryos or tail biopsies was isolated and 
diagnostic fragments were amplified using a premix containing the above 
primers as detailed in Materials and Methods. Primers 95, 96, 97 and 98 
comprise a nested set which amplify the wild type TGFpi allele (625bp). 
TGF 0 and PGK-1 amplify the null allele (375bp) (see Figure 6).
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2.4.2 Screening for D5MU268 Alleles by PCR.
Genomic DNA from scored F2 embryos was analysed by PCR for the presence of either a 
C57 and/or NIH polymorphic allele using microsatellite D5Mit268 primers (obtained from 
Research Genetics or synthesised in-house on an Applied Biosystems 391 DNA synthesiser 
by E. O’Hare). The PCR protocol used consisted of 33 cycles of the following sequential 
steps: Denaturation (95°C for I minute), annealing (55°C for 1.5 minutes), elongation 
(72°C for 1 minute). An additional elongation step (72°C for 15 minutes) was implemented 
after completion of 33 cycles. 5p,l of the PCR reaction was analysed by electrophoresis. 
However, since the size differential between the NIH and C57 polymorphisms was only 20 
nucleotides the PCR results were analysed on a 4% Metaphor intermediate melting 
temperature gel (see Figure 7).
2.5 Histochemistry.
2.5.1 Preparation of TESPA Coated Slides.
Sterile microscope slides for use in tissue sectioning were immersed for 30 seconds in 70% 
Ethanol, 10% HC1 followed by sterile Milli-Q water, then 95% Ethanol. The slides were 
then baked at 150°C for at least 2 hours and allowed to cool before being dipped in a fresh 
2% TESPA (3-aminopropyltriethoxysilane) (Sigma)/acetone solution, followed by four 
washes in 100% acetone and two washes in sterile Milli-Q water. The slides were dried at 
42°C overnight and stored in dust-free boxes before use.
2.5.2 Preparation o f  Tissue for Embedding.
Conceptuses were dissected free of the uterus and fixed in ice-cold, fresh, filtered 4% 
paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 6-20 hours. Fixation was 
carried out at 4°C with continuous rotation. Tissue was washed at 4°C in cold PBS (1 
tablet/100 ml (Unipath) for 30 minutes, 0.85% saline for 30 minutes, 70% ethanol : 0.85% 
saline for 15 minutes, 100% ethanol: 0.85% saline twice for 15 minutes then 70% ethanol 
twice for 15 minutes. The tissue could be stored at this stage for an indefinite period. The 
conceptuses were processed through a Shandon Citadel automatic processor on a 24 hour 
cycle. This cycle comprised 100% ethanol, five washes in methanol, 100% ethanol, 50% 
ethanol: 50% chloroform, two washes in chloroform, one in xylene and finally two washes 
in paraffin wax. The embryos were embedded in paraffin wax in a known orientation and 
stored at 4°C.
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Figure 7 - Screening F2 T G Fpl K nockout M ice for NIH and C 57-D erived  
A lleles at D5M U268.
DNA extracted from TGFp 1+/- and -/- embryos at 9.5dpc was screened for the presence 
of polymorphic NIH (150bp) and/ or C57 (125bp) -derived alleles at the chromosomal 
locus D5Mit268 by PCR. Due to the small size differential, the PCR products were 
analysed on a 4% intermediate melting point agarose gel. Lane 1 shows the PCR result 
from a homozygous C57 (CC) embryo; lane 2 shows the PCR result from a heterozygous 
NIH/ C57 (NC) embryo and lane 3 shows the PCR result from a homozygous NIH (NN) 
embryo. In all screening PCR reactions a negative (no DNA) and positive (pure-bred C57 
and NIH non-transgenic DNA) control was assessed alongside the experimental PCR 
reactions.
L = 1 kb ladder. 
X = 50 bp ladder
2.5,3 Cutting Tissue Sections.
All tissue embedded in paraffin wax was placed in a microtome and 6pm serial sections cut. 
These were transferred as intact strips onto a clean microscope slide and floated on a 30% 
ethanol solution. Once the strip had fully extended it was carefully transferred to a water 
bath containing fresh Milli-Q water at 42°C. Sections were picked up using a clean non- 
TESPA coated microscope slide and checked using a stereo microscope. Suitable sections 
were re-floated and picked up with TESPA coated microscope slides and left to dry on a 
42°C hot plate for at least four hours. Slides were stored at 4°C with dessicant in dust-free 
boxes.
2.5.4 Haematoxylin and Eosin Staining.
Slides were dewaxed twice in HistoclearTM for 5 minutes then rehydrated in two, x 2 
minute washes of 100% ethanol, followed by 2 minute immersions in an ethanol series 
comprising 90%, 80%, 70%, 50% and 30% ethanol in Milli-Q water. Sections were stained 
in filtered Harris’ haematoxylin (Gurr) for 30 seconds, rinsed in running tap water for 1 
minute. The stain was fixed in Scott’s Tap water (20g MgSO^ 20g NaHCC>3/ litre of water) 
and the slides rinsed in running water for 1 minute. Sections were stained in filtered eosin 
(5g yellowish eosin (Gurr), 50 ml saturated acetic picric acid, 400 ml water, 2.5g potassium 
dichromate, 50 ml 100% ethanol added in this order for a 500 ml stock solution; the stock 
was diluted 1 in 4.5 with water for a working concentration) for 30 seconds, then rinsed 
briefly in running water. The slides were immediately rehydrated and prepared for mounting 
as described in Materials and Methods 2.5.6).
2.5.5 May-Grunwald Geimsa Staining.
9.5dpc conceptuses were dissected free of maternal tissue using sterile watchmakers forceps 
and morphologically scored. The yolk sac was carefully tom and half the embryo removed 
for genotyping. The remains of the conceptus was used to generate blood smears, by gently 
daubing the open yolk sac and cut embryo onto a clean TESPA slide. The blood smears 
were quickly dried onto the slides using a fan, then fixed in methanol for 5 minutes. The 
slides were immersed in filtered May-Grunwald stain (BDH) (freshly diluted to 50% with 
buffered distilled water) for 6 minutes then transferred into Geimsa stain (BDH) (freshly 
diluted to 7.5% with buffered distilled water) for 8 minutes. This step was repeated and the 
slides washed rapidly in buffered distilled water (pH6.8) three times. The slides were then
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allowed to stand in buffered distilled water for 1 minute to allow differentiation to take 
place. Slides were dried rapidly using a fan.
2.5 .6  Preparation and M ounting of Slides.
After staining, the sections were dehydrated through an ethanol series in Milli-Q water 
(30%, 50%, 70%, 90%, 100%, 100%, 2 minutes each) then incubated in two baths of 
Histoclear™, 5 minutes each. Coverslips were attached in a fumehood using DPX 
mountant (Gurr). The mounted slides were left to dry overnight.
2.6 Immunohistochemistry
2 .6 .1  a  Smooth-M uscle Actin Antibody Staining.
Tissue was sectioned and mounted onto TESPA-coated slides as described in Materials and 
Methods 2.5. The sections were dewaxed by immersion in Histoclear™ twice for 10 
minutes, then rehydrated in a descending series of washes; firstly 100% Ethanol twice for 5 
minutes, then 2 minutes each in 90, 80 and 70% ethanol in Milli-Q water. Endogenous 
peroxidase activity was inhibited by a 15 minute immersion in methanol containing 4% 
H2Q2, then the slides were washed three times in PBS. All washes were 5 minutes long 
unless otherwise stated. Non-specific binding of the antibody to the section was prevented 
by blocking the tissue for 30 minutes with 0.1% gelatin, 0.1% BSA (bovine serum 
albumin) (both Sigma) plus 2.5% sheep serum, 2.5% mouse serum (both Seralab) in PBS. 
Meanwhile, the primary (mouse anti-human a  smooth-muscle actin monoclonal antibody) 
(Sigma A2547) and secondary (sheep anti-mouse) (Amersham RPN1001) antibodies were 
pre-blocked together at a ratio of 1 : 3 in 400ml PBS containing 0.1% mouse serum. This 
process took place at room-temperature with rotation for 90 minutes.
The pre-blocked antibody complex was applied to the tissue sections and incubated for 60- 
90 minutes at room-temperature in a moist chamber. The slides were washed three times in 
PBS and a presorbed avidin-biotin complex (Dako, ABC kit) was applied to the tissue. 
After a 30 minute incubation period, the slides were washed twice in PBS and incubated for 
10 minutes in a solution of 3-3’ Diaminobenzidene (DAB) (Sigma) (1 tablet dissolved per 
15ml PBS, filtered and activated by the addition of 15ml H2Q2 imediately prior to use). 
Finally, the slides were washed briefly in PBS, then running water for 10 minutes. The 
tissue is counter-stained lightly with haematoxylin for visualisation, and the slides are 
dehydrated and mounted (see Materials and Methods 2.5).
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2.7. In Situ Hybridisation.
Table 4. Antisense Probes.
Mouse cDNA Plasmid Linearised by: RNA
polymerase
Probe length
t, globin 
(Dickson et a l , 
1995)
pGEM3 Eco RI Sp6 360bp
full-length
TGFpi
(Dcrynck et al., 
1986)
Blucscribc+ Hind III Sp6 l,254bp
Table 5. Sense Probes.
Mouse cDNA Plasmid Linearised by: RNA
polymerase
Probe length
£ globin 
(Dickson et al., 
1995)
pGEM3 Bam HI T7 360bp
full-length 
TGFP2 
(Millan etal., 
1991)
Blucscribc+ Hind III T7 l,245bp
Tables 4 and 5. A Summary of Templates and Probes used for Whole-mount and 
Radioactive In Situ Hybridisation During this Project.
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2.7.1 Radioactive In Situ Hybridisation.
2.7.1.1 Radioactive R iboprobe Synthesis.
In order to generate a 35S-labelled riboprobe, the plasmid containing the insert of choice 
was linearised using appropriate restriction enzymes with respect to the T7, T3 and/or SP6 
promoters (see Tables 4 and 5), ethanol precipitated and resuspended in clean 1 x TE at a 
known concentration, lp g  DNA template in lp l TE was incubated at 37°C for 1.5-3 hours 
with the appropriate polymerase and reaction buffer (0.04M Tris-HCl pH 8.0, 8mM 
MgG2, 1 mM spermidine, 0.025M NaCl) (Gibco BRL) and O.lmM DTT, ImM ATP, 
CTP and GTP, 7.5mM UTP-S, 0.3mg/ml BSA (RNase and DNase free) (all Pharmacia) 
and 75pCi S^U TP (Amersham) (dried into a RNase-free 1.5 ml eppendorf tube), 30 units 
RNAguard^M (Pharmacia) in a total volume of 20|xl with DEPC water. The reaction was 
terminated by incubation with 0.15 units DNasel in lxDNase buffer (0.1M NaOAc pH 
5 .0 ,5mM MgC12, lOmM DTT (added fresh), 50 units R N A g u ard ^M  anci 0.05mg polyA. 
The reaction mix was separated through a G50 sephadex nick-column (Pharmacia). The 
column was firstly equilibrated with 3 ml column buffer (03M  NaOAc pH5.0, lOmM Tris- 
HCl pH 7.5, 1 mM EDTA pH 8.0. 0.1% SDS, 10 mM DTT (added fresh). The probe 
mixture was eluted through the column with 2 volumes column buffer and the final fraction 
retained. An equal volume of phenol pH 5.0 was added, mixed and microcentrifuged for 
10 minutes. The aqueous phase was retained and extracted with an equal volume of 
chloroform: isoamyl alcohol (49 : 1). Three volumes of ethanol were added to precipitate 
the riboprobe. The RNA was pelleted by microcentrifugation for 15 minutes and the pellet 
washed t\yice in 70% ethanol in DEPC water. The riboprobe was resuspended in 100ml 
alkali digestion buffer (40 mM NaHC03 pH 10.2, 60mM Na2C03, lOmM DTT (added 
fresh)) and alkali-digested for a predetermined time at 60°C.
The length of alkali-digestion is governed by the following equation (Cox et al., 1984): 
Incubation time (minutes) = (Lo - Li) / (0.11 x Lo x Li)
where Lo = Original length of riboprobe (Kb) 
and Li = Required length of riboprobe (Kb)
The alkali digested probe was quenched on ice and 10pl 0.1M NaOAc pH 6.0, 0.05mg 
PolyA added before the sample was separated using a G50 sephadex nick column
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(Pharmacia) as before. The eluted sample was extracted as before with phenol pH 5.0 and 
49 : 1 chloroform : isoamyl alcohol before ethanol precipitation.
The pellet was resuspended in an appropriate volume of 50mM DTT calculated so that a 1 in 
10 final dilution would result in a solution at 3 x 10^ cpm/ p,l . The 10 x stock solution of 
riboprobe was stored at -20°C for up to 14 days before use.
2.7 .1 .2  Pretreatm ent o f  Tissue Sections.
All pre and post-hybridiastion washes were performed using 250 ml glass troughs 
(Solmedia). Slides were held in a glass microscope slide carrier. All washes took place at 
room temperature unless otherwise stated.
Slides were dewaxed twice in Histoclear™ for 10 minutes then rehydrated in three, 2 
minute washes of 100% ethanol, followed by 2 minute immersions in an ethanol series 
comprising 90%, 80%, 70%, 50% then 30% ethanol in Milli-Q water. The slides were 
equilibrated in 0.85% saline for 5 minutes and then immersed in PBS for 5 minutes. The 
tissue was refixed in fresh 4% PFA/ PBS for 20 minutes then washed twice in PBS for 5 
minutes. The sections were incubated with 40pg/ml proteinase K in PKB (50 mM Tris-HCl 
pH 7.5, 5mM EDTA pH 8.0) for 7.5 minutes then washed for 3 minutes in PBS. This was 
followed by further fixation in 4% PFA/ PBS for 5 minutes. The tissue was acetylated in 
0.1M triethanolamine with freshly added 0.2% acetic anhydride for 10 minutes then washed 
for 5 minutes in PBS followed by 0.85% NaCl. The sections were dehydrated by 2 minute 
washes in an ascending ethanol in Milli-Q water series ( 30%, 50%, 70%, 80%, 90% then 
100%). The slides were left to air dry under cover at room temperature.
2.7 .1 .3  H ybridisation of Probe to Tissue Sections.
The riboprobe was applied to selected tissue sections at a 1 in 10 dilution (3 x 104 cpm/ p,l) 
in a freshly made hybridisation mix comprising 0.3M NaCl, lOmM Tris-HCl pH 8.0, 5mM 
EDTA, lOmM NaP04 pH 6 .8 , 10% dextran sulphate, 1 x Denhardts, 0.5 mg/ml tRNA, 
0.5 mg/ml PolyA, 50 mM DTT. The hybridisation mixture and probe were mixed and 
heated to 80°C for 3 minutes and quenched on ice. 3-7pl of the riboprobe mixture was 
carefully pipetted onto individual tissue sections then covered with a coverslip. Coverslips 
were cut using a diamond pen in order to fit individual tissue sections. They were placed
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carefully onto the sections to prevent air bubble formation and to protect the tissue. The 
slides were placed in a humid chamber containing a tissue soaked in 4  x SSC, 50% 
formamide and sealed with tape for hybridisation overnight at 55°C.
2.7.1.4 Post Hybridisation W ashes.
Slides were transferred quickly to a glass slide holder, then washed sequentially in the 
following: 5 x SSC, 0.1% 2-mercaptoethanol for 15 minutes at 50°C; 2 x SSC, 50% 
formamide, 1% 2-mercaptoethanol for 20 minutes at 65°C; four, 10 minute washes at 37°C 
in RNase buffer (lOmM Tris-HCl pH 8.0, 5mM EDTA, 0.5M NaCl) followed by a 30 
minute incubation in RNase buffer plus 20pg/ml RNase A at 37°C then a 15 minute wash 
in RNase buffer; followed by 2 x SSC, 50% formamide, 1% 2-mercaptoethanol at 65°C 
for 20 minutes; 2 x SSC at 50°C for 15 minutes; then 0.1 x SSC at 50°C for 15 minutes. 
The sections were dehydrated in an ethanol series in Milli-Q water (50%, 70%, 90%, 
100%) for 2 minutes each. The slides were allowed to dry in a dust-free environment then 
dipped for 10 seconds in a 0 .1% gelatin, 0.01% chrome alum solution and allowed to dry 
before emulsion (Ilford) was applied.
2.7.1.5  Autoradiography.
All autoradiograpic procedures were carried out in darkroom conditions illuminated with 
Kodak 904 filtered light. Slides were dipped in a 45°C, 50% solution of Ilford K5 
emulsion/ 1% glycerol. The emulsion was allowed to dry for 1.5-2 hours in a light-tight 
environment. Dry slides were stored in light-tight boxes with dessicant at 4°C prior to 
developing. The period of storage (7-14 days) was governed by the expression levels of the 
mRNA under investigation.
After the sections had been exposed for an appropriate period of time they were developed 
at room temperature by agitation in 20% Phenisol (Ilford) for 3 minutes, followed by 30 
seconds in 1% acetic acid, then 30 seconds in Milli-Q water and fixed in a fresh 30% 
solution of sodium thiosulphate for 5 minutes. The developed slides were washed in cold 
running water for a minimun of 1 hour before staining.
2.7.1.6 Staining Radioactive In Situ Slides.
Slides were stained in filtered Harris’ haematoxylin (Gurr) for 30 seconds, rinsed in 
running tap water for 1 minute. The stain was fixed in Scott’s Tap water (20g MgSC>4, 20g
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NaHCQy litre of water) and the slides rinsed in runnng water for 1 minute. The slides were 
then prepared for mounting, see Materials and Methods 2.6.6.
2.7.2 Whole-Mount In Situ Hybridisation.
2.7.2.1 Preparation of Em bryo Pow der.
14.5dpc embryos were dissected free of maternal and extraembryonic tissue and rinsed in 
clean PBS. Using sterile forceps the embryos were cut into several pieces and transferred to 
an autoclaved homogeniser. The tissue was homogenised, and 4 volumes of ice-cold 
acetone were added. The homogenate was mixed and left on ice for 30 minutes. The 
mixture was aliquoted into 1.5 ml eppendorf tubes and microcentrifuged for 10 minutes at 
room temperature. The supernatant was removed, the pellet washed in ice-cold acetone and 
centrifuged again to re-pellet the tissue. The liquid was completely removed by careful 
pipetting, and the pellet lifted out onto a disc of filter paper. The pellet was then spread 
between 2 filter discs and allowed to dry at room temperature overnight. The dried flakes 
were ground to a fine powder with a sterile pestle and mortar.
The embryo powder could be stored at 4°C indefinitely.
2.7.2.2 Preparation of D IG -Labelled Riboprobe.
A template of the probe of interest was prepared by linearisation of the appropriate plasmid, 
using a suitable restriction enzyme (see Tables 4  and 5) and incubated, as follows with the 
appropriate RNA polymerase in the following synthesis mixture: 13p,l sterile distilled 
water, 2[xl 10 x transcription buffer (0.04M Tris-HCl pH 8.0, 8mM MgCl2, 1 mM 
spermidine, 0.025M NaCl) (Gibco BRL), 0.2mM DTT (Gibco BRL), ImM ATP, ImM 
CTP, ImM GTP, 0.65mM UTP, 0.35mM digoxigenin-UTP, pH8.0 (Boehringer 
Mannheim), l[xl linearised plasmid DNA at a concentration of lp,g/p,l, 50 units 
RNAguardTM (Pharmacia) and 10 units T7 or SP6 RNA polymerase (Boehringer 
Mannheim) were added sequentially to an RNAse-free 1.5ml eppendorf and carefully 
mixed. The synthesis mixture was microcentrifuged for 10 seconds and incubated at 37°C 
for 2 hours, whereupon a lp.1 aliquot was removed and run on a 1% agarose gel containing 
0.5p,g/ml EtBr. If an appropriately sized, discrete RNA probe band at approximately 10 
times the intensity of the residual template band was clearly visible then the protocol was 
continued. This indicated that approximately 10p,g RNA probe had been synthesised.
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The RNA was precipitated by the addition of lOOpl 1 x TE, lOpl 3M NaOAc and 300pl 
ethanol. The tube was inverted gently 10 times and incubated at -20°C for 30-60 minutes. 
The RNA was pelleted by centrifugation in a bench-top microfuge at 4°C for 10 minutes. 
The pellet was washed twice in 70% ethanol/ sterile water then air-dried for a minimum time 
in a fume hood.
The probe was resuspended in sterile 1 x TE at approximately O.lpg/ml and stored at 
-20°C. If an unduly long period elapsed between probe synthesis and use, the integrity of 
the probe was reassessed by agarose gel electrophoresis.
2.7.2.3 Preparation and Prehybridisation of Tissue.
Embryos for use in whole-mount in-situ hybridisation were dissected free from the maternal 
tissue using sterile watchmakers forceps. The conceptuses were washed in chilled ET 
medium and fixed overnight at 4°C by rotation in fresh 4% PFA.
All washes were undertaken with constant rotation in sterile 5 ml bijous (Sterilin) at room- 
temperature unless otherwise stated. Washes were removed using sterile pasteur pipettes.
Post-fixation the embryos were dehydrated by washing twice in PTW (PBS, 0.1% Tween- 
20) at 4°C followed by 5 minutes each in 1 : 3, 1 : 1 and then 3 : 1 methanol/ PTW, then 
twice with 100% methanol. They were rehydrated by being taken through this series in 
reverse and then washed three times in PTW. In order to increase the accessability of the 
target RNA, the tissue was treated with lOpg/ml proteinase K in PTW for 10 minutes. The 
embryos were not rocked during this stage to prevent tissue damage. They were then 
washed in a 2mg/ml freshly prepared glycine (Sigma) solution in PTW and refixed using 
fresh 0.2% glutaraldehyde (Sigma)/4% PFA in PTW for 20 minutes. The embryos were 
then washed twice for 5 minutes with PTW. The PTW was replaced with two washes of 1 
ml prehybridisation mix (50% formamide, 5 x SSC pH5.0, 50pg/ml yeast RNA, 1%SDS, 
50pg/ml heparin (both Sigma)) with the second wash containing the riboprobe at lp,g/ ml. 
The embryos were incubated thus at 60°C for 3-16 hours.
Post-hybridisation embryos were stored at -20°C indefinitely.
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2.7 .2 .4  Post Hybridisation W ashes.
Post-hybridisation, the embryos were washed in the following to remove unbound probe: 
Twice in solution 1 (50% formamide, 5 x SSC pH5.0, 1% SDS) for 30 minutes at 60°C, 
twice in 1: 1 solution 1 : solution 2 (0.5M NaCl, lOmM Tris-HCl pH 7.5, 0.1% Tween- 
20) for 10 minutes at 60°C, three times in solution 2 for 5 minutes at 37°C and twice in 
20pl/ml ribonuclease A in solution 2 for 30 minutes at 37°C. Then the embryos were 
washed with solution 2, then solution 3 (50% formamide, 2 x SSC pH5.0) at room- 
temperature for 5 minutes, followed by 2 washes of solution 3 for 30 minutes at 65°C. 
Finally the embryos were washed 3 times for 5 minutes in TBST (0.14M NaCl, 2.7mM 
KC1, 25mM Tris-HCl pH 7.5,0.1% Tween-20).
2.7 .2 .5  Im m unocytochem ical D etection  of Probe.
The embryos were preblocked in 10% heat-inactivated sheep serum in TBST for 60-90 
minutes. During this period, the antibody was presorbed as follows: 3mg of embryo 
powder, 0.5ml TBST, 5p,l sheep serum and lp,l anti-digoxigenin antibody coupled to 
alkaline phosphatase (Boehringer Mannheim) were placed in a clean 1.5 ml Eppendorf tube 
and rotated at 4°C for 60 minutes. The antibody mixture was microcentrifuged for 1 minute 
and the supernatant recovered. The supernatant was diluted to 2 ml with 1% sheep serum in 
TBST and used to replace the 10% serum preblocking the embryos. This was rocked 
overnight at 4°C.
The following day the embryos were washed three times for 5 minutes, then five times for 
1 hour in TBST. This was followed by three, 10 minute washes in fresh NTMT (lOOmM 
NaCl, lOOmM Tris-HCl pH 9.5, 50mM MgCl2> 0.1% Tween-20). In order to detect the 
signal the embryos were incubated in a light-tight box with NTMT contaning freshly-added 
4.5|xl NBT (Nitro Blue Tetrazolium salt) and 3.5p,l BCIP (5-bromo-4-chloro-3-indoyl 
phosphate) (both Boehringer Mannheim) per ml of NTMT. The embryos were rocked for 
the first 20 minutes.
When the colour had developed to the desired extent, the embryos were washed twice in 
fresh NTMT then stored for a short time in the dark in PTW until the conceptuses had been 
photographed. If necessary, the level of background could be reduced by washing the 
embryos in methanol for 10 minutes, isopropanol for 15 minutes then Histoclear™ for 15 
minutes. Embryos were placed in a 70% glycerol/ PBT solution for photography. They 
were not fixed as this was found to reduce the sensitivity of the TGFp 1 genotyping PCR.
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2.8. Statistical Methods
2.8.1 Null H ypothesis.
In a project where data will be analysed statistically, it is important to define a null 
hypothesis. A null hypothesis allows groups of data to be compared; under the assumption 
that they are from the same population, and therefore do not differ. Having assumed this, 
the correct conclusions can be drawn from any statistical analyses undertaken. In this study, 
the genotypic ratios of offspring from TGFf51+/- intercrosses and reciprocal crosses 
between TGFpl+/+ and TGFpl+/- animals were ascertained by PCR of genomic DNA. 
Since each TGFfU allele is expected to assort independently, a Chi-squared (%2) ‘goodness 
of fit’ statistical test was used to determine whether the observed data differed significantly 
from the expected data (provided the smallest expected data class was not ^ 5).
The null hypothesis used in this case assumed that there were no factors affecting the 
observed ratios of offspring. Using Mendelian principles, a ratio of 1 : 2 : 1 TGFP1+/+ : 
T G Fpl+/-: TGFpl-/- is expected in animals generated by TGFpl+/- intercrosses. A 1 : 1 
TGFpi+/+ : TGFpi+/- ratio is expected in animals generated by reciprocal TGFpl+/- x 
TGFpl+/+ crosses. Deviations from these expected ratios implies that another factor is 
contributing to the result, and would therefore lead to the rejection of the null hypothesis 
and the formulation of an alternative hypothesis. This is the process used throughout this 
project.
All of the conceptuses examined in this study were scored using an objective scoring 
system. Using a null hypothesis, statistical analysis of this data was executed under the 
assumption that no factors were contributing to the observed ratios. Thus, it was expected 
that any observed defects should be random and segregate evenly throughout all members 
of a litter regardless of genotypic class.
2.8.2 The Chi-Squared (x ^ G o o d n e s s  of Fit* Statistical Test.
In order to assess whether an observed set of data represents a chance deviation from the 
values predicted by a null hypothesis, the results can be evaluated using a y }  test.
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Where:-
)(2 = 2  (observed - expected')2 
expected
The y l  value is inversely related to the goodness-of -fit between the experimental results 
and the null hypothesis under test. By placing the y l  value in context with the appropriate 
degrees of freedom (dof) for the calculation (dof = number of classes of data analysed - 1); 
probability (p) can be calculated, p is the probability that the observed set of data could have 
occured by chance. In this project p values of ^ 0.05 were taken as significant. This implied 
that there was a 5% or less chance that the observed results were the same as the expected 
results.
y l  cannot be applied to small data sets i.e. those with an expected outcome > 5 in any 
individual class.
2.8.3 Student’s t Test.
Throughout this project the Student’s t test was used to test whether or not two samples of 
data come from the same, or different populations when both samples contained less than 
thirty pieces of data. The Students’s t test compares the standard error of the difference of 
the means between the samples in terms of the t distribution. The t distribution is 
symmetrical about a mean of zero, and varies according to the size of a sample i.e. the 
smaller the sample, the greater the difference required by the t test for a significant result.
Where:-
s = S ,jx -m ea n ,)2 +J^jX^ffiean2l 2 
nj + n2 -2
t = mean, - meam
S V l ± l
ni n2
x is any piece of data from a sample, n = the number of pieces of data in a sample, s is the 
standard deviation here shown calculated for a two-sample t test, where the samples contain 
an unequal number of members.
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The found t value is used to find the probability (p) value of the two samples tested coming 
from the same population. In this project p-values of ^0.05 were taken as significant.The 
number of degrees of freedom is calculated as follows:
Degrees of freedom = ^  + n2 -2
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Chapter 3 
RESULTS. 
INTRODUCTION.
The pre- and post-natal phenotypic effects of the TGFpl null allele have been 
characterised by several groups on a number of ill-defined genetic backgrounds (Shull et 
al., 1992, Kulkami et al., 1993 & Dickson et al., 1995) (see Introduction!. For the 
purposes of this project, the TGFpl null allele was bred to 93.75% purity on inbred 
NIH/ Ola (NIH), inbred C57B17 6J/ Ola (C57) and inbredl29/ Sv/ Ola (129) genetic 
backgrounds by F. Cousins. Therefore, the aim of this project was to investigate the 
onset and penetrance of the pre- and post-natal phenotypes of TGFpl knockout mice in 
each of these strains.
Defined intercrosses were also used in this study: FI mice were produced by 
intercrossing C57 and NIH mice; F2 mice were produced by intercrossing FI mice (see 
Materials and Methods).
3.1 Survival of TGF|31+/- and -/- Mice to Weaning 
on Different Genetic Backgrounds.
3.1.1 T G Fpl Heterozygous Intercrosses.
The original characterisation of the TGFpi knockout phenotype identified the cause of 
post-natal death of 50% TGFpi-/- mice to be a multi-focal inflammatory disorder 
occurring at roughly 3-4 weeks of age (Shull eta l., 1992 & Kulkami et al., 1993). 
TGFpi-/- mice appeared to be healthy until approximately 12-14 days of age 
whereupon they develop a progressive wasting syndrome. Thereafter they became 
distinguishable from their littermates due to their significant lack of body weight and
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typically hunched posture (Kulkarni et al., 1993). These observations were replicated 
by Dickson et al, (1995) using a mixed genetic background.
Genotype data accrued by the PCR of tail genomic DNA (see Figure 6) of mice at 
weaning (approximately 3 weeks of age), from TGF(3l+/- intercrosses on NIH, C57 
and 129 backgrounds was compared to the expected 1 : 2 : 1  TGFpl +/+ : +/- : -/- 
ratio of genotypes using %2. As predicted, the results show a loss of T G Fpl-/- 
animals on each background (see Graph 1; Tables 6 and 7). In each case the observed 
ratio of genotypes differs significantly from the expected 1 : 2 :1  ratio.
There is a range in the number of surviving TGFpl-/- animals on each background, 
with the NIH homozygous null mice appearing to have a greater ability to survive to 
weaning relative to 129 and C57 strains. No C57 -/- animals were observed to survive 
to weaning. All of the surviving null pups were noted by F. Cousins/ D. Duggan as 
having a severely runted appearance, as did a number of TGFpi+/- offspring on each 
genetic background. In this experiment, animals classified as runts were those 
expected by F. Cousins/ D. Duggan to die imminently.
A %2 analysis of the number of ‘normal’ mice i.e. total numbers of mice of each 
genotype minus the runts of that genotype (see Table 7; Graph 2) shows that the 
abnormalities noted in each genetic background do not segregate randomly, but are 
associated with the presence of a TGFpl null allele. Also, a 1 : 2 TGFpl+/+ : +/- ratio 
should be occuring in each strain despite the loss of TGFpl-/- animals, if the TGFpi 
allele has no effect on the TGFpl+/- animals. This was assessed in each cross using a 
%2 test. It was found that there had been no significant loss of NIH TG Fpl+/- 
animals; however, on both C57 and 129 backgrounds a significant loss of TGFpl+/- 
offspring had occured by 3 weeks of age.
Therefore, it can be concluded that the TGFpl null allele is a major contributory factor 
in the death of a significant number of conceptuses on NIH, 129 and C57 genetic 
backgrounds by 3 weeks of age. As expected from previous reports, the majority of 
TGFpl-/- conceptuses were dead or dying by this time point. However, there is a 
strain-specific difference in the survival to 3 weeks post-partum of TGFpl-/- animals: 
It appears that TGFpl+/- and -/- animals bred onto an NIH background may be less 
prone to death prior to 3 weeks post-partum than those on a C57 and 129 genetic 
background. However, further work is required to pin-point the onset of lethality.
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Graph 1. TGFpl +/+ : +/- : 1 : 2 : 1  Ratios at Weaning.
The expected ratio of TGFpl+/+ : +/-: -/- animals generated by TGFpl+/- intercrosses at 
any developmental stage is 1 : 2 : 1 .  Graph 1 shows the observed genotype ratios of 
NIH, C57 and 129 animals at weaning (around 3 weeks of age). In the calculation of 
ratios, the number of TGFpl+/+ animals was taken as ‘1’. There is clearly a strain- 
dependent difference in the ability of TGFpi+/- and -/- animals to survive to weaning.
Graph 2. Observed Percentage of Phenotypic TGFpi Knockout Animals at 
Weaning in Each Genotypic Class.
The post-natal TGFpl knockout phenotype is lethal and invariably affects all TGFpi-/- 
and a proportion of the TGFpl+/- animals which survive to birth. Graph 2 shows the 
percentage of animals in each genotypic class in NIH, C57 and 129 mice which were 
noted (D. Duggan, & F. Cousins) to be exhibiting signs of the TGFpl knockout 
phenotype at weaning. In the C57 strain, no TGFpl-/- mice survived to birth; this is 
represented as a 100% abnormality.
NIH C57 129
□  +/+ 
■  +/- 
□  -/-
NIH C 57 129
□  +/+ 
■  + / -  
0 - / -
Table 6.
Strain +/+ +/- -/- Dead Total +/+ : +/- : -/- 
Ratio
NIH 66 110 15 27 218 1:1.7:0.3
[0] [5] [15]
C57 124 179 0 15 318 1:1.4:0
[0] [10]
129 58 66 2 5 131 1:1.1:0
[0] [4] [2]
Table 7.
Strain 1 : 2 : 1
TGFP1+/+ : +/- : -/- 
Total Animals
1 : 2 : 1
TGFpl+/+ : +/- : -/- 
Normal Animals
1 : 2
TGFpl+/+ : +/- 
Total Animals
NIH p=<0.01 p=<0.01 p=0.24
C57 p=<0.01 •a II A o o p=<0.01
129 p=<0.01 p=<0.01 p=<0.01
Tables 6 and 7. Genotype Ratios of NIH, C57 and 129 Mice at 3 Weeks of Age 
from TGFpl+/- Intercrosses.
Genomic DNA was isolated from tail biopsies taken at weaning from 
mice derived from TGFpi+/- intercrosses and used to ascertain TGFpl 
genotype by PCR (see Materials and Methods). The numbers in square 
brackets represent the number of notably runted animals, i.e. those 
expected to die, in each genotypic class. Genotype ratios were tested 
for significant deviation from the expected 1 : 2 : 1  TGFpi+/+ : +/- : -/- 
and 1 : 2 TGFpi+/+ : +/- ratios using % 2  tests. Totals of ‘normal’ 
animals were calculated by the subtraction of runts from the total 
number in each genotypic class.
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3.1 .2  T G F pi+ /-  x T G F p i+ /+  R eciprocal Crosses.
The investigations of Dickson et al (1995) showed that, in TGFJ31+/- intercrosses on a 
mixed genetic background, a 25% loss of TGFpi+/- animals occured in utero. It was 
also reported that a significant 20% loss of TGFpl+/- embryos occured in TGFpl+/- x 
TGFpl+/+ crosses when the mother was TGFpi+/-. Paternal yolk-sac imprinting was 
excluded, and it was postulated that factors such as maternal environment and litter size 
may compromise the development of TGFpi+/- conceptuses in utero.
In order to ascertain whether or not there was a directional loss of TGFpl+/- animals 
prior to 3 weeks post-partum, mice generated by reciprocal TGFpl+/+ x TGFpi+/- 
crosses on NIH, C57 and 129 strains were genotyped at 3 weeks of age by the PCR of 
genomic tail DNA (see Tables 8 and 9). If factors such as maternal environment were 
acting on these genetic backgrounds a significant deviation from the expected 1 : 1 
TGFpi+/+ : +/- ratio would result only when the mother was TGFpi+/-. Since a 20% 
loss of TGFpi+/- conceptuses bom to aTGFpi+/- mother has been reported previously 
(Dickson et al., 1995); each set of data was subjected to two y }  ‘goodness of fit’ tests: 
Firstly, was the data comparable to, or significantly different from the expected 1 : 1 
TGFpl+/+ : TGFpl+/- ratio? Secondly, was the data also comparable to, or significantly 
different from a 20% loss of TGFpi+/- pups? i.e. was p^0.05 when the data was 
compared to a 1 : 0.8 TGFpl+/+ : TGFpl+/- ratio? (Table 9).
Given the small predicted loss of heterozygotes, any significant effects acting on the mice 
used in this experiment may be masked due to the relatively small data sets genotyped in 
each genetic background. It is notable that the ratio of +/+ : +/- mice generated on C57 
and NIH backgrounds by crossing TGFpi+/- female mice with TGFpl+/+ male mice 
drops in both cases from 1 : 1 to 1 : 0.7 and 1 : 0.8 respectively when compared to the 
reciprocal cross, whereas the 129 ratio is unaffected by direction. However, the data did 
not differ significantly from 1 : 1 TGFpi+/+ : +/-, hence, it was important to use two %2 
‘goodness of fit’ tests in order to check if the data was consistent with both no loss of 
TGFp 1+/- conceptuses and a 20% loss of TGFp 1+/- conceptuses.
When the results for male TGFpi+/- x female TGFpl+/+ mice, shown in Table 8, are 
analysed using a %2 ‘goodness of fit’ test for the expected ratio of 1 : 0.8 TGFp 1+/+ : +/- 
pups; the only significant difference found was in the 129 strain (p=0.04). A probability 
value nearing significance was also seen on the NIH background (p=0.06) - suggesting 
that there is no loss of TGFpl+/- conceptuses in 129 and NIH animals in this cross,
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when the father is TGFpl+/-. This is consistent with the results of Dickson et al. (1995). 
When the data for male TGFpl+/+ x female TGFpi+/- mice, shown in Table 9, is 
analysed by %2, no significant differences from the expected ratios are found. However, 
the p value for C57 animals bom to a TGFpi-f-/- mother is very small (p=0.06) when the 
data is compared to a 1 : 1 TGFpl+/+ : TGFpi+/- ratio, conversely, the p value for a 1 : 
0.8 TGFpl+/+ : TGFpi+/- is 0.51, i.e. highly consistent with a 20% loss of 
heterozygous animals, but the sample size was too small to make this a significant result.
In general, these results are neither consistent with a 20% loss qx. with no loss of 
TGFpl+/- embryos in both directions of the cross, due to a lack of data. In an attempt to 
circumvent this effect, the samples from each individual strain was pooled and analysed 
statistically. Again, the ratio of TGFpi+/+ : +/- dropped from 1 : 1, to 1 : 0.8 when a 
TGFpi+/- animal was the mother. The data was significantly different from a 20% loss 
of TGFp 1+/- animals when the mother was TGFpl+/+: However, when the mother was 
TGFpl+/-, the data was consistent with a 20% loss of TGFp 1+/- animals (p>0.90) - and 
with a 1 : 1 TGFpl+/+ : +/- ratio (p=0.09), although the probability of this result 
occurring by chance was substantially lower.
Although the genotype ratios are highly suggestive of a small heterozygous loss 
occurring when a TGFpl+/- animal is the mother, these results show that if there is 
any directional effect on the production of TGFpl+/- mice from reciprocal TGFpl+/+ 
and +/- crosses, it is very small, i.e. ^20%. Therefore, samples of a much greater size 
would be required to demonstrate this loss on any specific genetic background. A loss 
of TGFpi+/- animals when the mother is TGFpl+/-, would probably be due to the 
effect of reduced levels of circulating TGFpi in TGFpl+/- mothers as opposed to 
wild type mothers. It is notable that there appears to be an absence of a directional 
effect on the 129 genetic background (see Discussion 4.4).
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Table 8. Genotype Ratios of NIH, C57 and 129 Mice at 3 Weeks of Age 
from Female TGFpl+/+ x Male TGFpl+/- Crosses.
Strain +/+ +/- Total TGFpl
+/+:+/-
Ratio
1:1
p value
1:0.8  
p value
NIH 141 141 282 1 : 1 >0.90 0.06
C57 68 67 135 1 : 1 0.85 0.22
129 68 76 144 1 : 1.1 0.51 0.04
TOTAL 277 284 561 1 : 1 0.85 <0.01
Table 9. Genotype Ratios of NIH, C57 and 129 Mice at 3 Weeks of Age 
from Female TGFpi +/- x Male TGFpl+/+ Crosses.
Strain +/+ +/- Total TGFpl
+/+:+/-
Ratio
1:1
p value
1:0.8  
p value
NIH 56 48 104 1:0.8 0.43 0.73
C57 55 37 92 1:0.7 0.06 0.51
129 49 48 97 1:1 >0.90 0.31
TOTAL 160 133 293 1:0.8 0.09 >0.90
Tables 8 and 9. No Directional Effect on the Observed Genotype Ratio Generated 
By TGFpl+/+ and TGFpl+/- Reciprocal Crosses.
These tables show data detailing TGFpi genotype ratios from 
T G Fpl+/+  x +/- reciprocal crosses at weaning of NIH, C57 and 129 
inbred strains of mice. Using a X2 ‘goodness of fit’ test the probability 
of the ratios of surviving mice differing significantly from 1 : 1 and 
1 : 0.8 was assessed.
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3.2 Analysis of the Genotype Ratio at Birth of 
Pups from TGFpi+/- Intercrosses.
The genotype ratios of NIH, C57, FI litters from TGFpi+/- intercrosses at birth were 
characterised by Bonyadi et al. (1997) concomitant to this study. This information is 
central to the present study, and is therefore tabulated in Table 10. For the purposes of 
this study the genotypic ratio at birth of pups from TGFpi+/- intercrosses on a 129 
background was also of interest (Table 10). In each experiment genomic DNA from 
one day-old pups was genotyped by PCR and the results compared to expected 1 : 2 : 
1 TGFpl+/+ : +/-: -/-, 1 : 1 TGFpl+/+ : -/- and 1 : 2 TGFpl+/+ : -/- ratios using x 2 
‘goodness of fit ‘ tests. By birth, a significant loss of TGFpl-/- pups had occured in 
each genetic background.
An overview of TGFp 1 genotype ratios at birth of pups from all genetic backgrounds 
is presented in Graph 3.
There is an extreme variation in the percentage of prenatal death in TGFpl+/- and -/- 
animals. Percentages were calculated as follows: Firstly, heterozygotes; the total 
number of surviving TGFpi+/- pups was halved, divided by the number of 
TGFpl+/+ animals genotyped, then multiplied by 100; secondly homozygous nulls - 
the total of surviving TGFpl-/- pups was divided by the number of TGFpl+/+ pups, 
then multiplied by 100. The results show that pups from an NIH background are the 
least affected, with an approximate 28% loss of TGFpl+/- and an 18% loss of 
TGFpi-/- conceptuses in utero. On the 129 genetic background, 29% of TGFpi+/- 
animals die before birth. 74% of the 129 TGFpl-/- animals are lost in utero. All C57 
TGFpi-/- animals are lost before birth. In the FI reciprocal NIH x C57 intercross 
70% of TGFpl-/- conceptuses died pre-natally. Around 12% of TGFpl+/- 
conceptuses on the C57, and reciprocal FI genetic backgrounds died in utero.
Thus, by birth, the TGFpi null allele has had a strong influence on the loss of pups 
on each of the genetic backgrounds studied in this project. There is a striking variation 
in the degree of lethality suffered by TGFpi+/- and TGFpi-/- conceptuses between 
the genetic backgrounds studied. Thus, it can be concluded that there are a number of 
differences between the inbred strains used in this project which may have a direct or 
indirect effect on the penetrance of the TGFpl knockout phenotype. These differences 
may be genetic or epigenetic, or involve a combination of factors.
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Strain + /+ + /- -/- Total Ratio 1 : 2 : 1  
T G Fpi 
+/+  : + /- 
: -/-
1 : 2 
T G Fpl 
+/+  : +/-
1 : 1 
T G Fpi 
+/+  : -/-
NIH 89 129 73 291 1 : 1.4 : 0.8 p=0.07 p=0.01 p=0.21
C57 68 122 0 190 1 : 1.8 : 0 p=<0.01 p=0.46 T3 II A O o
NIH x 
C57
50 90 15 155 1 : 1.8 : 0.3 p=<0.01 p=0.50 p=<0.01
C57 x 
NIH
29 50 9 88 1 : 1.7: 0.3 T3 II A O b ►—
j* p=0.48 p=<0.01
129 39 55 10 104 1 : 1.4 : 0.3 T3 II A O o p=0.05 n A o o
 
»—»
Table 10. A Strain-Specific Loss of TGFp 1+/- and -/- Pups Occurs in utero .
>100 pups from TGFpi+/- intercrosses were sacrificed on the day of 
birth and genotyped by PCR using genomic tail DNA. The results were 
compared to the expected 1 : 2 : 1  TGFpl+/+ : +/- : -/- and 1 : 2 
TGFP1+/+ : +/- and TGFpi+/+ : -/- genotype ratios using a 
‘goodness of f it’ test, p values are shown above. The data shown 
above for C57, NIH and reciprocal FI intercrosses are from Bonyadi e t  
a l . ,  1997.
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NIH C57 129 F1
■ +/+ 
□ +/-
11- / -
Graph 3. T G Fpl +/+ 1 : 2 : 1  Ratios at Birth.
The expected ratio of T G F p l+/+ : +/- : -/- animals generated by T G Fpl+ /- intercrosses at 
any developmental stage is 1 : 2 : 1 .  Graph 3 shows the observed genotype ratios of 
NIH, C57, 129 and FI animals at birth (Bonyadi et al., 1997). In the calculation of 
ratios, the number of T G F pl+ /+  animals was taken as ‘1’. There is clearly a strain- 
dependent difference in the ability of TGFP 1+/- and -/- animals to survive to birth.
3.3 Analysis of 9.5dpc Embryos.
Work done on TGFpl knockout mice at birth and 3 weeks post-partum had shown 
that a variable lethality due to the TGFpl knockout allele occurs in utero on each 
genetic background studied. Therefore, it was decided to investigate the developmental 
stage and cause of lethality in each strain and in the defined FI intercross.
3.3.1 Comparison of Developmental Staging for Wild Type 
NIH, C57 and 129 Embryos.
In order to ascertain the range of developmental variations in wild type embryos on 
NIH, C57, 129 and FI genetic backgrounds, a control panel of >75 embryos from 
TGFP1+/+ intercrosses from each strain was morphologically scored using the 
modified version of Brown and Fabros’ scoring system (see Materials and Methods! 
(Table 11). This scoring system provides an objective, additive analysis of key 
developmental landmarks at 9.5dpc, and therefore facilitates the comparison of 
morphological scores between strains. This study was undertaken to provide a baseline 
for future scoring before a long-term morphological study of TGFpl+/- intercross 
litters at 9.5dpc was undertaken.
The rate of total resorptions in the wild type intercrosses was 8-10% at 9.5dpc in each 
strain studied. Resorptions were defined as a decidual mass containing a dead embryo, 
at any stage of necrosis. Other abnormalities in conceptuses occured at a rate of around 
10%. Upon analysis, these abnormalities were found to comprise embryos 
developmentally delayed by 0.75-1.0dpc and conceptuses found to be dying for 
unidentified reasons rather than specific morphological abnormalities. Interestingly, 
there was a clear strain-specific difference in the typical littersizes of these strains; on 
average, NIH litters contained 11 conceptuses; FI, 9 conceptuses and C57 and 129 
litters, 8 conceptuses. There was a strain-specific difference in the average 
morphological score; but, as the standard deviations indicate, there was still a 
considerable spread in the range of scores for each strain. Thus, despite the larger 
littersizes, it appears that in general, NIH and FI conceptuses develop more efficiently 
than 129 and C57 conceptuses. These observations are consistent with the 
characteristics of the NIH, C57 and 129 inbred strains published in Mouse Genome 
(Festing, 1993).
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Strain Total Resorptions Average 
Litter Size
Average 
Morph. Score
NIH 92
[5=5%]
7
(8%)
11 31.0 ±  2.2
C57 94
[7=7%]
8
(8.5%)
8 26.0 ± 3.8
129 70
[7=10%]
7
(10%)
8 27.5 ± 2.9
FI 112
[9=8%]
10
(9%)
9 29.0 ± 2.8
Table 11: Analysis of Resorption and Abnormality Rate in TGFpl+/+ Intercrosses 
on Different Genetic Backgrounds.
70-120, 9.5dpc wild type embryos from NIH, C57, 129 and FI genetic 
backgrounds were generated using TGFpl+/+ parents. The conceptuses 
were dissected free from maternal tissue and assessed using a modified 
version of Brown and Fabros’ scoring system (see M aterials and 
M ethods) to give a morphological score. Resorptions were defined as 
any decidual mass containing a necrotic embryo.
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3 .3 .2  Analysis of Genotype and Phenotype Ratios of 
Em bryos from T G Fpi+/- Intercrosses at 9.5dpc.
In order to ascertain the onset and cause of pre-natal death of TGFpl-/- embryos, 
litters generated by C57, NIH, 129 and FI (C57 x NIH reciprocal crosses) TGFpl+/- 
intercrosses were morphologically scored and TGFpl genotyped by PCR using a 
whole clean conceptus or half-embryo. >100 conceptuses from each genetic 
background were scored and classified as TGFpl+/+, +/-, -/- or unknown genotype. 
The latter class comprised conceptuses either partially or totally resorbed for an 
unknown reason.
Each TGFpi+/- intercross genotyped at 9.5dpc should have resulted in a 1: 2 : 1 
TGFpl+/+ : +/-: -/- ratio of embryos if being homozygous for the TGFpi null allele 
did not result in pre-organogenesis death (see Graph 4). Likewise, if the TGFpl null 
allele had no affect on mid-gestation development, there should be few conceptuses 
with an identifiable abnormal phenotype, and the observed phenotype should not 
segregate with genotype (see Graph 5). In order to analyse these two hypotheses, the 
data in Table 12 was subjected to two y 2 ‘goodness of fit’ tests: Firstly, to ascertain 
whether there was a significant deviation from the expected 1 : 2 :1  total genotype ratio 
on each genetic background (see Table 13). The p values for each strain are all >0.05, 
except C57 (p=<0.01), this suggests that there is a significant loss of TGFpl-/- 
embryos in this strain before 9.5dpc. TGFpi-/- conceptuses on this background 
appear to be extremely compromised, and only 11% survive to 9.5dpc, at which point 
4/ 5 were severely abnormal. Since there is no significant loss of any other class of 
conceptus on any other genetic background prior to 9.5dpc, this appears to be a strain- 
specific phenotype, leading to the death of the majority of C57 TGFpi-/- conceptuses 
prior to 9.5dpc. A y 2 test for C57 1 : 2 +/+ : +/- ratio gives a p value of 0.35, showing 
no significant loss of TGFp 1+/- conceptuses prior to this stage of gestation (see Table 
13). No TGFp 1+/- conceptuses had been lost on any of the other strains studied.
Secondly, a y 2 ‘goodness of fit’ test was used to ascertain whether or not the severe 
abnormalities recorded among conceptuses from these genetic backgrounds were 
segregating randomly, or with a specific genotype. Observed totals of normal 
conceptuses were calculated by subtracting the number of severely abnormal 
conceptuses from the total number of conceptuses scored in each class. Severely 
abnormal conceptuses were defined as those whose specific defect or combination of 
defects would probably prove lethal during mid-gestation. On every genetic
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background studied except NIH (p=0.08) the number of normal conceptuses deviated 
significantly from an expected 1 : 2 : 1  TGFpl+/+ : +/- : -/- ratio (see Table 13). 
Therefore, the identified phenotype is not randomly segregating with genotype - it is 
notable that no severely phenotypic conceptuses were genotyped as TGFpi+/+.
Thus, the data implies that there are 3 key stages where TGFpl is vital to normal 
development: Pre organogenesis, mid-gestation and 2-3 weeks post-partum.
89% of C57 TGFpi-/- animals are lost prior to 9.5dpc, whereas the TGFpl null allele 
on a 129 and reciprocal FI genetic background leads to an increased chance of 
developing a severe mid-gestation phenotype. There is no significant occurrence of a 
mid-gestation phenotype on the NIH genetic background. However, the relatively 
small sample size may be affecting the statistical significance of the segregation of the 
NIH TGFpl null allele with the phenotype. Data presented in Results 3.2 and 3.1 
show that 80% of NIH TGFp 1-/- conceptuses are bom but die at around 3 weeks 
post-partum.
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Graph 4. TGFpl +/+ : +/- : 1 : 2 : 1  Ratios at 9.5dpc.
The expected ratio of TGFpl+/+ : +/-: -/- animals generated by TGFpl+/- intercrosses at 
any developmental stage is 1 : 2 : 1. Graph 4 shows the observed genotype ratios of 
NIH, C57, 129, reciprocal and total FI conceptuses at 9.5dpc. There is no significant 
directional difference in the FI TGFpi+/- intercross. In the calculation of ratios, the 
number of TGFpi+/+ animals was taken as *1*. Notably, there has been a striking loss 
of C57 TGFpi -/- conceptuses prior to 9.5dpc.
Graph 5. Observed Percentage of Severely Abnormal TGFpl Knockout 
Conceptuses at 9.5dpc in Each Genotypic Class.
Upon dissection each TGFpi knockout conceptus was morphologically scored. Graph 5 
shows the percentage of animals in each genotypic class in NIH, C57, 129, reciprocal 
and total FI conceptuses which were scored as being severely abnormal. There is no 
significant directional difference on the prevalence of the TGFpi knockout mid-gestation 
phenotype in FI conceptuses. A strain-dependent percentage of the total TGFpl+/- and 
-/- embryos scored in each genotypic class were scored as severely abnormal.
2.5
NIH C57 129 CN NC F1
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0 %
F1CN NCNIH C57 129
I 0 +/+
■ +/-
□ -/-
Strain +/+ +/- Dead Total Ratio
NIH 29
[0]
49
[8=16%]
23
[9=39%]
5 106 1:1.7:0.8
C57 44
[0]
74
[11=15%]
5
[4=80%]
10 133 1:1.7:0.09
129 26
[0]
49
[6= 12%]
23
[18=78%]
5 106 1:1.9:0.9
FI
(C57 x 
NIH)
30
[0]
62
[8=13%]
23
[12=52%]
8 123 1:2 .1:0.8
FI
(NIH x 
C57)
27
[0]
57
[8=14%]
27
[16=60%]
7 118 1:2 .1:1
FI
Total
57
[0]
119
[16=13%]
50
[28=56%]
15 241 1:2.1:0.9
Table 12. Genotype and Phenotype Ratios of NIH, C57, 129 and Reciprocal FI 
Embryos at 9.5dpc from TGFpl+/- Intercrosses.
The table shows the total number of conceptuses scored and genotyped 
by PCR on each genetic background studied at 9.5dpc. The total 
numbers are expressed as 4 classes ie. TGFpl+/+, +/-, -/- or dead 
(unknown genotype). Conceptuses of an unknown genotype were either 
totally or partially resorbed. The numbers in square brackets represent 
the number of severely phenotypic animals of each genotypic class; this 
number is expressed as a percentage of the total number of animals of 
each genotypic class.
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Strain 1 : 2 : 1  
TGFpi 
+ / +  : +/- : -/- 
Total animals
1 : 2 
TGFpi 
+/+ : + / -  
Total animals
1 : 1 
TGFpi 
+ / +  : -/- 
Total animals
1 : 2 : 1
TGFpi
+/+ : +/■ : -/-
Normal animals
NIH p=0.61 not determined p=0.40 p=0.09
C57 p=<0.01 p=0.35 ^3 II A O o p=<0.01
129 p=0.68 not determined p=0.65 p=<0.01
FI
(C57 x 
NIH)
p=0.37 not determined p=0.34 p=0.01
FI
(NIH x 
C57)
p=0.75 not determined p=>0.90 p=0.03
FI Total p=0.36 not determined p=0.56 p=<0.01
Table 13. Statistical Analysis of Genotype and Phenotype Ratios of NIH, C57, 129 
and Reciprocal FI Embryos at 9.5dpc from TGFpl+/-Intercrosses.
Genotype ratios of observed and expected total and normal embryos 
were compared using ‘goodness of fit’ tests. The number of normal 
conceptuses was calculated by the subtraction of those identified as 
severely phenotypic from the total number of conceptuses in each 
genotypic class.
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3 .3 .3  D efin ition  of the Abnormal Mid-Gestation Phenotype 
Observed in T G Fpl+/- and -/- Conceptuses.
In a previous study Dickson etal., 1995 characterised the TGFpl knockout phenotype 
on a mixed genetic background and found that the primary defects were restricted to 
extra-embryonic tissue, namely the yolk-sac vasculature and haematopoietic system. 
One aim of this study was to identify any strain-specific differences in the 
manifestation of the TGFpl knockout phenotype. By using a morphological scoring 
system modified for use between 8.5 and 10.5dpc (see Materials and Methods) an 
objective and quantitative assessment of the TGFpi knockout phenotype on the 
genetic backgrounds studied could be made.
The embryos were scored using a dual system. Firstly the exact developmental stage 
of a number of landmark characteristics was assessed and scored (score 1). This was 
used additively as an indicator of the exact developmental age of the conceptus. 
Secondly, each conceptus was scored on an abnormality scale (score 2). 
Abnormalities of any embryonic feature were quantified using a standard system. This 
score reflected the severity and number of defects suffered by the conceptus. Since the 
conceptuses scored tended to exhibit different combinations and extremities of defects, 
these scores are not strictly additive. However, when presented together they can 
provide a basic indication of the divergence between the three genotypic classes on 
each genetic background.
The range of scores 1 and 2 for TGFpi+/+, +/- and -/- conceptuses on C57, NIH, 
129 and reciprocal FI genetic backgrounds are presented as box-plots (Graphs 6a- 
10b, presented in Appendix 1). The graphs show that for score 1, although there is a 
slight developmental delay in TGFp 1+/- and -/- compared to TGFpl+/+ conceptuses, 
the scores vary only slightly between the different genotypes in each strain. 
Conversely, when score 2 is compared between genotypes, it is obvious that whereas 
TGFpl+/+ conceptuses tend to be developmentally normal; TGFpl+/-, and especially 
TGFpl-/- conceptuses have suffered a range of developmental defects by 9.5dpc.
A closer analysis of the data shows that regardless of genetic background, the severe 
gross abnormalities observed at 9.5dpc associated with the TGFpi null allele mainly 
affect extra-embryonic structures and the haematopoietic system. For the purposes of 
this study these defects can be broken down into several categories: Inadequate/ 
complete lack of yolk sac vasculature, severe yolk sac anaemia; defects of the allantois
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and chorion, i.e. the allantois contains blood clots, appears blocked or, as in several 
severe cases, fails to form an adequate chorio-allantoic junction; haemorrhage(s) in the 
embryo and/ or yolk sac; a swollen pericardium; necrosis, or the yolk sac and/or 
embryo retarded by >0.5dpc. Occasionally other combinations of severe 
abmormalities were observed and recorded.
By 9.5dpc, the embryonic circulation is normally connected to the extra-embryonic 
circulation via the allantois and the umbilical vessels as well as the vitelline vessels. 
The vitelline vein and artery are the first major vessels to appear in the yolk sac and 
form the basis of the branching plexus of blood vessels containing haemoglobinised 
red blood cells typically seen in the murine yolk sac at 9.5dpc. However, the most 
common defect of the vascular system identified in this study was a yolk sac with a 
reduced number of small, inadequately branching vessels with delicate connections. 
Usually this phenotype manifested itself as the appearance of an unbranched vitelline 
vein and artery in the absence of any other vessels. This was sometimes accompanied 
by areas of aberrant capilliary network development in the yolk sac. Occasionally 
haemorrhages of blood were observed between the endodermal and mesothelial layers 
of inadequately vascularised intact yolk sacs. The most severe manifestation of the 
vascular phenotype noted was an apparently complete failure of yolk sac 
vasculogenesis in the presence of persistent anastamosing blood islands (see Figures 8 
and 9 for photographic examples of the TGF[3l knockout yolk sac phenotype).
Defects in the allantois and chorion were common in the TGF(3l+/- and -/- 
conceptuses. The typical abnormalities scored were either a completely empty 
umbilical artery/ vein, the appearance of blood clots and/ or Tumps’ in the umbilical 
artery/ vein or a chorion distended with blood (see Figure 11). In a few extreme cases 
there had been a failure of the allantois to make a connection with the chorion.
Anaemia was observed in severely abnormal TGF(3l-/-and +/- intact yolk sacs. This 
aspect of the phenotype was observed independently, or in association with vascular 
defects, i.e. well vascularised intact yolk sacs could appear pale and conversely, yolk 
sacs with severe vascular defects could contain red blood cells. The degree of anaemia 
seen was variable; from a yolk sac appearing pallid in comparison to its littermates, to 
the presence of completely non-haemoglobinised blood in the vessels of the yolk sac 
(see Figures 8 and 9).
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Figure 8 - Morphological Analysis of Dissected TGFpi Knockout 
Conceptuses at 9.5dpc.
9.5dpc conceptuses generated by TGFpl+/- intercrosses were dissected free from the 
maternal tissue, morphologically scored and genotyped by the PCR of genomic DNA. 
(A) and (B) show a normal TGFpi+/+ conceptus with well-developed extra-embryonic 
vasculature containing haemoglobinised blood. (C), (D), (E) and (F) are all TGFpi-/- 
conceptuses with abnormal vasculature. (C) exhibits minimal branching of the major yolk 
sac vessels. There is a total absence of any major branching vessels in (D), and the 
embryo appears necrotic. (E) and (F) show a blood lake between the extra-embryonic 
tissue layers, despite the well-vascularised appearance of the yolk sac.
Scale bar = 600pm.
bv = blood vessel, ec = ectoplacental cone, h = haemmorhage, ys = yolk sac.

Figure 9 - Morphological Analysis of Dissected TGFpi Knockout 
Conceptuses at 9.5dpc (2).
(A) - (E) all have characteristics of the TGFpl knockout mid-gestation phenotype. (A) 
and (B) show a TGFpl-/- embryo in an avascular yolk sac. Both (C) and (D) exhibit yolk 
sac anaemia, despite having an apparently well-formed vasculature. Persistent blood 
islands in (E) demonstrate severe developmental delay. The embryo has arrested at 
around 8.0-8.5dpc and is extremely abnormal.
Scale bar (A) - (D) = 600pm. (E) = 225pm
bi = blood island, bv = blood vessel, hf = head fold, ys = yolk sac.

Figure 10 - Morphological Analysis of Dissected TGFfJl Knockout 
Embryos at 9.5dpc.
TGFpl embryos generated by TGF|31+/- intercrosses were dissected free from the yolk 
sac and morphologically assessed. (A) and (B) shows both aspects of a normal 
TGFpi+/+ embryo at 9.5dpc, whereas TGFf31-/- embryos (C) and (D) both have severe 
abnormalities. (C) has hydrocephaly. (D) has severe oedema; the heart is swollen and a 
haemmorhage has occurred in the cardiac region.
Scale bar = 375pm.
bb = branchial bars, in (A) numbered 1-3, da = dorsal aorta, h = heart, lb = limb bud, me 
= mesencephalon, op = otic pit, ov = optic vesicle.
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Figure 11 - D efects O bserved in the C irculatory System  o f T G F p i-/-  
Em bryos at 9 .5dpc.
Photographs (A), (B) and (C) illustrate defects observed in the TGFpl knockout mid­
gestation phenotype. In a wild type conceptus, the umbilical artery and vein are both 
clearly visible, discrete and continuously full of haemoglobinised blood. The umbilical 
vessels fuse with a visible developing plexus of vessels in the chorion. However, (A) 
shows a distended umbilical vessel only half-full of blood. Embryo (B) has clots or 
‘lumps’ lining its umbilical vessels. There is also a collection of blood in the chorion. (C) 
exemplifies the pericardiac swelling observed in abnormal TGFpi knockout mice. 
Additionally, a small haemmorhage has occurred around the heart.
am = amnion, bb = branchial bars, ch = chorion, h = heart, lb = limb bud, pe = 
pericardium, um = umbilical vessels, ys = yolk sac.
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The embryo per se in all conceptuses studied appeared grossly normal. However, a 
number of embryos contained haemorrhages, either around the heart or dorsal aorta. 
Several phenotypic conceptuses also appeared to have grossly swollen pericardia, a 
secondary defect normally associated with the cessation of blood-flow in the yolk sac 
plexus. A very small number of embryos from the study exhibited hydrocephaly. 
Photographic examples of these defects are shown in Figures 10 and 11.
In conclusion, there does not appear to be any strain-specific difference in the 
manifestation of the TGFpl mid-gestation phenotype as analysed here using gross 
morphological means. On all genetic backgrounds studied the defining attributes of the 
TGFpl knockout phenotype were aberrant yolk sac vasculogenesis, defective chorio­
allantoic development and yolk sac anaemia. The defective haematopoiesis and 
vasculogenesis occur both independently of one another and together. Other defects 
included blood pools in the yolk sac and embryo and extreme swelling of the 
pericardium. These findings are comparable with those characterised by Dickson et 
al., 1995.
3.4. Analysis of Embryos at 11.5dpc.
3.4.1 Severe Defects in Vasculogenesis and Haematopoiesis  
Lead to Death at 10.5-12.0dpc.
Previous accounts of the mid-gestation phenotype in TGFpi+/- and -/- embryos report 
that severely abnormal embryos were lost prior to 11.5dpc secondary to defective yolk 
sac development (Dickson et al., 1995). In this project, an analysis of genotype and 
phenoype ratios of NIH, 129 and FI conceptuses at 11.5dpc was undertaken for a 
number of reasons. Firstly, to check the efficacy of the morphological scoring system 
in assessing the potential lethality of the phenotype; and secondly, to pinpoint 
precisely the developmental age of death of embryos on each of the genetic 
backgrounds studied.
>100 conceptuses from TGFpi+/- intercrosses on NIH, 129 and FI backgrounds 
were examined and scored (Table 14; Graph 11). Those found to be phenotypic and/ 
or dead or dying were scored with respect to the severity of the phenotype. At 11.5dpc 
the yolk sac is fully vascularised. A well-defined branching plexus of vessels extends 
completely around the yolk sac, and it should be easy to separate the vitelline artery 
and vein. In this study, a severe phenotype was defined as an avascular yolk sac, or
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the absence of a full yolk sac plexus but the presence of inadequate/ disorganised 
vessels. This was typified by yolk sacs which exhibited only an unbranching vitelline 
artery and vein. A yolk sac with delicate vessels sustaining a normally developing 
conceptus was scored as a minor phenotype. In each of the conceptuses examined, the 
embryo per se was either normal, in a normal or mildly phenotypic yolk sac or dead/ 
dying in a severly abnormal yolk sac. Photographic comparison of severely 
phenotypic and non-phenotypic conceptuses is shown in Figures 12 and 13 .
The results show that no TGFpl+/+ conceptuses in each strain studied had severe 
defects at 11.5dpc. Only conceptuses which possessed a TGFpl null allele had 
become severely phenotypic at mid-gestation. However, the percentage of TGFpl+/- 
and -/- conceptuses judged to be severely abnormal varied greatly between genetic 
backgrounds (Graph 12). Again, the least affected background at mid-gestation was 
NIH. Using a y }  ‘goodness of fit’ statistical test it was found that like at 9.5dpc, the 
ratios of total embryos on a 129 and FI genetic background did not deviate 
significantly from the expected 1 : 2 : 1  TGFpi+/+ : +/-: -/- ratio (p=<0.06 in each 
case), whereas, on an NIH background p=>0.40 (Table 15).
In a TGFpl+/- intercross, the number of TGFpi+/+ conceptuses should equal the 
number of TGFpl-/- conceptuses at any developmental age if there is no other 
factors) acting to affect this ratio. Thus, any significant loss of TGFpi-/- conceptuses 
can be identified by comparing the ratio of observed TGFpl+/+ : TGFpi-/- to the 
expected 1 : 1 ratio using a y }  ‘goodness of fit’ test. The results show that a 
significant loss of TGFp 1-/- conceptuses had occured by 11.5dpc on both the 129 and 
FI genetic backgrounds (p=<0.01 and p=0.03 respectively) but not the NIH genetic 
background (p=0.30). Therefore a significant proportion of affected 129 and FI 
TGFpl-/- embryos had already been resorbed or were too degraded to genotype by 
PCR by 11.5dpc.
Calculations to ascertain ratios of normal embryos in each genotype again show that a 
significant proportion of 129 and FI TGFpi+/- and -/- conceptuses are severely 
phenotypic at 11.5dpc (p<0.01), whereas on an NIH background p=0.09. Numbers 
of normal conceptuses were calculated by the subtraction of the number identified as 
severely phenotypic from the total in each genotypic class.
Loss of TGFpl+/- conceptuses and the occurrence of a severe phenotype in 
TGFpl+/- conceptuses was analysed statistically (see Table 15). No significant
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deviation from an expected 1 : 2 +/+ : +/- ratio of total or normal conceptuses was seen 
on any genetic background. However, the probability of deviation from the expected 
number of normal TGF(3l+/- conceptuses was 0.07 on a 129 background, whereas 
p=>0.30 in NIH and FI strains, implying that use of larger data sets might have 
produced statistically distinct results.
Thus it would appear that the defective yolk sac phenotype of the TGFpi-/- embryos 
mid-gestation phenotype is not variable between strains, and always occurs between 
10.5 and 12.0dpc, as previously reported (Dickson et al., 1995). However, there is a 
strain-specific penetrance of the severe mid-gestation TGFpi knockout phenotype, 
illustrated by a lower prevalence of the phenotype on a NIH genetic background 
compared to 129 and FI strains.
Any significant loss of heterozygous embryos, or occurence of a severe phenotype at 
11.5dpc in the TGFJ31+/- embryos is unclear; certainly - a number of severely 
abnormal TGFpl+/- conceptuses were identified on all genetic backgrounds at 9.5 and 
11.5dpc. The p values indicate that 129 TGFP1+/- conceptuses are more prone to 
developing a severe mid-gestation phenotype than those from FI and NIH genetic 
backgrounds. Previous work suggests that a small sub-set of TGFpl+/- animals may 
be affected in each strain (Dickson et al., 1995), thus, the use of relatively small 
sample sizes may be masking any strain-specific contributions to onset and severity of 
the mid-gestation TGFpl knockout phenotype in TGFpl+/- conceptuses.
To summarize, this data is comparable with the results shown in Table 12, i.e. the 
genotype and phenotype ratios of TGFpl+/- intercrosses analysed at 9.5dpc: It also 
closely reflects data of observed genotype ratios of pups at birth from TGFpl+/- 
intercrosses on NIH, 129 and reciprocal FI genetic backgrounds (Bonyadi et al., 
1997). There is a strain-specific difference in the penetrance of the TGFpl knockout 
mid-gestation phenotype: NIH conceptuses are least affected, whereas a significant 
loss of FI and 129 TGFpi -/-conceptuses had occurred by 11.5dpc. Severely affected 
embryos die between 10.5 and 12.0dpc as a result of yolk sac insufficiency.
71
Table 14.
Strain +/+ +/- -/- Unknown Total Ratio
NIH 34 62 26 10 132 1:1.8:0.8
[0] [6= 10%] [8=31%]
129 37 55 10 13 115 1:1.5:03
[0] [4=8%] [4=40%]
FI 29 57 14 8 108 1:2:0.5
[0] [7=12%] [9=64%]
Table 15.
Strain
1 : 2 : 1
TGFpl
+/+ : +/- : -/-
Total
Embryos
1 : 2 
TGFpl 
+/+ : +/- 
Total 
Embryos
1 : 1 
TGFpi 
+/+ : -/- 
Total 
Embryos
1 : 2 
TGFpl 
+/+ : +/- 
Normal 
Embryos
1 : 2 : 1  
TGFpi 
+/+ : +/- : -/- 
Normal 
Embryos
NIH p=0.42 p=0.65 p=0.30 p=0.37 p=0.09
129 p=0.01 p=0.16 T3 II A O o H-
‘ p=0.07 p=<0.01
FI p=0.02 p=>0.90 p=0.03 p=0.52 p=<0.01
Tables 14 and 15. Genotype and Phenotype Ratios of NIH, 129 and FI 
Conceptuses from TGFpi+/- Intercrosses at 11.5dpc.
>100 conceptuses from TGFpi+/- intercrosses on NIH, 129 and FI 
genetic backgrounds at 11.5dpc were dissected from maternal tissue and 
morphologically scored, then genotyped by PCR using genomic DNA. 
Numbers in square brackets indicate conceptuses scored in each 
genotypic class as haying a severe phenotype, dead or dying - but not 
yet resorbed; these figures are also expressed as a percentage of the 
genotypic class. The data was analysed u s in g /2 ‘goodness of f it ’ tests. 
Numbers of normal conceptuses were calculated by subtracting the total 
of severley phenotypic conceptuses from the total in each genotypic 
class.
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Graph 11. T G Fpl +/+ 1 : 2 : 1  Ratios at 11.5dpc.
The expected ratio of T G Fpl+ /+  : + /-: -/- animals generated by TGFP1+/- intercrosses at 
any developmental stage is 1 : 2 : 1 .  Graph 11 shows the observed genotype ratios of 
NIH, 129 and total FI conceptuses at 11.5dpc. In the calculation of ratios, the number of 
T G F p l+/+ animals was taken as ‘1’. The apparent loss of TG Fpi+ /- animals on the 129 
genetic background is statistically insignificant.
Graph 12. Observed Percentage of Severely Abnormal T G Fpl Knockout 
Conceptuses at 11.5dpc in Each Genotypic Class.
Upon dissection each T G Fpl knockout conceptus was morphologically assessed. Graph 
12 shows the percentage of animals in each genotypic class in NIH, 129 and total FI 
conceptuses which were severely abnormal, and therefore judged to be unable to survive 
through m id-gestation. Thus, a strain-dependent percentage of the total surviving 
T G F p l+ /-  and -/- em bryos in each genotypic class were observed to be severely 
abnormal.
NIH 129 F1
□  +/+ 
■ +/- 
□  -/-
-
I I
NIH 129 F1
□ +/+ 
■ +/- 
□  -/-
Figure 12 - Morphological Analysis of TGFpl Knockout Conceptuses at 
11.5dpc.
Conceptuses generated by TGFpl+/- intercrosses were dissected free from the maternal 
tissue, morphologically assessed and genotyped by PCR of genomic DNA. A normal 
TGFpi+/+ conceptus at 11.5dpc (A), (B) has a full, branching plexus of yolk sac vessels 
containing haemoglobinised blood. (C) shows a healthy TGFpi+/+ embryo, whereas (D) 
illustrates a typical dead embryo dissected from a necrotic yolk sac. Note the 
developmental delay.
Scale bars (A), (B) = 850(nm (C), (D) = 675p,m.
bb = branchial bars, bv = blood vessel, h = heart, lb = limb bud, pe = pericardium, s = 
somite, w  = vitelline vessels.
AysV
+ / +
Figure 13 - Morphological Analysis of TGFpl Knockout Conceptuses at 
11.5dpc.
Compared to (A) and (B) (Figure 12), conceptuses (A), (B) and (C) displayed here all 
have defects of the extra-embryonic vasculature. (A) has a delicate, relatively unbranched 
yolk sac plexus. Some vessels appear anaemic and a large haemmorhage has occurred in 
the region of the embryonic heart. The yolk sac vessels in (B) also appear delicate, and 
have pronounced extra-embryonic anaemia. Yolk sac (C) shows a striking example of 
inadequate branching in the major yolk sac vessels. A small amount of haemoglobinised 
blood is present. The embryo in the yolk sac was found to be dead.
Scale bars = 850pm.
bv = blood vessel, ha = haemmorhage, ys = yolk sac.
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3.5 Analysis of Anaemia in TGF(3l Knockout 
Mid-Gestation Conceptuses.
3.5.1 No Variation in the Expression of ^-Globin mRNA is 
Seen In 8.5dpc FI Conceptuses from TGF(3l+/- Intercrosses.
Analysis of the gross anaemic phenotype of the TGFpl knockout mice is problematic; 
the observed vascular phenotype may have made an direct or indirect contribution to 
the apparently anaemic state of the yolk sac. Thus, the anaemic appearance of yolk 
sacs carrying a TGFpl null allele may be due either to a specific defect in the 
haemoglobinisation process, or to a reduction in the absolute number of circulating 
erythroid cells, or both. A reduction in circulating erythroid cells could be a secondary 
effect of the TGFpl knockout vascular phenotype, since the proper development of 
the blood islands is required for the differentiation of haematopoietic precursors (see 
Introduction).
In an attempt to address this problem, 30, FI conceptuses from four TG Fpl+/- 
intercross litters at 8.0-8.5dpc were dissected free from the maternal tissue, and fixed 
overnight in 4% PFA. Thereafter, they were hybridised by whole-mount in situ 
hybridisation with an antisense ^-globin mRNA probe, as described in Materials and 
Methods 2.8. A number of control embryos were hybridised using a sense ^-globin 
mRNA probe.
At 8.0-8.5dpc, the blood islands form an anastomosing corona around the top of the 
murine yolk sac. This spreads towards the base of the yolk sac as other blood islands 
in the yolk sac anastomose to form primitive blood vessels and by 9.0-9.5dpc, the 
vascular plexus of the yolk sac has begun to develop. During this period the vitelline 
artery and vein have started to branch, and other yolk sac vessels are formed. 
Haemoglobinised blood is visible in the yolk sac circulation.
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+/+ +/- -/-
0 0 0 0
+ 1 3 1
= 12.5% =20% =14%
++ 4 6 3
=50% =40% =43%
+++ 3 6 3
=37.5% =40% =43%
Total 8 15 7
= 100% = 100% = 100%
Table 16. There is No Difference in the Level of Hybridisation of a £-Globin 
Antisense mRNA Probe on 8-8.5dpc FI Conceptuses from TGFpi+/- Intercrosses.
30 FI conceptuses from TGFpl+/- intercrosses were hybridised with 
an antisense mRNA ^-globin probe by whole-mount in situ 
hybridisation. The intensity of signal was scored; 0, +, ++, +++, and 
the conceptus was photographed and genotyped by PCR.
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Figure 14 - £-globin Whole Mount In Situ Hybridisation on TGFpl+/- 
Intercross Litters at 8.5dpc.
>30 8.0-8.5dpc TGFpi knockout conceptuses were subjected to whole mount in situ 
hybridisation using an anti-sense ^-globin mRNA probe. The degree of positive staining 
was scored, and each embryo genotyped. Photographs (A), (B) and (C) show that there 
is no striking difference in the level of ^-globin mRNA expression regardless of TGFpl 
genotype at around 8.5dpc. The positive stain above corresponds to the anastomosing 
corona of blood islands seen in the developing yolk sac.
Scale bar = 150pm.
bi = blood islands, hf = head folds, ht = heart, ys = yolk sac.

In this experiment, the resulting level of ^-globin hybridisation was scored as 0, +, 
++, or +++ depending on signal intensity. Assessment of several landmark 
developmental features ensured that the conceptuses scored were of comparable 
developmental ages. Then the conceptuses were photographed and retrospectively 
genotyped by PCR (see Materials and Methods!. As shown in Table 16, there is no 
obvious genotypic relationship to the level of expression of ^-globin mRNA at 8.0- 
8.5dpc in FI conceptuses (see Figure 14).
Thus at 8.5dpc in FI conceptuses there is no clear genotype-specific difference in the 
expression level of ^-globin mRNA. This is in concordance with the findings of 
Dickson et al. (1995), working on a mixed genetic background. Dickson et al. (1995) 
also reported that by 9.5dpc there was an obvious downregulation of ^-globin mRNA 
positive cells in TGFpi mutant yolk sacs.
3.5.2 May-Grunwald Giemsa Staining Can Be Used to 
Identify Anaemia in FI TGF(il+/- Intercross Litters.
One of the defining characteristics of the TGFpl knockout phenotype is the 
occurrence of anaemia in the yolk sacs of TGFpl+/- and -/- conceptuses. At 8.0- 
8.5dpc the level of ^-globin mRNA expression in TGFpl+/+ and -/- yolk sacs is 
comparable. However, by 9.0-9.5dpc, the two genotypic classes are easily 
distinguishable. Dickson et al., 1995 postulated that this was due to an overall 
reduction in the number of circulating erythroid cells, not a specific defect in the 
haemoglobinisation process. This experiment can address the latter, but not the 
former, aspect of the TGFpl knockout anaemic phenotype.
In order to investigate further the anaemic mid-gestation phenotype of the FI TGFpl 
knockout conceptuses, the level of haemoglobinisation in erythroid cells was analysed 
histologically. Blood smears were made from the opened yolk sacs of the four litters 
of FI conceptuses used in Results 3.5.3, and stained with May-Grunwald Giemsa 
stain (see Materials and Methods). The littermates were dissected and morphologically 
scored at 9.5dpc and half of the embryo was retained for isolation of genomic DNA 
for genotyping by PCR. 29 slides were scored.
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+/+ +/- -/- Non-
Phenotypic
Phenotypic
Mean Proportion of
Haemaglobinised
Cells
0.43
± 0 .0 9
0.36 
± 0.10
0.25
± 0 .0 9
0.41
±0.08
0.25
±0.08
Mean Proportion 
of Dead/ Damaged 
Cells
0.15
±0.04
0.14
±0.05
0.17
±0.03
0.15
±0.04
0.17
±0.04
Number of Samples 9 14 6 20 9
Table 17. Assessment of Haemoglobinisation in FI Conceptuses from TG Fpl+/- 
Intercrosses at 9.5dpc.
The table shows figures derived from 29 informative blood smears 
from 9.5dpc littermates. Three, x 40 fields of view each containing 
>100 cells were counted and the proportion of haemoglohinised and 
dead/ damaged primitive erythroid cells for each conceptus calculated 
as a proportion of the total cells counted. On average, the total number 
of cells counted per conceptus was >500. Student’s t test was used to 
compare the different genotypic and phenotypic classes of data.
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Graph 13a. The Mean Proportion of Haemoglobinised Cells (score 1) 
Observed in Blood Smears from TGFpi+/- Intercross Litters in Each 
Genotypic Class.
Blood smears were made from morphologically scored littermates from TGFpl+/- 
intercrosses. The graph shows the mean proportion of haemoglobinised cells (score 1) 
counted in blood smears from yolk sacs of genotypes 1 (TGFpi+/+), 2 (TGFpi+/-) and 
3 (TGFpl-/-). There is a significant difference between the mean proportion of 
haemoglobinised cells observed in TGFpi+/+ and -/- conceptuses.
Graph 13b. The Mean Proportion of Haemoglobinised Cells (score 1) 
Observed in Blood Smears from TGFpl+/- Intercross Litters from Normal 
and Abnormal Yolk Sacs.
Blood smears were made from morphologically scored littermates from TGFpi+/- 
intercrosses. The graph shows the mean proportion of haemoglobinised cells (score 1) 
counted in blood smears from conceptuses scored upon dissection as anaemic (p) or 
normal (/). There is a significant difference between the mean proportion of 
haemoglobinised cells observed in conceptuses scored as anaemic and normal.
Box and W hisker Plots: The data is presented as follows; the box represents the 1st
to 3rd quartiles, the line in the centre of the box is the median value and the whiskers
cover the remaining data. Stars represent individual pieces of outlying data.
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Graph 14a. The Mean Proportion of Dead/ Dying Cells (score 2) Observed 
in Blood Smears from TGFpl+/- Intercross Litters in Each Genotypic 
Class.
Blood smears were made from morphologically scored littermates from TGFpi+/- 
intercrosses. The graph shows the mean proportion of dead/ dying cells (score 2) counted 
in blood smears from yolk sacs of genotypes 1 (TGFP1+/+), 2 (TGFpl+/-) and 3 
(TGFpl-/-). There is no significant difference between the mean proportion of dead/ 
dying cells observed in TGFpl+/+ and -/- conceptuses.
Graph 14b. The Mean Proportion of Dead/ Dying Cells (score 2) Observed 
in Blood Smears from TGFpi+/- Intercross Litters from Normal and 
Abnormal Yolk Sacs.
Blood smears were made from morphologically scored littermates from TGFpl+/- 
intercrosses. The graph shows the mean proportion of dead/ dying cells (score 2) counted 
in blood smears from conceptuses scored upon dissection as anaemic (p) or normal (/). 
There is no significant difference between the mean proportion of dead/ dying cells 
observed in conceptuses scored as anaemic and normal on dissection.
Box and W hisker Plots: The data is presented as follows; the box represents the 1st
to 3rd quartiles, the line in the centre of the box is the median value and the whiskers
cover the remaining data. Stars represent individual pieces of outlying data.
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Figure 15 - A ssessm ent o f the Proportion of H aem oglobinised C ells from  
TGF|31 K nockout C onceptuses at 9.5dpc.
Blood smears were made from dissected and morphologically scored yolk sacs 
(Materials and Methods 2.5.5). The blood was subjected to May-Grunwald Geimsa 
staining and the proportion of haemoglobinised and dead/ dying cells calculated. On 
average a total exceeding 500 cells from 3 fields of view were counted per smear. Pinkish 
cells were counted as haemoglobinised (examples here indicated by arrowheads). The 
results suggested a significant reduction in the proportion of haemoglobinised cells 
present in TGF|31-/- and anaemic yolk sacs compared to normal littermates. The 
proportion of cells scored as dead/ dying did not alter with respect to genotype/ 
phenotype.
Scale bar = 12pm.
Blood cells were counted thus: Total cells in three, x 40 magnification fields of view 
were counted on each slide and the number of cells judged to be haemoglobinised and 
the number appearing to be dead/ damaged recorded. Each field of view counted 
contained >100 cells - on average, the number of primitive erythroid cells counted per 
conceptus exceeded 500. A pinkish hue identified the onset of haemoglobinisation of 
these cells (Weiss et al.y 1994) (Figure 15). The total proportion of haemaglobinised 
and dead/ damaged cells was calculated for each yolk sac (Table 17). This data is also 
presented in box-plots (Graphs 13 and 14). Clearly there is a striking difference in the 
proportion of haemoglobinised cells counted between TGFpl+/+ and -/- conceptuses 
(p=<0.01), also between conceptuses scored as anaemic and non-anaemic at 
dissection (p=<0.01). However, the proportion of dead/ dying erythroid cells appears 
to be indistinguishable between genotypic and phenotypic classes (p=>0.05). This 
observation was validated by statistical comparison of these data sets using Student’s t 
test.
Thus, there appears to be a delay/ specific defect in the process of haemogloginisation 
of blood cells in TGF(31 knockout yolk sacs, rather than an illusion of anaemia created 
by blood loss from defective vessels. However, the latter may contribute to the 
anaemic phenotype and to the overall reduction in circulating erythroid cells as 
reported by Dickson etal. (1995).
3.6 Histological Analysis of the TGF|31 
Knockout Mid-Gestation Phenotype.
3.6.1 Specific A bnorm alities in D issected Yolk Sacs from F I  
TG Fpi+/- Intercross Litters.
In a normal yolk sac the mesothelial and endodermal cell layers are closely apposed 
except in the regions where they are separated by blood vessels. However, reports of 
the mixed genetic background TGFpl and TpR-II (Dickson et al., 1995) (Oshima et 
at., 1996) knockout mice mid-gestation phenotypes both demonstate specific 
abnormalities of yolk sac integrity.
In order to assess the yolk sac phenotype of TGFJ31 knockout mice, four litters of FI 
conceptuses were dissected and morphologically scored at 9.5dpc. Half of the embryo 
was used for isolation of genomic DNA for genotyping by PCR; and the rest of the
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conceptus was placed into a vial of fresh 4% PFA and fixed overnight prior to 
embedding and sectioning (see Materials and Methods).
Sections of yolk sac from each conceptus were examined histologically. Three 
sections from each of the 32 conceptuses were scored for abnormalities, and scored on 
a scale of 1-8. There were two main defects identified: Firstly, the degree of buckling 
i.e. the ‘looped out’ appearance of the yolk sac endoderm relative to the endothelial 
and mesothelial layers; and secondly, the amount of shearing i.e. the separation of 
contacts along the plane of the endothelial cells or dilation of endothelial tubes (see 
Figure 16 for photographic examples). In both cases a score of 1-4 denoted a normal 
yolk sac, a score of 5-6 was counted as mildly affected and a score of 7-8 was counted 
as severely affected. These results are shown in Table 18 and Graph 15.
The results imply that the presence of a TGFpl null allele has either directly or 
indirectly reduced the level of cell-cell adhesion in the FI yolk sacs in this study. This 
has resulted in an increased incidence of shearing and and buckling between the 
endothelial layers in TGFpi-/- and TGFpl+/- yolk sacs. It is plausible also that the act 
of tearing the yolk sac, making blood smears and the retrieval of half the embryo for 
genotyping as well as the fixation proccess have contributed to an accentuated result.
These findings comply with those of Dickson et al. (1995) working on a mixed 
genetic background. TGFpi is known to modulate both the formation of the ECM, 
and the proliferation of endothelial cells (see Introduction!. Dickson et al. reported no 
difference in either the overall number of endothelial and mesothelial cells, nor in the 
levels of Bromodeoxyuridine (BrdU) incorporation into the nuclei of yolk sac 
endothelial and mesothelial cells between TGFpl+/+ and -/- conceptuses. Therefore, 
endothelial hyperplasia was excluded as a cause of the observed defects. However, a 
reduction in the expression levels of flk -1, a molecular marker of embryonic 
endothelial cells was identified in TGFpl-/- yolk sacs (Dickson et at., 1995) which 
implies a possible defect of maturation/ differentiation in the endothelial cells in 
TGFpi knockout yolk sacs.
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Score +/+ +/- -/-
1-4 5 8 0
=Normal yolk sac ( 1) (2)[1]
5-6 1 10 5
=MiId defects (4)[1] (2)[2]
7-8 0 1 1
=Severe defects U )[0]
Total number of 6 20 6
yolk sacs scored d )[0] (7) [2] (2) [2]
Mean 3.7 ± 0.7 4.9 ± 1.2 5.7 ± 0.7
Table 18. Histological Assessment of Yolk Sac Buckling and Shearing in FI 
Conceptuses from TGFpi+/- Intercrosses at 9.5dpc.
Conceptuses from four FI litters were morphologically scored, 
genotyped by PCR and the opened yolk sacs embedded and analysed 
histologically for shearing and buckling. Three sections from each 
conceptus were examined and a quantitative score assigned for each 
attribute. Numbers in parenthesis indicate those conceptuses which 
were scored as slightly phenotypic upon dissection, that is the yolk sac 
vasculature was developing, but may have appeared delicate or been 
slightly developmentally delayed. The numbers in square brackets 
indicate the conceptuses which were scored as severely phenotypic. 
These conceptuses had major defects of the extra-embryonic 
vasculature, ranging from a lack of branching and major vessel 
formation to a completely avascular yolk sac. Data was tested for 
statistical significance using the Student’s t test.
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Graph 15a. Abnorm alities Observed via Histology in Dissected Yolk Sacs 
from T G Fpl+/- Intercross Litters
The graph shows the mean score from opened, embedded yolk sacs of genotypes 1 
(TGFpl+/+), 2 (TGFP1+/-) and 3 (TGFpl-/-). Sections of each yolk sac were assessed 
for the degree of endodermal buckling and shearing between the tissue layers, on a scale 
of 1-8, where 8 represented the most severe defect. There is a significant difference 
between the mean scores of TGFpl+/+ and -/- conceptuses.
Graph 15b. Abnorm alities Observed via Histology in Dissected Yolk Sacs 
from T G Fpl+/- Intercross Litters, Expressed as a Function of Phenotype.
Tissue sections were made from the opened, embedded yolk sacs of morphologically 
scored littermates from TGFpl+/- intercrosses. These were assessed for the degree of 
endodermal buckling and shearing between the tissue layers, on a scale of 1-8, where 8 
represented the most severe defects. The graph shows the mean scores from conceptuses 
which, upon dissection had a defective extra-embryonic vasculature (p) or were normal 
(/). There is no significant difference between the mean scores for conceptuses scored as 
phenotypic and normal on dissection due to the observed range of phenotypic severity.
Box and Whisker Plots: The data is presented as follows; the box represents the 1st
to 3rd quartiles, the line in the centre of the box is the median value and the whiskers
cover the remaining data. Stars represent individual pieces of outlying data.
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Figure 16 - Histological Analysis of Dissected TGFpl Knockout Yolk 
Sacs at 9.5dpc.
Yolk sacs from embryos generated by TGFpl+/~ intercrosses were dissected free from 
the maternal tissue and morphologically scored. Half of the embryo was retained for 
genotyping by PCR. Sections from the opened, embedded yolk sacs were examined 
histologically. Each yolk sac was scored for endodermal buckling and shearing of the 
tissue layers in the plane of the endothelial cells. (A) shows a normal TGFpl+/+ yolk 
sac. The vessels are discrete and contain blood cells. (B) shows an abnormal yolk sac 
from a TGFpi-/- embryo. There is minimal association between the tissue layers, which 
has resulted in the formation of dilated endothelial tubes.
Scale bar = 45pm.
be = blood cell, di = dilated endothelial tube, en = endothelium, n = endoderm, v = 
vessel. Arrowheads indicate regions where cell - cell adhesion has been disrupted.
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3.6.2 Analysis of Unperturbed T G Fpl Knockout Conceptuses 
in utero by Radioactive In Situ Hybridisation.
The gross yolk sac defects seen in TGFpl null animals at 9.5dpc are evident when the 
yolk sac is sectioned and examined histologically. However, in these cases the yolk 
sac is opened prior to embedding to facilitate excision of half of the embryo for 
genotyping by PCR. Consequentially, the mechanical pressures exerted upon the yolk 
sac during dissection and fixation may have an effect on the typical shearing and 
buckling defects identified in mutant yolk sacs. It is also impossible to draw 
conclusions about leaks of blood cells from defective yolk sac vasculature in yolk sacs 
processed in this manner.
In order to examine and compare yolk sacs from TGFpl+/- intercrosses whilst 
minimising secondary effects on the phenotype, two FI and one NIH litter at 9.5dpc 
were dissected free of the uterus only and embedded while still in the decidual tissue. 
The conceptual masses were fixed overnight in 4% PFA, embedded and sectioned 
(Materials and Methods). To genotype the embryos with minimal disruption to the 
conceptus, sections were selected for the presence of optimal tissue for genotyping by 
radioactive in situ hybridisation using an antisense mRNA 1.2kb TGFpl probe 
(Materials and Methods 2.7). TGFpl is known to be expressed in the endocardium, 
endothelial cells of the embryo and allantois at 9.5dpc. Control sections were 
hybridised with a sense mRNA 1.2kb TGFp2 probe.
The resulting sections were scored for probe signal intensity (see Table 19) in the 
relevant tissues and therefore classified either as TGFpi(+/+ or +/-), or TGFpl-/-. 
Hereafter the former class of conceptuses will be referred to a Class (i) - and the latter 
class of conceptuses referred to as Class (ii). Since TGFpl is known to be strongly 
expressed in the deciduum at 9.5dpc, this was used as a positive experimental control. 
That is, if an embryo had a low TGFpl signal intensity, yet a cell-specific, positive 
signal in the deciduum it was interpreted that the in-situ hybridisation was successful 
and that the embryo was TGFpl-/- (see Figure 17).
To summarise; Out of 23 conceptuses scored, 18 were scored as positive; i.e. 13 with 
a weak signal and 5 as strongly positive. These might comprise the TGFpl+/- and 
TGFpl+/+ conceptuses respectively. More importantly, 5 were clearly scored as 
TGFpl-/-, i.e. the percentage of the total number of conceptuses estimated to be 
TGFpl-/- was close to the expected 25% of the total number scored.
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Class (i). Class (ii).
Strain Strong TGFpi Intermediate No TGFpl Total Litters
Signal TGFpl Signal Signal
NIH 2 5 1 8 1
(1) [2] (1)
FI 3 8 4 15 2
(1) (2) [1] (1) [2]
Total 5 13 5 23 3
(1) (3) [3] (2) [2]
Table 19. Estimation of Genotype of Conceptuses from TGFpl+/- Intercrosses at 
9.5dpc by Radioactive In Situ Hybridisation.
Certain sections from NIH and FI conceptuses at 9.5dpc from  
TGFpl+/- intercrosses were subjected to radioactive in situ 
hybridisation using a full length TGFpl antisense mRNA probe. The 
level of intensity of the resulting signal was scored and classified as 
TGFpl(+/+/ +/-) i.e. Class (i); or TGFpl-/- i.e. Class (ii). Parallel 
sections to those used for radioactive in-situ hybridisation were 
examined histologically. Sections were scored on a number of criteria 
i.e. yolk sac integrity and the development of the embryo. Each 
conceptus was classified as normal, mildly phenotypic or severely 
phenotypic. In each genotypic class, the numbers in parenthesis 
represent conceptuses scored as mildly affected and numbers in square 
brackets show the number of conceptuses judged to be severely 
phenotypic.
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Figure 17 - Estimation of the Genotype of Intact TGFpl Knockout 
Conceptuses at 9.5dpc Using Radioactive In Situ Hybridisation.
Suitable sections from TGFpl+/- intercross litters were subjected to radioactive in situ 
hybridisation using a full-length TGFpi antisense mRNA probe. (A), (C), (E) and (G) 
show the corresponding darkfield images to those shown in (B), (D), (F) and (H). (A) 
and (B) show an embryo and decidua which were strongly positive for TGFpi. This 
conceptus was thus classified as class (i). (C), (D), (E) and (F) illustrate examples of 
conceptuses which contained an embryo which was negative for TGFpl, whereas the 
decidua was positive for TGFpl. These conceptuses were classified as class (ii). A sense 
TGFpl mRNA probe was used as a negative control (G), (H).
Scale bar = 750pm.
d = decidua, h = heart, hf = head folds, nt = neural tube.

3.6.3 Identification of Conceptuses with the TG Fpi 
Knockout Phenotype at 9.5dpc.
Neighbouring sections to those used in Results 3.6.1 were used for histological 
analysis. This strategy allowed the histological examination of the yolk sac in the 
closest approximation possible of its in vivo state. By embedding and sectioning the 
conceptuses without removing the decidual tissue, the mechanical stresses on the yolk 
sacs were minimised. Selected sections were subjected to haematoxylin and eosin 
staining, then examined for defects of the embryo and extra-embryonic tissue. 
Conceptuses used were all embedded and sectioned in the same orientation.
It was found that defining phenotypic attributes fell into the following categories: i) 
shearing of the yolk sac along the plane of the endothelial cells, typically resulting in 
the appearance of greatly extended endothelial tube and exovasation of erythroid cells 
into the yolk sac cavity; ii) oedema and necrosis of the embryo and iii) developmental 
retardation; iv) two conceptuses exhibited specific defects of the developing placenta. 
The yolk sac, developing placenta and embryo proper in each conceptus were all 
scored as either being normal, having a mild defect, or having severe defects (see 
Figure 18).
As shown in Table 19, 4/ 5 of the conceptuses scored as having no signal when 
hybridised with a full-length TGFpl riboprobe were also judged to be phenotypic. 
Conversely, 1/ 5 conceptuses scored as having a strong TGFpl signal after 
radioactive in situ hybridisation was found to have defects of the extra-embryonic 
tissue. 6/ 13 of the conceptuses scored as being weakly positive for TGFpi signal 
exhibited histological traits of the TGFpl knockout phenotype. These results are in 
concordance with the data reported in Results 3.3; i.e. the TGFpl knockout 
phenotype shows incomplete penetrance at mid-gestation on the NIH and FI genetic 
backgrounds; and, a proportion of TGFpl+/- conceptuses have been identified as 
severely phenotypic at 9.5 and 11.5dpc on both genetic backgrounds.
The main abnormality occurring in all strains studied at mid-gestation is a defect of 
cell-cell adhesion in the yolk sac manifested as shearing of tissue layers along the 
plane of the endothelial cells (see Figure 20). Since no buckling was seen in these 
complete yolk sacs compared to the opened yolk sacs examined in Results 3. 5. 2, it is 
likely that buckling is a secondary effect of the dissection, fixation and embedding 
process in opened yolk sacs. The varying degrees of leakage of blood cells into the
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yolk sac cavity seen in these conceptuses is probably a secondary effect of the vascular 
aspect of the TGFpl knockout phenotype. This may have been a contributory factor in 
the anaemic appearance of some whole conceptuses with the TGFpi knockout 
phenotype, also the finding by Dickson et al. (1995) that whole-mounted 9.5dpc 
TGFpi-/- yolk sacs had a 90% reduction in the number of circulating erythroid cells.
The embryo per se in each conceptus was assessed; in particular, the cardiovascular 
system was examined. No specific abnormalities were seen. However, one embryo, 
scored after radioactive in situ as having an intermediate amount of TGFpl signal, 
exhibited signs of necrosis; and one, scored after radioactive in situ as having no 
signal, was developmentally retarded (see Figure 19). These defects are possibly the 
secondary consequence of yolk sac insufficiency.
The developing placenta was examined in the region of the chorio-allantoic 
connection. Gross morpholgical scoring of littermates from TGFpl+/- intercrosses at 
9.5dpc revealed defects of the chorio-allantoic connection in a number of conceptuses 
on all genetic backgrounds. These fell into a number of classes; either the chorion was 
distended with blood, the umbilical vessels contained blood clots or the umbilical 
artery and /or vein appeared to be empty. In extreme cases there had been failure to 
make a successful chorio-allantoic connection. Unfortunately, it was impossible to 
score accurately the allantois’ in these conceptuses for malformations as had been 
planned. All conceptuses used had been embedded in the same orientation, however 
the angle of the umbilical vessels remained unpredictable and resulted in uninformative 
sections. In this study, 2 conceptuses assessed as having a severe abnormal phenotype 
were also scored as possibly having a reduced or flattened spongiotrophoblast layer 
(Figure 19). It is unknown whether this defect was a primary or secondary effect of 
the knockout.
The employment of this strategy has allowed an appraisal of whole NIH and FI 
conceptuses from TGFpl+/- intercrosses whilst causing minimal disruption to the 
yolk sac structure. The TGFpi knockout yolk sac phenotype, identified by gross 
morphological scoring, has been characterised histologically, i.e. shearing between the 
endothelial layers, dilation of the endothelial tubes and exovasation of erythroid cells 
into the yolk sac cavity. In this limited survey there does not appear to be any disparity 
in the manifestation of the mid-gestation phenotype with respect to genetic 
background. However, a far larger and more detailed study would be required to 
confirm this.
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Figure 18 - H istological Assessment of Intact TGFpi Knockout
Conceptuses at 9.5dpc (1).
Sections parallel to those shown in Figure 17 were selected for histological assessment of 
the TGFp 1 knockout mid-gestation phenotype. In particular the embryonic cardiovascular 
system, the yolk sac, the allantois and the placenta were inspected. (A) shows a class (i) 
conceptus whereas (B) and (C) are class (ii). Note the developmental delay of 
approximately 1.0-1.5 days suffered by conceptus (C).
Scale bar = 300pm.
h = heart, hf = head folds, nt = neural tube, p = placenta, ys = yolk sac.

Figure 19 - H istological Assessm ent of Intact TGFpl Knockout
C onceptuses at 9.5dpc (2).
Photographs (A) and (B) are higher magnifications of the yolk sacs of embryos (A) and 
(B) (Figure 18). Photographs (C) and (D) are higher magnifications of sections (A) and 
(B) respectively. (A) and (C) illustrate normal TGFpl+/+ yolk sac structure. The vessels 
are discrete and contain blood cells. Reduced cell-cell adhesion has resulted in dilated 
endothelial tubes and exovasation of blood cells in photos (B) and (D). Arrowheads 
indicate obvious areas of disruption of cell-cell contacts.
Scale bar = (A), (B) 50pm (C), (D) 25pm.
be = blood cell, di = dilated endothelial tube, en = endothelium, n = endoderm, v = 
vessel. Arrowheads indicate regions where cell - cell adhesion has been disrupted.
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Figure 20 - H istological Assessm ent of Intact TGFpl Knockout
Conceptuses at 9.5dpc (3).
Conceptuses (A) and (B) (Figure 18) were scored for defects of the extra-embryonic 
vasculature including placental defects. A normal placenta has organised tissue layers 
clearly visible (A). Conceptus (B) which was classified class (i), exhibited a 
disorganised, less dense placenta in which the spongiotrophoblast layer appeared 
underdeveloped. Photograph (C) is a higher magnification of developmentally delayed 
conceptus (C) (Figure 18). The arrowhead indicates an area of infiltration in the head fold 
mesenchyme. The tissue appear less dense, and suggests the onset of necrosis.
Scale bar = 50pm.
hf = head folds, gi = giant cells, la = labyrinthine spongiotrophoblast, sp = 
spongiotrophoblast.
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3.7 Reduced a  Smooth-Muscle Actin Expression 
in TGFpl-/- Yolk Sacs.
Pericyte cells are found in close contact with endothelial cells in the developing vessel 
wall and are thought to play a regulatory role in microvascular integrity and endothelial 
cell function during angiogenesis. There have been a number of reports suggesting a 
connection between pericytes and TGFp (Sato & Rifkin, 1989 & Antonelli-Orlidge et 
al., 1989). a  smooth-muscle actin is known to be a marker for pericytes (Herman et 
al., 1985). TGFpl is reported to induce the expression of a  smooth-muscle actin in 
2D microvascular culture systems (Madri et al., 1992) and to induce the expression of 
a  smooth-muscle actin in pericytes in culture (Verbeek et a l., 1994). Hence, an 
investigation of a  smooth-muscle actin protein expression was undertaken in 
conceptuses from TGFpi+/- intercrosses and is described below.
3.7.1 Opened FI Yolk Sacs.
The dissected, opened yolk sac, half-embryo and chorion from FI conceptuses were 
sectioned and examined histologically in Results 3.5.3. Genomic DNA was isolated 
from the removed half-embryo and used to genotype the conceptus by PCR. In this 
experiment, neighbouring sections of tissue to those used in Results 3.5.2 which 
contained both of large and small vessels were subjected to immunohistochemistry 
using an antibody for a  smooth-muscle actin (see Materials and Methods!. Five slides 
prepared from normal TGFpl+/+ conceptuses and seven slides prepared from 
TGFpl+/- and -/- conceptuses judged to have abnormal yolk sac vasculature were 
used. Sections of a 14.5dpc embryos were used also as a positive experimental 
control.
a  smooth-muscle actin positive vessels were counted in 3 sections per conceptus. It 
was found that 5/ 5 of the TGFpl+/+ yolk sacs contained a  smooth-muscle actin 
positive cells, as did 3/ 7 of the phenotypic yolk sacs. However, 4/ 7 TGFP1+/- and 
-/- abnormal yolk sacs were completely devoid of a  smooth-muscle actin positive 
vessels (see Table 20).
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3.7.2 Unperturbed NIH and FI Yolk Sacs.
Undisrupted FI and NIH conceptuses were sectioned and examined histologically in 
Results 3.6. The embryos were classified as either Class (i) (TGFpl+/+ / +/-) or 
Class (ii) (TGFpi-/-) by radioactive in-situ hybridisation. In this experiment, 
neighbouring sections of tissue to those used in Results 3.6.2 were subjected to 
immunohistochemistry using an antibody for a  smooth-muscle actin (see Materials 
and Methods). Six slides prepared from normal Class (i) conceptuses and seven slides 
prepared from conceptuses judged to have a vascular phenotype which also failed to, 
or which hybridised very weakly with the TGFpl radioactive in-situ probe were 
utilised. The tissue used in this experiment facilitated the use of the embryonic heart as 
an internal positive control on each slide. The heart provides a strong positive signal 
for a  smooth-muscle actin. Sections of a 14.5dpc embryos were used also as a 
positive experimental control.
a  smooth-muscle actin positive vessels were counted in 3 sections per conceptus. 
Since it is known that a  smooth-muscle actin positive cells are found in the wall of 
developing major vessels, particular attention was paid to the umbilical and vitelline 
vessels. It was found that 5/ 6 of the Class (i) yolk sacs and major vessels contained a  
smooth-muscle actin positive cells, as did 2/ 7 of the phenotypic yolk sacs. 1/ 6 of the 
Class (i) extra-embryonic tissue and 1/ 7 of the phenotypic yolk sacs examined 
showed an intermediate number of positive cells. That is some positive cells were 
visible in the smaller yolk sac vessels, but none were seen in the major vessels. 4/ 7 
abnormal yolk sacs had no a  smooth-muscle actin positive vessels (see Table 20).
3.7.3 The Vascular Defects Observed at 9.5dpc in T G F p i-/-  
Yolk Sacs May Be Due to a Reduced Number of Perivascular  
Pericytes.
In both of the above experiments the level of a  smooth-muscle actin expression in the 
yolk sac and major vessels of normal conceptuses and those judged to have the 
TGFpi knockout phenotype were compared. Sections from a non-transgenic 14.5dpc 
embryo were used in both experiments as a positive control for the antibody. In the 
unpertubed yolk sacs, the embryonic heart could also used as an intrinsic positive 
control for a  smooth-muscle actin staining.
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Summary of a  smooth- 
muscle actin staining in 
opened yolk sacs.
Summary of a  smooth- 
muscle actin staining in 
unperturbed yolk sacs.
TG FP1+/+, 
normal yolk sacs
5/ 5 strongly positive 
0/ 5 negative
5/ 6 strongly positive 
1/ 6 weakly positive 
0/ 6 negative
TGFP1+/- and-/-, 
abnormal yolk sacs
3/ 7 strongly positive 
4/ 7 negative
2/ 7 strongly positive 
1/ 7 weakly positive 
4/ 7 negative
Table 20. a  Smooth-Muscle Actin Staining in Opened and Unperturbed Yolk Sacs 
from Normal and Abnormal TGFp 1 Knockout Conceptuses at 9.5dpc.
Normal and abnormal, dissected and unperturbed yolk sacs from  
TGFpi+/- intercross litters were stained with an antibody for a  
smooth-muscle actin and the number of positive staining extra- 
embryonic vessels counted in three sections from each conceptus. Yolk 
sacs which did not appear to have any major vessels were not included 
in the study.
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Figure 21 - Expression of a  Sraooth-Muscle Actin Protein in TGFfM
Knockout Conceptuses at 9.5dpc (1).
a  smooth-muscle actin is a marker for perivascular pericytes, cells involved in 
maintaining vascular integrity. Intact and dissected yolk sacs were incubated with an a  
smooth-muscle actin antibody and the number of positive-staining major vessels 
calculated. In all experiments sections from a 14.5dpc embryo were included as a positive 
control (A). (B) shows an example of positive a  smooth-muscle actin staining in the 
heart, and (C) is an example of positive a  smooth-muscle actin staining in the allantois.
Scale bar = (A) (B) 125pm (C) 50pm.
al = allantois, ht = heart, lu = lung, nt = neural tube, ve = vessel.
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Figure 22 - Expression of a Smooth-Muscle Actin Protein in TGF(31
Knockout Conceptuses at 9.5dpc (2).
This panel shows an example of major vessels from class (i) and class (ii) 
conceptuses showing contrasting levels of a  smooth-muscle actin staining. (A) and 
(B) are photos of vitelline vessels, (C) and (D) show large yolk sac vessels. Note 
that (B) and (D) are class (ii) conceptuses - and both are negative for a  smooth- 
muscle actin staining compared to (A) and (C), class (i) littermates.
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In both cases, the only conceptuses found to be devoid of any a  smooth-muscle actin 
positive cells in the extra-embryonic vasculature were TGFpl-/- or TGFpi+/- and 
severely abnormal. However, 4/ 14 TGFpl-/- or TGFpl+/- severely abnormal 
conceptuses scored had a  smooth-muscle actin positive cells in the yolk sac and/ or 
major vessels. This finding may be explained by the range of severity of the TGFpl 
knockout phenotype at mid-gestation, the influence of maternal TGFpi on the 
developing conceptus and a possible requirement of a threshold number of pericytes 
for vessel intergrity.
Thus, the defects in the murine yolk sac vasculature observed at mid-gestation in 
TGFpi knockout conceptuses may be due in part to the effects caused by an absence 
of, or defect in, the normal differentiation of pericytes. Photographic examples of a  
smooth-muscle actin positive and negative TGFp 1 knockout embryos and yolk sacs 
are shown in Figures 21 and 22).
3.8 The Possible Involvement of a Genetic 
Modifier Linked to D 5 M U 2 6 8  in Determining 
Embryonic Phenotype.
3 .8 .1  Screening Scored F2 TG Fpl+/- and -/- Conceptuses  
from TG Fpl+/- Intercrosses.
Concomitant work by this group has shown that a strain-specific polymorphism in a 
modifier gene exists between NIH and C57 strains of mice. This modifier 
polymorphism is estimated to be responsible for 80% of the variance in genetic effect 
of the pre-natal lethal phenotype of mice carrying 2 copies of the C57 polymorphism. 
D5Mit268 is genetically linked to this modifier, and therefore an excellent marker for 
this gene (Bonyadi etal.> 1997).
By 3 weeks of age a significant number of C57 TGFp 1+/- animals have died due to an 
unknown cause; this is not the case with NIH TGFpl+/- animals. 89% of C57 
TGFpi-/- embryos die before 9.5dpc whereas 80% of NIH TGFpl-/- conceptuses 
survive to birth (Bonyadi e ta i, 1997). The majority of FI TGFpl-/- conceptuses die 
at 10.5-12.0dpc with yolk sac insufficiency. Since there is an obvious disparity in the 
onset and penetrance of the TGFpi knockout phenotype on the different genetic 
backgrounds studied in this project, the association between phenotype, TGFpl
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genotype and strain-specific alleles of the modifier gene at 9.5dpc was studied in an 
attempt to dissect the role of the modifier gene in prenatal lethality.
On an FI genetic background, all embryos should be heterozygous at D5Mit268y with 
one allele from the NIH strain (N) and one from the C57 strain (C). Likewise every 
embryo on an NIH genetic background should be homozygous NN at D5Mit268, and 
C57 conceptuses should all be homozygous CC at D5MU268 (see Discussion 4.4.2). 
The effect of this polymorphism on the distribution of the TGFpl knockout 
phenotypes was investigated in >260, 9.5dpc F2 embryos from TGFpl+/- 
intercrosses. The F2 genetic background was chosen for this study because each 
embryo has a 1 : 2 : 1 chance of being either NN : CN : CC at D5MU268. Therefore, 
using D5Mit268, it was possible to follow non-random segregation of alleles of the 
modifier gene.
The F2 conceptuses were dissected free of maternal tissue and scored using an 
objective morphological scoring system. Genomic DNA was isolated from the whole, 
cleaned conceptus and used to genotype and screen the embryo by PCR (Materials and 
Methodsf The observed TGFpi genotype distribution and ratio of normal and 
abnormal conceptuses are shown in Table 21 and Graphs 16 and 17. All of the defects 
identified by morphological scoring were comparable to any seen at mid-gestation on 
the other genetic backgrounds studied, i.e. inadequate yolk sac vasculature, an 
abnormal allantois and/ or yolk sac anaemia. These defects occurred solely in 
TGFpl+/- and -/- conceptuses.
It is estimated that 65% of the TGFpl-/- animals die in utero (M. Bonyadi, pers. 
comm.). No significant loss of F2 embryos had occured prior to 9.5dpc. However, 
when the TGFpl+/+ : + / - : - / -  1 : 2 : 1  genotype ratio for phenotypically normal 
conceptuses was calculated; p=<0.01. The number of normal conceptuses was 
calculated by subtracting those classified as severely abnormal from the total in each 
genotypic class (see Table 22). Therefore, F2 TGFpl-/- conceptuses die at mid­
gestation, in similar proportions to those on an FI genetic background.
Tables 21, 22 and 23. Correlation of TGFpi Knockout Phenotype, Genotype and 
Screening Class in 9.5dpc F2 Conceptuses.
>260 embryos from TGFpi+/- intercrosses on an F2 genetic 
background were morphologically scored and genotyped by PCR. All 
of the TGFpi+/- and -/- conceptuses were screened fora  strain-specific 
polymorphism at D 5 M U 2 6 8 , the locus of a strain-specific TGFpl 
modifier gene. The screening and scoring data are correlated here in an 
attempt to provide an accurate picture of the role of the modifier gene 
in the developmental onset of TGFpi phenotype. Numbers in 
parenthesis represent the number of conceptuses from each genotypic 
or screening class (NN/ CN/ CC) scored as severely abnormal. The 
observed results were analysed using a x2 ‘goodness of fit’ statistical 
test. The number of normal embryos was calculated by subtracting the 
number of severely abnormal conceptuses from the total in each 
genotypic/ screening class.
Table 21. Genotype and Abnormal Phenotype Ratios of F2 Conceptuses 
at 9.5dpc from TGFpl+/- Intercrosses.
Strain +/+ +/- -/- Dead Total
F2 62 129 53 18 262
(0) (22=17%) (28=53%)
Strain Ratio
TGFpl
+/+ :+/- : -/-
1 : 2 : 1
TGFpl
+/+ :+/- : -/-
Total
embryos
1 : 1 
TGFpi 
+/+ : -/- 
Total 
embryos
1 : 2 : 1  
TGFpl 
+/+ :+/- : -/- 
Normal 
embryos
F2 1 : 2.1 : 0.8 p=0.28 p=0.35 p=<0.01
Table 22. Incidence of Phenotype with a TGFpl Strain-Specific  
Polymorphism in F2 TGFpi+7- and -/- Embryos at 9.5dpc.
Genotype NN at 
D 5 M U 2 6 8
CN at 
D 5 M U 2 6 8
CC at 
D 5 M i t 2 6 8
Total NN : NC : CC 
Ratio
F2+/- 30
(2=7%)
66
(9=14%)
33
(11=33%)
129
(22=
17%)
1 : 2 : 0.9
¥ 2 - 1 - 14
(2=14%)
31
(19=61%)
8
(7=88%)
53
(28=
53%)
1 : 2.2 : 0.6
Table 23. Analysis of the Incidence of a Marker for a TGFpl Strain- 
Specific Modifier Gene and Phenotype in F2 TG Fpi-/- Embryos at 
9.5dpc.________ ___________________________________ _________________
Total Embryos 
1 : 2 : 1  
NN : CN : CC
Severely Abnormal 
Embryos 
1 : 2 : 1  
NN : CN : CC
Normal Embryos 
1 : 2 : 1  
NN : CN : CC
F2 TGFP1+/- p=0.78 p=0.02 p=0.61
F2 TGFpl-/- p=0.23 p=0.07 , .. ................. P=0.01
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Graph 16. F2 TGFpi +/+ : +/- : 1 : 2 : 1 Ratios at 9.5dpc.
The expected ratio of TGFpl+/+ : +/-: -/- animals generated by TGFpl+/- intercrosses at 
any developmental stage is 1 : 2 : 1 .  Graph 16 shows the observed genotype ratios of F2 
conceptuses at 9.5dpc. In the calculation of ratios, the number of TGFpl+/+ conceptuses 
in each genotypic class was taken as ‘ 1’. There is no significant loss of TGFpi+/- or -/- 
animals prior to 9.5dpc.
Graph 17. Observed Percentage of Severely Abnormal F2 TGFpl 
Knockout Conceptuses at 9.5dpc in Each Genotypic Class.
Upon dissection each TGFpl knockout conceptus was morphologically scored. Graph 
17 shows the percentage of F2 conceptuses which were scored as being severely 
abnormal in each genotypic class. Only a proportion of the total TGFpl+/- and -/- 
embryos scored in each genotypic class were scored as severely abnormal.
□  +/+ 
■  +/-
□  -/-
F2
F2
□  +/+ 
■  +/- 
□  -/-
Graph 18. 1 : 2 : 1 NN : CN : CC Ratios in F2 TGFpi+/- and -/- 
Conceptuses at 9.5dpc.
The role of the parental origin of the strain-specific modifier gene in prenatal lethality of 
animals generated by TGFpl+/- intercrosses was investigated. >260 F2 conceptuses 
were dissected, morphologically scored and genotyped for TGFpi. All TGF1+/- and -/- 
conceptuses were further screened for alleles of the strain-specific modifier gene. Using a 
polymorphism, it was possible to tell by PCR if a conceptus had two NIH-derived alleles 
(NN), two C57-derived alleles (CC), or was heterozygous (CN) at the modifier gene 
chromosomal location D5MU268. The expected ratio of was 1 : 2 : 1  NN : CN : CC in 
both genotypic classes. In the calculation of ratios, the number of NN conceptuses in 
each genotypic class was taken as ‘1’. The apparent loss of TGFpi-/- CC conceptuses 
prior to 9.5dpc is not significant.
Graph 19. Observed Percentage of Severely Abnormal F2 TGFpl+/- and 
-/- Conceptuses at 9.5dpc in Each Screening Class.
Upon dissection each TGFpi knockout conceptus was morphologically scored. All 
TGFpl+/- and -/- conceptuses were further screened for the origin of their alleles of the 
strain-specific modifier gene. Graph 19 shows the percentage of TGFpl+/- and -/- F2 
conceptuses which were scored as being severely abnormal in each screening class. A 
proportion of the total TGFpl+/- and -/- embryos in each screening class were scored as 
severely abnormal.
■ +/- 
□  -/-
NN CN CC
■  +/- 
□  -/-
All of the TGFpl+/- and -/- conceptuses were screened by PCR for the presence of 
the C and/ or N polymorphism at D5Mit268 (see Materials and Methods and Figure 
7) and the phenotype, TGFpl genotype and screening data for each conceptus 
correlated (see Table 22; Graphs 18 and 19).
X2 ‘goodness of fit’ tests were used in both TGFpi+/- and -/- genotypes in order to 
clarify if there was a either a significant loss of conceptuses from a specific screening 
class prior to 9.5dpc, or if the TGFpi mid-gestation phenotype was segregating 
randomly with respect to the genotype at D5MU268. If this were the case, then neither 
of the calculations would result in a significant p value. In all of the above-mentioned 
X2 tests a ratio of 1 : 2 : 1 NN : CN : CC was expected. The data shows that there is 
no loss of F2 TGFpi+/- embryos at 9.5dpc, regardless of which polymorphic marker 
is present at D5MU268. However, the incidence of a severe phenotype in F2 
TGFpi+/- embryos may segregate with C57 homozygosity, or C57/ NIH 
heterozygosity at D5MU268: However, there was a disparity in the significance of the 
statistical data - whereas there was a high probability that the proportion of normal F2 
TGFpi+/- conceptuses was unrelated to the strain-specific polymorphism (p=0.61), 
the probability of the variation seen in the ratios of observed and expected abnormal 
conceptuses in each screening class was p=0.02. This effect was caused by 
insufficient sample size. The number of normal conceptuses was calculated by 
subtracting those scored as severely abnormal from the total in each screening class. 
All statistical data is shown in Table 23.
The same statistical tests were applied to the F2 TGFpi-/- data. Although there was a 
43% loss of CC conceptuses prior to 9.5dpc, this loss was not significant, due to the 
relatively low number of animals examined (p=0.23). The p values for both the 1 : 2 : 
1 NN : CN : CC segregation of normal and abnormal conceptuses were low; p=0.01 
and p=0.07 respectively. Throughout this project, a p value of <0.05 was interpreted 
as significant.
Thus, F2 TGFpi-/- conceptuses are more likely to have a mid-gestation phenotype if 
they are CC or CN at D5Mit268.; 87.5% of CC F2 TGFp 1-/- conceptuses and 61% of 
CN F2 TGFpl-/- conceptuses were scored as severely phenotypic compared to 14% 
NN F2 TGFpl-/- conceptuses. It is possible that a proportion of CC TGFpl-/- 
conceptuses may die before 9.5dpc, however, a much larger sample size would be 
required to prove this. In the F2 TGFpl+/- embryos, there is no significant loss from 
any screening class prior to 9.5dpc, however, 33% of CC F2 TGFpl+/- conceptuses
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and 14% of CN F2 TGFpl+/- conceptuses were scored as severely phenotypic 
compared to 7% NN F2 TGFpi+/- conceptuses.
Therefore, it is probable that the presence of a C57-derived polymorphism at 
D5Mit268 may contribute to the onset and penetrance of phenotypes in F2 TGFpl+/- 
and -/- embryos (see Discussion 4.2.21.
3.8 .2  An NIH -Derived Allele for the M odifier Gene May  
Enable C57 Conceptuses to Survive to 9.5dpc.
During the investigation of the onset and manifestation of the TGFpl knockout 
phenotype (Results 3.3.2), a large preorganogenesis loss of C57 TGFpl-/- 
conceptuses was observed. The data showed that, compared to 42 C57 TGFpl+/+ 
embryos, only 5 homozygous null embryos survived to 9.5dpc. 41 5 of these 
conceptuses were scored as having a severe mid-gestation TGFpi knockout 
phenotype.
It was noted that three of the five surviving TGFpl-/- 9.5dpc conceptuses came from 
the same litter. It was also notable that this litter was abnormally large in comparison 
to the average C57 litter size at 9.5dpc i.e. 11 conceptuses compared to 8. It was 
possible therefore, that one (or both) of the parents of this litter, although 93.75% C57 
throughout the genome, had an NIH-derived allele at the modifier locus. 
Unfortunately, parental genomic DNA samples were no longer available for analysis 
and the TGFpi-/- conceptus DNA had been used in repeated genotyping. However, if 
any of the littermates screened were CN rather than CC at D5Mit268, it could be 
concluded that one of the parents of this litter was CN at D5Mit268. If this were the 
case, then using Mendelian rules of inheritance, the N allele would be transmitted to 
approximately 50% of offspring, resulting in a 1 : 1 CN : CC ratio.
The results show that out of 4  informative littermates screened, one was CC at 
D5Mit268 and three were CN at this locus, therefore showing that at least one of the 
parents of this litter was heterozygous for the strain-specific modifier gene 
polymorphism. Twenty other C57 TGFpi+/- embryo DNAs from the initial study 
representing eight different TGFpi+/- intercross litters (Results 3.3.2) were also 
screened as a control; no N alleles were detected. Present among the control sample 
were ten embryos from two litters also sired by the same stud mouse which fathered 3/ 
5 of the C57 TGFpl-/- embryos, thus, the N allele was probably transmitted by the
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dam. Therefore, it is possible that the CN maternal environment was also a 
contributory factor in the survival of these possible CN C57 TGFpi-/- embryos to 
9.5dpc.
3.9 A Summary of Results.
1. There are three periods of lethality in the TGFpl knockout mice: Firstly, prior to 
9.5dpc; secondly, mid-gestation; thirdly, 3 weeks post-partum. 89% of C57 
TGFpl-/- embryos die before 9.5dpc for an unknown reason. The majority of FI, F2 
and 129 TGFpi-/- embryos die at 10.5-12.0dpc with defects of the extra-embryonic 
tissue. The majority of NIH animals die at around 3 weeks of age due to a multi-focal 
inflammatory response. Thus, there is strain-dependent expressivity and penetrance of 
the TGFpi knockout phenotype.
2. A strain-specific proportion of TGFp 1+/- animals die prior to 3 weeks of age.
3. A small proportion of the observed lethality of TGFpl+/- and -/- embryos may be 
due to the maternal environment.
4. The mid-gestation phenotype in the TGFpl+/- and -/- conceptuses was typified by 
a combination of any of the following defects; inefficient formation of the yolk sac 
vasculature; abnormalities in the allantois and chorion; haemorrhages in the yolk sac or 
embryo; swelling of the pericardium; and yolk sac anaemia.
5. Histological examination of yolk sacs from TGFpl+/- intercross littermates with 
defective vasculature dissected at 9.5dpc, revealed separation of the tissue layers along 
the plane of the endothelial cells, dilation of the endothelial tubes and exovasation of 
erythroid cells.
6 . There is no difference in the abundance of ^-globin mRNA at 8.5dpc in TGFpl+/- 
intercross littermates. However, there was a significant downregulation in the number 
of haemoglobinised cells counted in blood smears taken from anaemic yolk sacs at 
9.5dpc, as assayed using May-Grunwald Geimsa staining.
7. Yolk sacs with the TGFpi knockout vascular phenotype have a lower number of a  
smooth-muscle actin staining cells around the large vessels compared to normal 
littermates. a  smooth-muscle actin is known to be a marker for perivascular pericytes.
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8. Possession of a C57-derived allele (C) at the chromosomal location D5Mit268 may 
compromise F2 TGFJ31+/- and -/- conceptuses at crucial stages during development. 
D5Mit268 has been shown to be linked to the locus of a TGFp 1 modifier gene in C57 
and NIH mice (Bonyadi et al., 1997). Three 93.75% pure, inbred C57 TGFpi-/- 
littermates which survived to 9.5dpc, albeit with severe abnormalities, were shown to 
have a one parent with an NIH-derived allele at D5MU268. DNA from the embryos 
themselves was unavailabe for screening.
93
Chapter 4
DISCUSSION.
4.1 Introduction.
This thesis presents evidence of a strain-dependent variation in the penetrance and 
expressivity of phenotypes in TGFpl knockout mice (Kulkami et al., 1993). The data 
was generated by a study of the TGFpi knockout phenotype at 9.5 and 11.5dpc, at 
birth, and at 3 weeks post partum. Previously, the phenotypic effects of the TGFp 1 
knockout allele were characterised in detail by Dickson et al. (1995) working on a 
mixed genetic background (12.5% 129/Sv/Ola (129), 37.5% C57BL/6J/01a (C57), 
50% NIH/Ola (NIH)). Dickson etal., reported a 50% loss of TGFpi-/- embryos and a 
25% loss of TGFp 1+/- embryos at around 10.5dpc caused by defective haematopoiesis 
and vasculogenesis in the extra-embryonic tissue. The surviving TGFpl-/- conceptuses 
died at approximately 3 weeks post partum due to the previously characterised multi­
focal inflammatory reaction (Shull etal., 1992; Kulkami etal., 1993 & Dickson etal., 
1995). However, because of conflicting reports regarding the penetrance of this 
phenotype (Shull et al., 1992; Kulkami et al., 1993; Dickson et al., 1995 & T. 
Doetchsmann, unpublished), the TGFpl knockout allele was bred to 93.75% purity on 
NIH, C57 and 129 genetic backgrounds (F. Cousins) for further investigation.
In this project, the onset and cause of lethality were studied in these three strains and 
defined intercrosses, i.e reciprocal C57 x NIH (FI) and FI x FI (F2). It was found 
that 89% of C57 TGFpi-/- embryos died for an unknown reason prior to 9.5dpc, 
whereas NIH TGFp 1-/- animals tended to die at around 3 weeks post-partum from a 
massive inflammatory reaction, as did all the other surviving TGFpi-/- animals. 
Differing numbers of FI, F2 and 129 TGFpi-/- conceptuses died between 10.5 and 
12.0dpc all due to severe defects of the extra-embryonic vasculature and anaemia. 
Thus, the defects seen at mid-gestation in the TGFpi-/- and +/- conceptuses tended to 
be a combination of abnormalities of the extra-embryonic tissue; i.e. inadequacy/
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complete failure of yolk sac vasculogenesis; haemorrhages in the yolk sac; blockage or 
blood clots in the allantois; swelling of the chorion and/ or yolk sac anaemia. 
Occassional defects of the embryo were seen; typically, slight developmental 
retardation, necrosis, and swelling of the pericardiac membrane and/ or haemmorhage 
around the heart. These observations coincide with reports that the first detection of 
TGFpi by in-situ hybridisation is at 7.5dpc within the blood islands of the yolk sac, 
the mesoderm of the allantois and the pro-angiogenic progenitors in the cardiac 
mesoderm (Akhurst etal., 1990).
Thus, there is a strain-specific difference in the expressivity of the TGFp 1 knockout 
phenotype and in the penetrance of the mid-gestation phenotype, but no strain-specific 
variation in the manifestation of the latter. Therefore, it appears that there are three key 
stages where TGFpl is vital for normal development: Prior to 9.5dpc, mid-gestation 
and 2-3 weeks post-partum.
4.2 Identification of the Strain-Dependent 
Expressivity and Penetrance of the TGFpi 
Knockout Phenotype.
4.2.1 Prenatal Assessment of the TGFpi Knockout Phenotype 
and Genotype Ratios.
4.2.1.1 Scoring 9.5dpc Conceptuses.
>100, 9.5dpc conceptuses from TGFpi+/- intercrosses from each of the NIH, C57, 
129, F2 and FI (both directions of the reciprocal NIH x C57 cross) genetic 
backgrounds were dissected free from maternal tissue with the yolk sac intact, 
morphologically scored then genotyped by PCR using genomic DNA. The observed 
Mendelian ratios of embryos in each genotypic class were compared to the expected 
ratios using a y }  ‘goodness of fit’ statistical test.
In order to objectively assess the more subtle morphological effects of the TGFpl 
knockout phenotype at 9.5dpc a two-part scoring system was used. The first part used 
a number of landmark characteristics to identify the precise developmental stage of the 
conceptus in question and gave ‘score 1*. The second part formed a detailed assessment 
of any abnormalities observed in the embryo or yolk sac, and gave ‘score 2 ’. 
Comparison of score Is for the genotypic classes of each strain revealed that there are
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no striking differences of the developmental stage of the conceptus between the 
different genotypes or strains at 9.5dpc. However, comparison of score 2s showed a 
striking relationship between the genotype of the embryo and the severity of the 
observed defects i.e. in general; a few minor defects were observed in TGFpi+/+ 
conceptuses. A wider range of defects, from the very minor to the more severe were 
seen in TGFpi+/- conceptuses whereas, the greatest incidence of more severe 
abnormalities were observed on the TGFpl-/- conceptuses.
The scoring system devised for use in this project gives an objective, quick, easy and 
accurate routine assessment of the gross morphology of murine 8.5-10.5dpc yolk sacs 
and embryos. Comparison of the numbers of conceptuses scored at 9.5dpc as severely 
abnormal with phenotype and genotype results from a similar study at 11.5dpc and at 
birth (Bonyadi et al., 1997) shows that this system can be used to reliably identify 
conceptuses with the lethal TGFpl mid-gestation phenotype. This approach in the 
study of post-implantation conceptuses is supported by evidence that a routine 
histological study reveals little more information than a detailed assessment of gross 
morphology (Langenfeld e ta l., 1988). Throughout this project, the use of this scoring 
system minimised subjective variation in the assessment of the litters studied, and 
standardised the classification of the abnormalities typically seen in TGFp 1 knockout 
conceptuses at 9.5dpc. Thus, the individual scores produced for each embryo and yolk 
sac could be reliably compared between genotypes and across strains to give an 
accurate picture of the effects of the TGFpi knockout at 9.5dpc. This led us to 
conclude that there was a strain-dependent difference in the penetrance in the TGFpl 
knockout mid-gestation phenotype, but the effects of the knockout at 9.5dpc did not 
differ between strains (see Discussion 4.2.2).
4.2.1.2 Assessm ent of the TG Fpi Knockout Phenotype at 
11.5dpc.
<100 11.5dpc conceptuses generated by TGFpi+/- intercrosses from each of the NIH, 
129 and FI genetic backgrounds were dissected free from maternal tissue, scored and 
genotyped by PCR using genomic DNA. The observed Mendelian ratios of embryos in 
each genotypic class were compared to the expected ratios using a x 2 ‘goodness of fit’ 
statistical test. By identifying the number of conceptuses which had died, and those 
which appeared to be severely phenotypic in each genotypic class, it was clear that there 
was a strain-specific difference in penetrance of the TGFpl knockout phenotype at 
mid-gestation (see Discussion 4.2.2).
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Scoring undertaken at this developmental stage was less rigorous since an obvious 
segregation of the normal and abnormal phenotypic classes had occurred by 11.5dpc. 
Due to the time of onset of the TGFp 1 knockout phenotype, affected conceptuses were 
either dead, or dying by this age and therefore easily recognisable. The results obtained 
at 11.5dpc bore out those obtained at 9.5dpc using the objective scoring system, and 
mirrored those obtained from neonates (Bonyadi et al., 1997). The dead embryos 
recovered at 11.5dpc had reached a developmental stage parallel to that of a 9.5- 
lO.Odpc embryo before death (see Figure 12). Unfortunately, due to the onset of 
necrosis in these conceptuses it was impossible to study an intact yolk sac. The cause 
of death was yolk sac insufficiency, and typically occurred between 10.5 and 12.0dpc.
It was notable that there had been distinct variations in the influence of the TGFp 1 
knockout allele(s) by 11.5dpc: Some conceptuses were completely normal, some yolk 
sacs with delicate vessels contained a normal embryo, whereas some contained an 
obviously dead or dying embryo. Thus, there may be a threshold requirement for 
TGFpl in compromised conceptuses, for example; certain TGFpl+/- and -/- embryos 
may need to form a fully-functional chorio-allantoic connection, or express a sufficient 
number of TGFpi receptors prior to 11.5dpc to ensure survival. The essential function 
of the extra-embryonic tissues in development will be discussed in detail below.
4.2.2 Strain-Specific D ifferences in Knockout Mice.
Gassic Mendelian dominant or recessive traits are attributable to a single locus, and can 
override other genetic or non-genetic factors. However, as in the TGFpi knockouts, 
there is not always a simple relationship between genotype and phenotype. Complex 
traits do not override the effects of other factors, hence - interactions with other loci, or 
the environment can result in a heterogeneous phenotype. There have been a number of 
examples of other knockout mice which exhibit variation in phenotype on different 
genetic backgrounds; for example, the TGFp3 (Proetzel et al., 1996), keratin 8 
(Baribault etal., 1994), epidermal growth factor receptor (EGF-R) (Threadgillef al. , 
1995 & Sibilia & Wagner 1995), BMP-4 (Winnier et al., 1995) and the cystic fibrosis 
transmembrane regulator (CTFR) (Rozmahel etal., 1996) mice.
The most striking of these is the EGF-R knockouts; where, as in the TGFpl 
knockouts, there were three definite lethal phenotypes. Lethality occured during the 
peri-implantation period due to degeneration of the inner cell mass in the CF-1 strain, at
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mid-gestation due to a reduced placental spongiotrophoblast layer in the 129/ Sv strain, 
and at three weeks post-partum due to multiple defects of the epithelium in the CD-I 
strain. All of the phenotypes were fully penetrant and non-overlapping. Embryo 
transfer experiments showed that maternal effects were not involved and examination of 
chimeras generated from EGF-R-/- ES cells suggested that the effects were intrinsic to 
the cell or tissue involved rather than due to variations in other factors. The observed 
strain-specific variations were postulated to be caused by the action of unidentified 
strain-specific modifier gene(s) (Threadgill etal,, 1995 & Sibilia & Wagner, 1995).
Modifier genes are defined as allelic variants at loci other than the one being modified 
which can act directly or indirectly on a phenotype; directly, by supressing or 
enhancing any of the genes involved in the patho-physiological pathway affected by the 
knockout, or indirectly, by facilitating an the use of an alternative pathway or gene 
product (Erickson, 1996). By intercrossing TGFpl+/- C57 and NIH animals, Bonyadi 
et al., (1997) used microsatellite polymorphisms between the two strains, linkage data 
and statistical analysis to identify the location of one strain-specific modifier gene 
responsible in part for the death/ survival of C57 and NIH TGFpl knockout animals 
(Bonyadi etal., 1997) (see Discussion 4.4). The identity and function of this modifier 
gene remain unknown, but IL-6 and FGF-R3 map closely to its location (Bonyadi et 
al., 1997).
Mapping and identifying modifier genes has become a natural extension of the 
characterisation of knockout mice. Thus, the use of different, polymorphic inbred 
strains, and defined intercrosses of those strains in the characterisation of knockouts 
can provide information regarding the function of the gene in vivo, as well as the other 
gene products which may modify the knockout phenotype.
4.3 Analysis of the TGFpi Knockout Phenotype.
4.3.1 Death Prior to 9.5dpc in the C57 T G Fpi-/-  Em bryos.
During the course of this project, an 89% loss of C57 TGFpl-/- conceptuses prior to 
9.5dpc was identified. No C57 TGFpi-/- survived to birth (Bonyadi et al., 1997). 
Ongoing work has found that a ratio of approximately 1 : 2 : 0 3  TGFpl+/+ : +/- : -/- 
C57 embryos exists at 8.5dpc (48 conceptuses studied) (Dr. J. Quinn pers.comm.). 
Dr. Quinn has not noted an excessive number of resorptions/ dead or dying 
conceptuses in the litters analysed nor any striking abnormalities in the surviving
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TGFpl-/- conceptuses. These observations suggest that death occurs in the period prior 
to 7.5dpc. This group has shown that one unknown modifier gene is responsible for 
around 80% of this effect, and that the different expressivity of the knockout phenotype 
in C57 animals is not due to selective failure or low transmission of the TGFpl null 
allele through the parental gametes (Bonyadi et al., 1997); however, we have been 
unable to categorically exclude any other reason for the early loss of C57 TGFpi-/- 
embryos or pinpoint the time of death.
There is conflicting evidence for the role of TGFp 1 in the pre/ peri implantation period. 
It is known that the maternal decidual and uterine tissue can respond to TGFp 1 in an 
autocrine fashion from 4.5dpc (Roelen et at., 1994); however, researchers disagree as 
to whether TGFpi or its receptors are switched on in embryonic tissue before 7.5dpc 
(see Introduction 1.4.1). The observation that TpR-II-/- embryos die at the same 
developmental stage, and with strikingly similar defects to the abnormal TGFpl+/- and 
-/- embryos (Oshima et al., 1996) would suggest that if TGFp is vital for pre/ peri 
implantation; it either signals via another receptor II, or a separate, compensatory 
pathway is invoked - indeed, this may be the root of the difference in expressivity of 
the TGFpi knockout phenotype between NIH and C57 inbred strains (see Discussion
4.2.2).
During pregnancy, a complex series of events including maternal immunosupression 
and modulation of the extra-cellular matrix (ECM) must take place to permit the foetus 
to develop in the uterus. It has been suggested that some cytokines such as TGFpl, IL- 
4 and IL-10 favour embryonic survival and growth (Jokhi et al., 1994). Studies have 
shown that in mice, the number of gamma-delta T cells - regulators of the maternal anti- 
foetal immune response at the maternal-foetal interface, increase in a strain-specific 
manner during pregnancy. The immunosuppressive ability of gamma-delta T cells can 
be blocked by the addition of an anti-TGFpi monoclonal antibody (Suzuki et al.,
1995). Thus, TGFpl may act in the deciduum either in a paracrine or autocrine fashion 
as an immunosupressor, permitting the embryo to develop without rejection.
In order to become capable of implanting into the uterine epithelium, the embryo must 
convert its external surface from a quiescent, non-adhesive state to an adhesive 
phenotype (Sutherland etal., 1988 & Sutherland etal., 1993). This activation is poorly 
understood, but the implantation process involves the blastocyst binding to fibronectin, 
collagen and laminin in the uterine stroma (Sutherland et al., 1988) and the invasion of 
the trophoblast tissue into the uterine stroma via interactions with laminin (Sutherland et
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al,., 1993). TGFp is known to regulate the expression levels of the integrins which bind 
fibronectin, collagen and laminin in vitro (Ignotz et al., 1989 & Heino & Massague, 
1989). ECM molecules are also involved in essential morphogenetic movements of 
tissue. For example, E-Cadherin knockouts (Larue et al., 1994) die in a 
developmental^ delayed state at 4.5dpc having failed to form a trophectoderm 
epithelium, whereas p i integrin knockouts (Stephens et al., 1995) die at 5.5dpc with 
defective morphogenesis of the primitive endoderm. TGFp 1 is known to upregulate p 1 
integrin in vitro (Heino & Massague, 1989). However, to more adequately discuss the 
cause of early loss in the C57 TGFpi-/- embryos, the developmental stage of death 
must be identified. This could be done by genotyping blastocysts and early- 
implantation embryos from TGFpi+/- intercrosses, then comparing the gross 
morphology and histology of littermates in the period immediately prior to lethality. The 
observed phenotype and stage of death should suggest further molecular investigations 
to the researcher.
The incomplete penetrance of the phenotype observed in C57 TGFpl-/- embryos may 
be due to a combination of two factors; the maternal environment and the genetic 
contribution of the remaining regions of the genome which are not homozygous pure 
C57 i.e. the genome of each C57 mouse is still approximately 3.0% NIH and 0.75% 
129 (see Discussion 4.4).
4.3.2 M olecular Aspects of the Formation of the Extra- 
Embryonic Vascular System.
The TGFpi knockout mid-gestation phenotype is typified by severe defects in the 
extra-embryonic vasculature and inefficient haematopoiesis. Both the endothelial and 
primitive eiythroid cell lineages arise from the haemangioblasts located in the blood- 
islands of the yolk sac. TGFpi is expressed in haemangioblasts and its descendant 
lineages throughout development (Akhurst etal., 1990). The formation of the vascular 
plexus of the murine yolk sac is a complex process, involving both vasculogenesis and 
angiogenesis. The former is the de novo formation of blood vessels from differentiating 
mesodermally-derived endothelial cell precursors, whereas the latter is the sprouting of 
new capilliaries from pre-existing blood vessels thus refining the vascular network. 
Both vasculogenesis and angiogenesis require the differentiation, maturation, migration 
and proliferation of endothelial cells and the remodelling of the ECM to facilitate the 
formation and stabilisation of lumenised vessels.
100
Both these processes involve a variety of molecular factors.
4.3.2.1 Regulation of Endothelial Cell Function.
Five receptor tyrosine kinases (RTK) have been identified; f lk - l , flt-1 , flt-4, tie-1 and 
tie-2 (also known as tek) (reviewed by Breier & Risau, 1996). Each has a specific role 
in blood vessel formation and are of fundamental importance in the transmission of 
angiogenic and differentiation signals in endothelial cells. The ligand of tie-1 is 
unknown, but tie-2 is the receptor of angiopoietin-1 which is expressed on vascular 
endothelial cells, and flk -l and fit-1 are the receptors of vascular endothelial growth 
factor (VEGF), a candidate regulator of angiogenesis. All have been knocked-out in 
vivo, flk -l is required for the blood-island formation, and flk-l-l- embryos die without 
yolk sac vessel formation, blood formation and with incomplete endothelial cell 
differentiation (Shalaby et al., 1995). fit-1 knockout embryos die at 9.0-10.0dpc with 
dilated embryonic blood vessels and a disorganised assembly of endothelial cells (Fong 
et al., 1995). The tie-1 homozygous null embryos died at ldpp with widespread 
oedema due to reduced vascular integrity, whereas tie-2 homozygous nulls died at 
around lO.Odpc with a greatly reduced number of endothelial cells and distended and 
leaky yolk sac and embryonic vasculature (Sato et al., 1995 & Dumont etal., 1994).
Expression studies of these knockouts show that different RTKs can be used to indicate 
the differentiation state of endothelial cells. In the flk-l-l- conceptuses, the markers of 
endothelial precursors, fit-1 and fit-4  were detectable. However, tie-2, a marker of 
angiogenesis expressed at the terminal differentiation of the enothelial cells, was not 
found (Shalaby etal., 1995). tie-1 and flk -l are markers of endothelial cell maturity - in 
the tie-2 homozygous mutants both tie-1 and flk -l were present, but at a much lower 
level than normal (Dumont et al., 1994). Thus, a complete comparison of the 
expression levels of the RTKs of the endothelial cells in normal and abnormal TGFpl 
knockout yolk sacs and vice versa could be used to pinpoint the precise differentiation 
stage of these cells, and the processes which are affected by each gene knockout. 
TGFpl is known to inhibit endothelial cell proliferation in 2D-culture and to elicit the 
formation of microvascular tubes in 3D culture (Madri et al., 1988). Martin (1996) has 
excluded any effects in the TGFpl knockout conceptuses on the proliferation rate of the 
endothelial cells, and excluded an overall downregulation of the number of endothelial 
cells in the abnormal TGFpi knockout yolk sac (Martin et al, 1996). in vitro, TGFpi 
can mediate the expression levels of flk -l  not fit-1 in endothelial cells (Mandriota et al., 
1996). These results imply that TGFpl is involved in the maturation of endothelial cells
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rather than commitment to the endothelial lineage. It has already been reported that, 
similar to the tie-2 knockouts, flk -l mRNA expression is down-regulated in abnormal 
TGFpi knockout yolk sacs (Dumont etal., 1994 & Dickson etal., 1995).
Recently, mutations in two genes involved in TGFpl signalling have been cited as the 
cause of hereditary human telangieactasia (HHT). The symptoms of HHT include 
vascular dysplasia and recurrent haemmorhage. Mutations in two genes have been 
identified for HHT, firstly, truncations in endoglin, the TGFp type III receptor found 
on endothelial cells (McAllister et al., 1994) and secondly, mutations in ALK-1 
(Johnson etal., 1996), a type one receptor shared by activin and TGFp which is also 
thought to be located on endothelial cells (J. Quinn & E. Duffle pers. comm.). These 
finding support a role for TGFpl in vascularisation, and maintenance of vascular 
integrity.
Tissue factor (TF) is the primary cellular initiator of blood coagulation, but is also 
involved in angiogenesis, inflammation, atherosclerosis and cancer. It is unknown 
whether TF exerts its role in vessel development directly or indirectly. TF knockout 
homozygous null conceptuses display a remarkably similar phenotype to that seen in 
the abnormal TGFp 1 knockout mice, namely; a grossly normal embryo but incomplete 
development of the yolk sac vitelline artery and vien, areas of aberrant capilliary 
development in areas of the yolk sac, blood lakes between the tissue layers of the yolk 
sac and exovasation of erythroid cells into the yolk sac cavity due to defective formation 
of the contacts between the endodermal and mesothelial layers of the yolk sac (Cameliet 
et a l, 1996). The defects were attributed to a defect in pericyte accumulation and 
function. This was proposed to have compromised vascular development at a critical 
time when vessels needed to develop a ‘muscular’ wall in response to physiological 
changes in blood pressure. This effect was postulated to be poorly accommodated by 
the yolk sac compared to the embryo, which is a more rigid structure. A down- 
regulation of a number of ECM markers diagnostic of mesenchymal cells was also 
noted (Cameliet etal., 1996).
This thesis presents evidence that a  smooth-muscle actin expression is downregulated 
in the yolk sac vasculature of abnormal TGFpi knockout conceptuses. a  smooth- 
muscle actin is a marker for perivascular pericyte cells. The precise function of 
perivascular pericytes is unknown, but they are thought to regulate endothelial cell 
differentiation, function and vascular integrity. For example, an absence of perivascular 
pericytes has been cited as the cause of micro-aneurysms in diabetic retinopathy (Nehls
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& Drenckhahn, 1993). As the developing vessel matures, pericytes migrate along the 
microvascular sprout and reach a maximal concentration as the new vessel is completed 
and its secondary branches are formed (Nicosia & Villaschi, 1995). TGFpi is known 
to induce a  smooth-muscle actin expression in pericytes (Verbeek et al., 1994), and 
cocultures of pericytes and endothelial cells can activate TGFp 1 possibly using it in 
cell-cell communication (Sato et al., 1989); thus, it is possible that the lack of vascular 
integrity observed in the abnormal TGFpl knockout conceptuses was due to the 
number of pericytes around the developing extra-embryonic vessels being below a 
critical level.
The apparent absence of pericytes (or mature pericytes) in the abnormal TGFpl 
knockout yolk sacs could be a function of abnormal or delayed differentiation of 
endothelial cells. In the abnormal TGFpl mutant yolk sacs flk -l  expression was 
downregulated, however in the TF-/- yolk sacs flk - 1 expression was unaffected. It is 
possible that intrinsic defects of mesenchymal differentiation are responsible for the 
lack of pericytes in abnormal TGFp 1 mutant yolk sacs.
Very recently, it has been shown that embryos and yolk sacs which are homozygous 
null for the angiopoietin-1 gene exhibit an abnormal vascular architecture and die at 
around 12.5dpc. The vasculature of these knockouts is reported to be less complex, 
with fewer branches and more homogenously-sized vessels (Suri et al., 1996). Using 
electron-microscopy, Suri et al. (1996) found that the principle defect was a failure to 
recruit pericyte precursors to the developing vascular system; and concluded that 
angiopoietin-1 played a crucial role in mediating reciprocal interactions between the 
vascular endothelium, the surrounding matrix and mesenchyme. In light of these 
findings, a complex model for vascular formation has been proposed (Folkman & 
D’Amore, 1996): Angiopoietin-1 produced by mesenchymal cells activates its receptor, 
tie-2 on endothelial cells. This leads to the production of a recruiting signal for 
mesenchymal cells. TGFpi is activated as the mesenchymal cells contact the 
endothelium (Antonelli-Oriidge et al., 1989); and induces the differentiation of the 
mesenchymal cells to pericytes (Rohovsky et al., 1996). Then, TGFpi inhibits 
proliferation of the endothelial cells and stimulates matrix deposition, permitting 
endothelial migration and facilitating vessel formation. Thus, the poor vascular integriy 
and reduced remodelling seen in both the tie-2 and angiopoietin-1 null conceptuses may 
be secondary effects caused by insufficient active TGFp 1.
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4.3 .2 .2  The R egulation  of the ECM in Formation of the Yolk 
Sac Vascular Plexus.
The correct formation of the extra-cellular matrix (ECM) is crucial for normal 
development of the murine vasculature. The ECM is important in the formation of 
vessels, the migration of endothelial cells, the formation of cohesive tubes and the 
maintainance of vessel integrity. TGFp 1 is involved in the modulation of degradation 
and remodelling of the ECM, and both processes are required for endothelial cell 
migration (Roberts and Spom, 1990). For example, long-term overproduction of 
TGFpi may be the cause of several human flbrotic disorders. In pig arteries, direct 
transfer of the TGFp 1 gene leads to a massive increase in ECM deposition (Nabel et 
al., 1993). Also, antagonists of TGFpl prevent restenosis in rat artery walls after 
angioplasty (Wolf etal., 1994). Thus, the ability of TGFpl to induce deposition of the 
ECM following injury may be developed to form the basis of a clinical therapy.
TGFpl can regulate the expression of a number of integrins. Integrins are the 
promiscuous molecules which control cell-adhesion to the ECM; for example, certain 
collagen, vitronectin and flbronectin (FN) receptors are upregulated in response to 
TGFpi (Heino & Massague, 1989; Ignotz et al., 1989). Interestingly, a number of 
ECM knockouts exhibit similar mid-gestation defects to those seen in abnormal 
TGFpi+/- and -/- conceptuses; suggesting that the TGFpl knockout phenotype might 
be mediated via effects on the ECM. Hence, ECM knockouts pertinent to TGFpl are 
reviewed below.
in vitro, TGFpi has been reported to induce the expression of FN and thus modulate 
the migration and adhesion of large vessel endothelial cells (Madri et al., 1989 & 
Hauser etal., 1993). The cause of death in the flbronectin (FN)-/- embryos is a failure 
in the formation of the extra-embryonic vasculature at the blood island stage. (George et 
al., 1993) Similar to the abnormal TGFpl knockout yolk sacs, shearing takes place 
between the tissue layers of the yolk sac, however - unlike the TGFpl knockouts; 
abnormal vessel formation and gross defects are also seen in the embryo per se. 
Disruption of a5  integrin, part of the FN receptor leads to a slightly later lethality: The 
yolk sac develops weak vessels comprised of distended endothelial tubes which leak 
erythroid cells into the yolk sac cavity similar to the TGFpi knockout phenotype. 
However, gross defects of the embryo were also observed (Yang etal., 1993).
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Antagonists of av  integrin, part of the vitronectin receptor, have been studied and also 
found to block vascular development and angiogenesis in normal animals. A 
preliminary report of the av  knockout phenotype reveals a split phenotype: A 
proportion of av-/- animals die during embryogenesis and a proportion survive to 
birth, whereupon they die post-natally due to extensive brain haemmorhages. No other 
organs were affected suggesting a tissue specific role for av  integrin in blood vessel 
development (Stromblad & Cheresh, 1996).
TGFpl is thought to have an influence on collagen synthesis and proteolysis (Cui & 
Akhurst, 1996). Both processes are co-ordinated in the migration and assembly of large 
vessel endothelial cells in culture (Iruela-Arispe et al., 1991). Ablation of the murine 
collagen I gene leads to embryonic death betwen 12 and 14dpc due to degeneration of 
developing erythroid cells and the liver, as well as the rupture of the great vessels. The 
phenotype of the yolk sac in mutant conceptuses was not commented upon (Lohler et 
al., 1984).
To date there has been no analysis of differential expression levels of any components 
of the ECM or their receptors in TGFpi knockout conceptuses, nor any reported 
studies of the expression level of TGFpi in the knockouts described above. A study of 
this nature would help to clarify the role of TGFpi in the modulation of the ECM, and 
the role of the latter in the formation of the extra-embryonic vasculature.
4.3.3 H aem atopoiesis in the Yolk Sac.
A proportion of the abnormal TGFpl knockout yolk sacs assessed at 9.5dpc were 
scored as anaemic. In some cases, there were no blood cells visible in the yolk sac 
vessels; in others, blood cells which appeared to be non-haemoglobinised were present 
in the yolk sac vasculature. Yolk sac anaemia was frequently, but not always 
accompanied by abnormalities of the extra-embryonic vasculature. Embryonic anaemia 
was infrequently observed at 9.5dpc, and did not necessarily accompany yolk sac 
anaemia.
Haematopoiesis in the developing mouse involves two spatially distinct phases under 
separate molecular controls, producing morphologically and biochemically distinct cell 
lineages (Medinsky et al., 1993; Godin et al., 1995 & Nakano etal., 1996): Primitive 
haematopoiesis commences in the blood islands of the yolk sac at 8.0-8.5dpc and 
definitive haematopoiesis begins in the AGM region of the embryo at around 9.5dpc.
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Haematopoietic activity begins in the foetal liver slightly later. Haematopoietic stem 
cells (HSC) from the yolk sac may contribute transiently to definitive haematopoiesis, 
but their exact role is unclear (Godin et a l ,  1995). By 14.0dpc the majority of 
circulating erythroid cells are derived from definitive precursors (Nakano et al., 1996). 
In the TGFpl knockouts, a very small proportion of embryos were scored as anaemic 
at 9.5dpc; however, we have made no attempts to assess the progress of definitive 
haematopoiesis in these embryos.
A number of other knockouts of genes involved in haematopoiesis have been 
generated, identifying molecular involvement in specific cell lineages in either primitive 
or definitive haematopoiesis, or both. However, since ablation of a gene crucial for 
primitive haematopoiesis typically leads to death at around 10.5dpc, it is hard to gauge 
fully the influence of the mutation on definitive haematopoiesis without in vitro 
experiments. For example, TAL-1/ SCL null mice lack primitive erythroid cells and 
explants in vitro fail to develop definitive erythroid and myeloid precursors (Shivdasani 
e ta l ,  1995). GATA-2-/- embryos also die due to failure of primitive haematopoiesis, 
and chimaeric mice generated with GATA-2 null ES cells have a markedly reduced 
number of definitive HSC or progenitor cells (Tsai, et al., 1994). There are a number 
of knockouts which die at around 15.0dpc due to defective definitive haematopoiesis, 
but undergo normal primitive haemtopoiesis; this occurs for example, in the c-myb-/- 
embryos (Mucenski, etal., 1991). Thus, it would be informative to assay the ability of 
the AGM region and foetal liver of anaemic from TGFpl+/- and -/- embryos to 
commence and sustain definitive haematopoiesis.
The combination of vascular and haematopoietic abnormalities observed in defective 
TGFpi knockout conceptuses, makes the anaemic phenotype harder to analyse. 
globin is a marker for haemoglobinisation. In situ hybridisation using an antisense 
mRNA ^-globin probe showed that normal TGFpi knockout conceptuses are 
indistinguishable at 8.5dpc i.e. all have an anastomosing corona of blood islands 
highlighted by an abundant, positive ^-globin signal. By 9.5dpc, on a mixed genetic 
background, the ^-globin signal is strikingly lower in some TGFpi+/- and -/- 
compared to TGFpi+/+ yolk sacs (Dickson etal., 1995). Using this data, Dickson et 
al., (1995) attributed the anaemic phenotype of TGFpi+/- and -/- yolk sacs to a 
downregulation of the total number of circulating erythroid cells caused by a decrease in 
the number of blood cells differentiating from haemangioblasts. This assessment was 
made after whole-mount in situ hybridisation on tom yolk sacs. In this thesis, data is 
presented to show that a degree of exovasation occurs in mutant yolk sacs, which may
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account for a loss of blood cells. However, no assessment was made in this project to 
compare the total number of mature/ immature blood cells in phenotypic and normal 
yolk sacs. This could be performed by comparing either standardised, total blood 
counts, or the expression levels of early haematopoietic markers in TGFpi+/+ and 
TGFpl-/- 9.5dpc yolk sacs such as GATAs 1 and 2. These are transcription factors 
involved in the proliferation and maintainance of early haematopoietic precursors (Tsai 
etal., 1994).
As mentioned above, the anaemic appearance of mutant yolk sacs could be due to 
exovasation of erythroid cells, or it could be due directly either to a defect in 
haemoglobinisation, or to a delay in the maturation process of the erythroid cells, or 
(most probable) to a combination of these defects. TGFpl can promote the 
haemoglobinisation process in certain cell lines (Chen et al., 1989). Indeed, in this 
project, a significant difference in the haemoglobinisation process (as monitored via the 
degree of May-Grunwald Geimsa staining) was seen between yolk sac blood smears 
taken from anaemic and non-anaemic TGFpi knockout conceptuses. However, the 
process of differentiation of haemangioblasts to descendant endothelial and erythroid 
lineages requires a normal ECM and normal stromal-cell interactions in the blood- 
islands. p i integrin forms part of the heteromeric receptor for a number of ECM 
molecules including FN. Both p i integrin and FN expression are thought to be 
modulated by TGFpl (Heino et al., 1989 & Basson etal., 1992). Yolk sac explants 
from chimaeric embryos generated with p i integrin deficient stem cells are reported to 
undergo yolk sac haematopoiesis, but at a drastically reduced level. They also have 
impaired HSC migration and cannot colonise the foetal liver (Hirsch et al., 1996). Both 
the FN and a 5  integrin-/- yolk sacs contain primitive erythroid cells while 
similtaneously exhibiting abnormal yolk sac vasculature and a gross amount of 
exovasation, similar to the defective TGFp 1 knockout yolk sacs: However, in these 
mutants the question of inefficient primitive haematopoiesis has not been addressed, 
although FN has long been thought to contribute to the process of erythropoiesis (Patel 
& Lodish, 1987 & 1994).
Interactions within the developing blood islands create the required microenvironment 
for the correct differentiation of haemangioblasts to endothelial and primitive erythroid 
cells in the blood islands. The completely anaemic phenotype of flk-\-l- conceptuses 
suggests that erythroid precursors do not form in the blood islands until the endothelial 
cells lining the blood island mature fully (Shalaby et al., 1995). Notably, the recent 
VEGF knockouts were reported to express f it-1, ilk -l, tie- 1 and tie-2, but at very low
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levels, and to have a normal density of endothelial cells i.e. the endothelial cells were 
present but their development was severely delayed. The defects seen in VEGF+/- and 
-/- conceptuses involved impaired vasculogenesis and angiogenesis in the yolk sac and 
embryo, as well as a substantially reduced number of blood cells in the yolk sac. 
Leakage from the blood vessels was not mentioned (Ferrara et al., 1996 & Carmeliet et 
aL, 1996).
The observed BMP-4 -/- phenotype underlines the requirement for correct interactions 
in the induction and development of the yolk sac blood islands for normal 
haematopoietic and vascular development. The BMP-4 knockout mice, like the TGFpl 
knockouts, die at a range of embryonic stages - depending on the genetic background. 
Death occurs between 6.5 and 9.5dpc with a variable phenotype. Conceptuses which 
develop to 8.5dpc and beyond are developmentally retarded, have truncated posterior 
structures and a reduction in the amount of embryonic and extra-embryonic mesoderm. 
The latter defect is postulated to lead to an overall reduction in blood islands and 
circulating erythroid cells; the blood islands arise as distinct areas of mesodermal 
proliferation induced by the yolk sac endoderm (see Figure 3). However, histological 
analysis of dissected yolk sacs from BMP-4 -/- embryos shows shearing of the tissue 
layers along the plane of the endothelial cells. This appears to result in the observed 
leakage of red blood cells and dilation of the endothelial tubes, as seen in abnormal 
TGFpi knockout yolk sacs. Therefore, it would have been interesting to have assayed 
expression levels of markers of the ECM and/ or endothelial maturity, or to have 
performed a total blood count in the BMP-4 knockouts, in an attempt to clarify the 
effects of this knockout on the induction and development of the primitive circulatory 
system.
Thus a contributory factor to the anaemic phenotype of the TGFp 1 mutant yolk sacs 
could be the failure of a proportion of the blood islands to develop into a suitable 
environment for complete haematopoietic differentiation.
4.3.4 Formation of the Chorio-Allantoic Connection.
The fusion of the allantois with the chorion is crucial for embryonic survival and begins 
at around 8.5dpc. By 9.5dpc the primitive vasculature of the allantois has connected to 
the chorionic vasculature and the umbilical vessels have formed. Thus, the developing 
placenta supercedes the yolk sac as the main matemo-foetal interface. A variety of 
chorio-allantoic defects were observed in the TGFpl knockout conceptuses; most
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commonly an empty umbilical artery and/ or vein, or the appearance of ‘lumps’ or 
blood clots in the umbilical vessels. This was sometimes accompanied by chorionic 
swelling.
As mentioned above, TGFpl is able to modulate the expression of a number of 
integrins, for example; increase the expression of p i integrin in vitro (Heino & 
Massague, 1989; Ignotz e ta l., 1989). p i integrin binds with a 4  integrin to form the 
heteromeric receptor for VCAM-1 as well as forming part of the receptor for FN, 
collagen and laminin. Prior to, and during chorio-allantoic fusion, a 4  integrin is 
expressed in the chorion and VCAM-1 is expressed in the allantois. Interestingly, both 
the homozygous null a 4  integrin and VCAM-1 knockout mice die at around 12.0dpc 
with varying degrees of failure of chorio-allantoic fusion and cardiac defects which 
culminate in pericardiac haemmorrhage. Also; the reported phenotype of the extra- 
embryonic tissues in the csk knockout embryos is very similar to that seen in abnormal 
TGFpl knockout conceptuses, i.e. inadequate circulation in the yolk sac and a 
disorganised allantois which does not form an adequate junction with the chorion 
(Imamato etal., 1993). There is a striking similarity between the abnormalities seen in 
the csk-/- embryos and those reported in FN-/- embryos (Imamato et al., 1993 & 
George et al., 1993). Thus, the absence of blood in the abnormal TGFpl knockout 
chorio-allantoic connections may be due to inefficient fusion of the chorion and 
allantois caused directly or indirectly by an incomplete expression of ECM molecules or 
their receptors.
The blood pools observed in the chorion of the TGFpi knockout conceptuses could be 
due to the inability of the compromised embryo to set up a fully functional circulation. 
The same distended chorion phenotype was also observed in the tie-2-/- conceptuses 
and attributed to a decrease in embryonic blood pressure due to haemorrhages 
throughout the yolk sac and embryo (Dumont et al., 1994). These haemorrhages were 
similar to those seen in the phenotypic TGFpi knockouts. The appearance of lumps in 
the allantois may be caused by a disorganised vascular endothelium, similar to that 
reported in the flt-l-/- embryos (Fong etal., 1995). A decrease in blood pressure in the 
conceptus due to leaks or to inadequately lumenised vessels would simultaneously slow 
down blood flow and contribute to the formation of these clots. A combination of these 
effects would result in a discontinuous connection between the embryo and primitive 
placenta and contribute to the described TGFpl knockout phenotype. However, a 
detailed comparative histological and molecular study of the allantois and chorion of
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normal and abnormal TGFp 1 knockout littermates is required to fully characterise the 
observed defects.
4.3.5 Defects O bserved in the Embryo p e r  se.
Throughout this project, very few defects of the embryo itself were observed. In the 
main these abnormalities comprised any combination of the following: Developmental 
retardation of the embryo by >0.5dpc, necrosis, the swelling of the pericardiac 
membrane and haemmorhage around the heart. All of these defects are attributable to 
the cessastion of blood flow throughout the yolk sac plexus. Pericardiac swelling is an 
indicator of osmotic imbalance in the embryo (Copp, 1995) and has been reported in a 
number of knockouts involving the circulatory system, for example, GATA-2-/- 
embryos die before 11.5dpc with marked anaemia and swollen pericardia. GATA-2 is a 
transcription factor crucial for haematopoiesis in mice (Tsai et al., 1994). However, the 
incidence of pericardiac haemmorhage may be another manifestation of defects of the 
ECM. Notably, collagen I homozygous null embryos die with ruptured great vessels, 
resulting in bleeding into the pericardiac space (Lohler et al., 1984). However, no 
gross cardiac abnormalities have been identified in the TGFpl knockout mice from 
TGFpl+/- intercrosses.
Dickson et al (1995) noted that the endothelial marker flk -l was downregulated in 
abnormal TGFpi knockout yolk sacs, whereas levels of signal were comparable 
between embryos regardless of phenotype or genotype. TGFpl may only exert an 
effect on discrete subsets of endothelial cells. For example; zebrafish cloche mutants 
lack a large proportion of blood cells, but the sole effect on endothelial cells is the 
absence of an endocardium (Stanier et al., 1995). There is also evidence that although 
yolk sac-derived angioblasts may migrate into the embryo to contribute to the 
vascularisation of the developing embryo, de novo differentiation of early endothelial 
cells occurs within the lateral splanchnic mesoderm of the embryo (Augustin et al., 
1994). Also, the proportion of av  integrin-/- animals which survive to birth, die due to 
extensive brain haemmorhages. No other organs were affected suggesting a tissue 
specific role for av  integrin in blood vessel development (Stromblad & Cheresh,
1996). Thus, tissue specific subsets of endothelial cells and ECM molecules may 
explain why no gross defects of the intra-embryonic vasculature have been noted in 
embryos from abnormal TGFpi knockout yolk sacs. However, Carmeliet et al., 
(1996) asserted that the reason that vascular defects were observed in the TF-/- yolk
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sacs, not the TF-/- embryos was because the embryo was a more rigid structure, and 
therefore better for supporting vessels.
4.4. Genetic and Epigenetic Factors Acting in the 
Onset and Manifestation of the TGFpi Knockout 
Phenotype.
4.4.1 M aternal Rescue of Phenotypic Embryos.
The mid-gestation phenotype in TGFpl-/- conceptuses has a strain-dependent 
penetrance: Conceptuses could be normal and survive to birth, or have single or 
multiple defects of the yolk sac of differing severity and die between 10.5 and 12.0dpc. 
It is probable that maternal rescue of affected embryos could be influencing the range of 
defects seen at 9.5dpc. Letterio et al., (1994) demonstrated that maternal radio- 
iodinated TGFpl could be transferred between the maternal and embryonic 
circulations, and two groups have shown that a greater proportion of TGFpl+/- and -/- 
conceptuses are abnormal when bom to a TGFpi-/- mother (Letterio et al., 1994 & 
Dickson etal., 1995). It would have been interesting to compare the expression levels 
of markers like f lk - l ,  a  smooth-muscle actin or markers of the ECM between litters 
from genetically identical TGFpi+/- and TGFpi-/- mothers, in an attempt to assess the 
effect of the maternal environment on the severity of the mid-gestation TGFpl 
knockout phenotype.
Additional cardiac defects were seen in embryos from TGFpl-/- mothers (Letterio et 
al., 1994). However, it is unknown whether these were directly due to a complete lack 
of TGFpl, or a secondary effect of decreased pressure in the yolk sac and embryonic 
circulation. There are strain-specific differences in the levels of circulating TGFpi; i.e. 
NIH and C57 have comparable amounts (around 5ng m l1), but 129 animals have an 
undetectable level (<lng m l1) (R. Akhurst & D. Grainger, unpublished). This finding 
may explain why there is no maternal effect seen in the reciprocal C57 x NIH crosses 
used to produce the FI genetic background (see Table 12). Other studies by this group 
show that there is a significantly greater loss of TGFpl+/- and -/- conceptuses in 
reciprocal C57 x 129 TGFpl+/- intercrosses when the mother is 129 (Dr. L-M Leong, 
pers. comm.). Thus, the greater penetrance of the mid-gestation phenotype in 129 
embryos may be due to a lesser capability for maternal rescue. Notably, there was no 
evidence for any directional loss of TGFp 1+/- offspring from reciprocal 129 TGFpl+/- 
x TGFpl+/+ crosses at 3 weeks post-partum. Studies have shown that there are no
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gross inter-strain differences in the expression of ALKs 1 and 5, or TpR-II mRNA in 
TGFpl+/+ embryos of each strain (J. Quinn and E. Duffie, pers. comm). However, 
we have not investigated the possible compensatory upregulation of any of the TGFp 1 
receptors in TGFpl+/- or -/- animals.
The TGFp 1+/- mothers used in this study are thought to have 50% of the normal level 
of circulating TGFpi (A. Kulkami pers.comm.). Dickson et al., (1995) showed that 
their observed 25% loss of TGFpl+/- embryos was rectified by transfer into a 
TGFpl+/+ mother. If a proportion of TGFpi+/- embryos are as similarly 
compromised as their TGFpl-/- littermates over a crucial developmental period, for 
example; the transition between yolk-sac and placental nutrition; they may compete with 
each other for the limited amount of maternal TGFpl for survival. As mentioned in 
Discussion 4.2.1.2, at 11.5dpc, a number of TGFpl+/- and -/- yolk sacs were 
observed to be mildly phenotypic but containing a dead/ dying embryo, whereas some 
mildly phenotypic yolk sacs contained a normal embryo, this dichotomy could be due 
to maternal rescue facilitated by the timely and efficient formation of a chorio-allantoic 
junction.
Other examples of heterozygous loss have been characterised. Most recently, the fully 
penetrant lethal phenotype of VEGF+/- embryos. In this case the effect was proposed 
to be due to a tightly-controlled ligand-dose effect of VEGF during development 
(Ferrara etal., 1996 & Carmeliet et al., 1996). The loss of TGFpl+/- embryos due to 
both the mid-gestation and the post-natal phenotype may be due to a number of other 
factors; environmental factors, such as the level of maternal TGFpl and competition 
between littermates for certain resources; or the genetic predisposition to lethality of a 
subset of TGFp 1+/- conceptuses (see Discussion 4.4.2).
Significant lethality was also observed post-natally during this project in the C57 and 
129TGFp 1+/- mice. This data suggests that a 50% loss of circulating TGFpl can be 
lethal. However, this phenotype was not fully penetrant either. TGFpl+/- loss and the 
disparity of the penetrance and expressivity of the TGFpl-/- phenotype may be due in 
part to genetic effects.
4.4.2 The Role of a Strain-Specific  M odifier Gene.
This group has shown that around 80% of the difference in expressivity of the 
TGFpi knockout phenotype in C57 and NIH is due to one co-dominant modifier
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gene (Bonyadi et al., 1997). Using linkage analysis, a region of the genome was 
pinpointed that predisposed TGFpi-/- pups to embryonic survival or death, 
depending on the parental origin of the alleles at that point. That is, working on an 
F2 genetic background; there was a significant dearth of pups with homozygous 
C57 (C) alleles at D5MU268 at birth, but the expected numbers of pups were bom 
which were homozygous NIH (N) and heterozygous CN at D5MU268 (Bonyadi et 
al. , 1997).
A modifier gene is defined as one that can act directly or indirectly at any point in 
patho-physiological pathway to supress or enhance the expression or activity of the 
genes (or related genes) involved in the expressivity or penetrance of a phenotype 
(Erickson, 1996). For example, it is thought that the higher activity of an alternative 
cyclic AMP-dependent, colonic chloride channel in C57 mice ameliorates the 
phenotype of the AF508 cystic fibrosis model when it is bred onto this genetic 
background (Rozmahel etal., 1996 & Erickson, 1996). In the case of the TGFpi 
knockouts, several candidate genes have already been excluded including TGFP2, 
TGFp3, TpR-II, Endoglin and IGFR2. IL-6 and FGF-R3 map close to this locus 
and have not yet been investigated (Bonyadi etal., 1997). Positional cloning is now 
required to identify the TGFp 1 modifier gene and characterise its role in the TGFp 1 
knockout phenotype.
In order to further examine the influence of D5Mit268 on TGFpl knockout mice, 
the ratio of NN : NC : CC conceptuses on each of the three genotypic classes was 
examined at 9.5dpc on the F2 genetic background. The expected ratio of screening 
classes was 1 : 2 : 1  NN : CN : CC, in each genotypic class. Each conceptus was 
morphologically scored (Discussion 4.2.1); and the prevalence of severe defects 
interpreted in TGFpi+/- and -/- conceptuses in terms of each screening class. The 
findings suggested a role for the modifier in both the early loss of CC TGFpl-/- 
conceptuses and in the ability of TGFpl+/- and -/- conceptuses to survive through 
the transition from yolk-sac to placental nutrition. It is possible that the C allele 
confers a higher requirement for TGFp 1 during development - consequently more 
CC TGFpl-/- embryos die before 9.5dpc than CN or NN TGFpl-/- embryos. The 
finding that 3/ 5 surviving C57 TGFpl-/- conceptuses at 9.5dpc, had a parent with 
an N allele at D5MU268, also lends credence to the postulate that TGFpi+/- and -/- 
embryos which are CC at D5MU268 are in some way compromised compared to 
NN or CN embryos of the same genotype. TGFp 1+/- embryos with a C allele may
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also have a greater requirement for TGFpl compared to littermates; however, their 
higher level of embryonic TGFpl may facilitate their survival to mid-gestation.
Thus,the presence of an N allele at D5Mit268 may reduce the embryo’s dependence 
on TGFpl, permitting embryos to survive to mid-gestation, at which stage all 
surviving TGFpl-/- conceptuses and TGFpl+/- CC conceptuses compete with each 
other and their littermates for maternal TGFpi. The modifier gene may however 
somehow permit redundancy, or the commencement of a different, compensatory 
developmental pathway.
There are a number of caveats for the work done on D5Mit268 in this study: Firstly, 
larger data sets would have better clarified the results - however, this would have 
involved many hundreds more mice and secondly, the mice used in this project to 
create the F2 genetic background were only 93.75% purebred. That is, in each C57, 
NIH (and 129) mouse used, the remaining 6.25% of the genome comprised 0.75% 
129, 3.0% NIH and 2.25% C57 genetic material. Unfortunately, wholesale 
retrospective screening at D5Mit268 was made difficult by the small amount of DNA 
yielded by embryos and the length of time the DNA samples had been in storage. 
Also, although we could discern between C57 and NIH contributions at D5MU268, 
we have not yet identified a specific marker for 129 in this region of the genome (A. 
Condie, pers. comm.), so we have no means of determining the role of the modifier 
gene in the 129 strain. Preliminary work done on reciprocal C57 x 129, and NIH x 
129 TGFpi+/- intercrosses by Dr. L-M. Leong shows a loss of TGFpl-/- and +/- 
pups in the C57 x 129 crosses when a 129 animal is the mother; but no similar effect 
in the NIH x 129 crosses. These results were unexpected. Previous work has 
shown that 129 mice have a much lower level of circulating TGFpi than compared 
to both C57 and NIH strains (D. Grainger & R. Akhurst, unpublished), and it was 
expected that this experiment would have shown a comparative rescue of TGFpl+/- 
and -/- pups in each cross when the mother was not 129.
Thus, there appear to be other factors contributing to the survival or death of 
TGFpl+/- and -/- embryos. In certain strains, maternal rescue may be a factor, but it 
is possible that other genetic effects are occurring which may not be as obvious on 
the genetic backgrounds used in Bonyadi et al. (1997). The modifier gene at 
D5Mit268 is only responsible for around 80% of the difference in expressivity of 
the TGFpi knockout between C57 and NIH mice. The remaining 20% could 
comprise a combination of environmental and other, lesser genetic effects.
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Unfortunately, to clarify these effects a further screening study would be required 
involving a massive number of animals, and possibly breeding the TGFp 1 knockout 
allele to more diverse inbred strains of mice.
4.5 Summary of Suggestions for Future Work.
1. The cause of early death in C57 TGFpi-/- embryos:
i) 6.5 and 7.5dpc embryos from TGFpl+/- intercrosses should be dissected, 
morphologically scored and genotyped. If a significant loss of TGFpi-/- embryos 
has occured prior to 6.5dpc, then blastocysts from TGFpi+/- intercrosses could be 
harvested and cultured, their progress monitored, then genotyped by PCR. 
Histological analysis of littermates from the period up to and including lethality 
should suggest suitable molecular investigations to pinpoint the cause of death.
2. The abnormal vascular phenotype:
i) The relative expression levels off lk - \yflt- \ , VEGF, tie- 1 angiopoietin-1 and tie-2 
in TGFpi+/+ and abnormal TGFpi-/- conceptuses could be used to assess the 
effect that the ablation of the TGFpl gene has on the differentiation state and 
proliferation and location of endothelial cells at mid-gestation.
ii) Examination of markers of the ECM, such as flbronectin, collagen, vitronectin, 
laminin, VCAM-1, p i integrin, a 4  integrin, a 5  integrin, av integrin in 9.0-11.5dpc 
TGFpi+/+ and abnormal TGFpi-/- conceptuses would clarify the relationship 
between the ECM, TGFpl and vascular dysplasia.
iii) A detailed inspection of mutant yolk sac ultrastructure by electron microscopy 
would lead to a precise characterisation of any defects in the cellular composition 
and integrity of yolk sac vessels.
3. The anaemic phenotype:
i) The relative number and differentiation state of developing primitive erythroid 
cells in the yolk sac could be analysed using haematopoietic markers such as 
GATAs 1 and 2 in normal and abnormal TGFp 1 knockout yolk sacs.
ii) A comparison between the abundance of ^-globin protein and mRNA expression 
may help in the characterisation of a specific defect in haematopoiesis. Performing in 
situ hybridisation/ immunohistochemistry on sections of conceptuses embedded 
intact may restrict the number of blood cells lost through exovasation.
iii) Comparative total blood cell counts as well as a detailed morphological 
assesment of blood cells from TGFpi+/+ and anaemic littermates at 9.5dpc would
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be informative. This could be achieved by complete yolk sac bleeding into a 
standard volume of a suitable medium, then histological analysis of a defined 
aliquot.
iv) Culture of AGM explants would reveal whether abnormal TGFpl-/- conceptuses 
also had impaired definitive haematopoiesis.
4. Chorio-allantoic defects:
i) The markers of the ECM and endothelial maturity mentioned above, would be 
informative in an asessment of defects of the chorio-allantoic connection. Mash2 
could also be used as a marker of the placental spongiotrophoblast layer 
(McLaughlin etal., 1996).
ii) Most importantly, a detailed, standardised histological study of the allantois and 
developing placenta should be undertaken. Parallel sections could be used for 
molecular investigations.
5. Maternal effects on the TGFpi knockout phenotype:
i) If there is any effect on compromised TGFp 1 knockout mice due to the maternal 
environment, it is relatively small. Thus, in order to refute or prove such an effect in 
all of the strains studied, far larger TGFpl+/- intercross and reciprocal TGFpi+/- x 
TGFpl+/- sample sizes are necessary at birth and/ or at 3 weeks of age.
ii) A comparison of the expression levels of markers like flk - 1 and a  smooth-muscle 
between litters from genetically identical TGFpi+/- and TGFpl-/- mothers, would 
help to dissect the effect of the maternal environment on the severity of the mid­
gestation TGFpi knockout phenotype.
6. TpR-II Knockouts:
ii) Breeding the TpR-II knockout allele onto different defined inbred strains of mice 
and characterising the phenotypes observed on each genetic background may lead to 
the discovery of more modifier genes pertinent to the action of TGFpi. 
Characterisation of the observed phenotypes and any modifiers would greatly 
enhance our understanding of the interaction between the TGFp isoforms, their 
receptors and other developmental pathways.
ii) A comparative study performed on the published TPR-II+/+ and -/- knockouts 
(Oshima et al., 1996) of the endothelial markers, ECM markers, clarification of the 
anaemic phenotype and yolk sac ultrastructure, at different developmental stages - as 
detailed above, may help to clarify the role of TGFpi and its receptors in the onset 
and severity of vascular dysplasia.
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7. Genetic effects on the TGFpi knockout phenotype:
i) Postional cloning of the C57/ NIH TGFpi modifier gene would enable full 
characterisation of the gene and dissection of its role in the differential expressivity 
of the TGFpl knockout phenotype.
ii) A marker for the equivalent 129 allele of the TGFpi modifier gene would help to 
further clarify the genetic effects of the TGFp 1 knockout.
iii) Other genetic effects may be occurring in the TGFp 1 knockout mice which may 
not be obvious on the genetic backgrounds used in the identification of the C57/ 
NIH modifier gene. Clarification of these would require a further screening study 
and possibly breeding the TGFp 1 knockout allele to different, more diverse inbred 
strains of mice.
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flapping of a major genetic modifier of embryonic 
lethality in TGFpl knockout mice
viortaza Bonyadi1, Sarah A. B. Rusholm e1,4, Frances M. C ousins1, Helen C. Su2, Christine A. Biron2, 
vfartin FarralR & Rosemary J. A khurst1,5
he transform ing  g row th  factor  pi (TGFpl) signalling 
,athway1,2 is im portan t  in em bryogenes is3 and has been 
^plicated in hereditary  haem orrhag ic  te langiectasia  (HHT)4,5, 
therosderosis6'7, tum origenes is8,9 and immuno- 
lOdulation10,11. Therefore, identification of factors which 
iodulate TGFpi bioactivity in vivo  is im portan t.  On a mixed 
enetic background, -50%  Tgfb1~'~ conceptuses  die mid- 
estation from defective yolk sac vascu logenesis3. The o the r  
alf are d e v e lo p m e n ta l^  normal b u t  die th ree  w eeks  
ostpartum  3-10'11. Intriguingly, th e  vascular defects of Tgfb1~'~ 
lice share  histological similarities to  lesions seen in HHT 
atients3-5. It has been  su g g es ted  th a t  d ichotom y in Tgfbl~'~ 
>thal phenotypes is due to  maternal TGFpl rescue of some, but 
ot all, Tgfb1~'~ em bryos12. Here w e  sh o w  th a t  th e  Tgfb1~'~ 
henotype dep en d s  on th e  genetic  background of the  
jnceptus. In NIH/Ola, C57BL/6J/Ola and  F1 conceptuses, 
yfb1~'~ lethality can be ca tegorized into th ree  developm enta l 
asses. A major codom inant modifier gen e  of embryo lethality 
-as m apped  to  proximal m ouse  chrom osom e 5, using a 
snome scan for non-m endelian  d istribution of alleles in 
lfb1~'~ neonatal animals which survive prenatal lethality. This 
»ne accounts for around  th ree  q uar te rs  of th e  genetic  effect 
»tween m ouse strains and  can, in part, explain th e  
stribution of th e  th ree  lethal pheno types .  This approach, 
iing neona ta l  DNA samples, is genera lly  applicable to  
entification of loci th a t  influence th e  effect of early 
nbryonic lethal m uta tions,  th u s  fu r ther ing  know ledge  of 
metic interactions th a t  occur during early m ammalian 
ivelopment in vivo.
In an earlier study, T g fb t /_ conceptuses of a mixed genetic back- 
ound (see M ethods) were found  to have one o f two lethal phe- 
Jtypes; m id -g e s ta tio n  loss d u e  to  de fec ts  in yo lk  sac 
sculogenesis and haem atopoiesis3 or death at three weeks post- 
irtum due to m ultisystem ic in flam m ation3,10,11. To investigate 
e effects that genetic background m ight have on prenatal lethal- 
r,the  Tgfbl null allele was bred onto C57BL/6j/01a and NIH/Ola 
ckgrounds (see M ethods). O ur analysis o f the neonatal TG Fpi 
notype ratios from  T g fb l+/~ in tercrosses d em o n stra ted  th a t 
netic factors clearly influence the frequency o f prenatal lethali- 
o f T g fb r1-mice (Fig. 1), w ith C57BL/6J/01a alleles predispos- 
l to prenatal lethality.
iVe set up Tgfbl+,~ x Tgfbl+/~ intercrosses between various com- 
n a tions o f  N IH /O la , C 5 7 B L /6 J/0 1 a  a n d  C 57B L /6J/01a  x 
H /Ola (FI) mice, to investigate w hether there was a m aternal 
ect12, w hether the m odifier gene(s) were dom inant or recessive 
d to make a crude estim ate o f the num ber o f genetic m odifiers 
ig. 1). Reciprocal crosses o f N IH /O la x  C57BL/6J/01a, and FI 
M H/Ola or FI x  C57BL/6I/01a dem onstrated  that there were 
significant germ cell or m aternal effects (Fig. 1), ruling out the
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Fig i  Genetic  b ackground  de te rm in es  incidence o f  Tgfb1~'~prenatal le thali­
ty. The p e r c e n ta g e  survival of  Tgfb1~'~ animals  to  birth  w as  es t im a ted  as 100 x 
(n u m b e r  o f  Tgfb7_/“/n u m b e r  of  T g fb l+/+). The d a ta  w e re  o b ta in e d  f rom  
screening (n) n e w b o rn  offspring of  T g fb l+,~ intercrosses. C57BL/6J/Ola, n = 
190; C57BL/6J/Ola x FI, n = 82; F1 x C57BL/6J/Ola, n = 245; C57BL76J/Ola x 
NIH/Ola, n = 84; NIH/Ola x C57BL76J/Ola, n = 155; F1 x F1, n = 630; F1 x 
NIH/Ola, n = 438; NIH/Ola x FI, n = 87; and  NIH/Ola, n = 241.
possibility that N IH /O la and C57BL/6J/01a Tgfbl+,~ m others dif­
fered in their ability to rescue T g f b l conceptuses (via m aternal 
T G F(3l)12 or to  su p p o rt in tra -u te rin e  developm ent o f Tgfbl~/~ 
conceptuses. Additionally, we excluded the existence o f X-linked 
m odifier loci by these reciprocal crosses, and  from  the observa­
tion  o f equal num bers o f male and female T g f b l mice at b irth . 
The inferred  -7 0 %  prenatal loss o f T g /h i_/~ conceptuses in the 
N IH /O la  x  C 57B L /6J/01a crosses (Fig. 1) w as in te rm e d ia te  
between the levels o f prenatal loss observed w ithin the two inbred 
stra ins, suggesting codom inance. The frequencies o f  surviving 
neonates on the N IH /O la and C57BL/6J/01a backgrounds and FI 
can be used to assess the goodness-of-fit o f a sim ple m endelian 
m odel to the frequencies o f survival found  in the two backcross 
and  F2 generations (F ig .l). There was no significant difference 
betw een the observed and expected frequencies (P>0.05) which 
indicates that the simplest genetic m odel consistent w ith the data 
is a single codom inant modifier.
To investigate the effect that genetic background has on the yolk 
sac phen o ty p e3, conceptuses derived from  Tgfbl+,~ intercrosses 
on different genetic backgrounds were exam ined at 9.5 days post- 
coitum  (dpc) (Fig 2a). The m ajo rity  o f C 57B L /6j/01a Tgfbl~'~ 
em bryos had died prior to 9.5 dpc. The single em bryo which sur­
vived to 9.5 dpc had a defective yolk sac. In contrast, there was no 
statistically  significant loss o f FI or N IH /O la  Tgfbl~!~ em bryos
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Genetic
Background
T G F p i+ T G F p lv"
All
Phenotypical ly 
Normal
Total Phenotypically
Normal
Defective yolk 
sac
C57BL/6J/01a 39 1 0 1
FI 57 50 22 28
NIH 29 23 15 8
Fig. 2 The le thal p h en o ty p e  o f Tgfb  1~'~ concep tuses is d e te rm in ed  by g en e tic  
backg round , a, The ta b le  show s th e  d istribu tion  of ph en o ty p es  o f 9.5-dpc 
T g f b concep tuses on  d iffe re n t g ene tic  backgrounds. Embryos w ere  collect­
ed from  Tgfb1*'~ in tercrosses g e n e ra te d  on an  NIH/Ola (NIH) o r C57BL/6J/Ola 
(C57) background , or by reciprocal crosses of NIH/Ola and  C57BL/6J/Ola (F1). 
The concep tuses w ere  dissected  from  th e  u te ru s  and  scored fo r m orp h o lo g i­
cal abnorm alities . DNA w as ex trac ted  and  th e  em bryos w ere  g en o ty p ed  re t­
rospectively. All w ild-type em bryos ap p e a re d  norm al, and  th e  only 
Tgfb/■ '"-associated abno rm al p h en o ty p e  seen a t  9.5 dpc w as a defec tive  yolk 
sac o r its secondary  co n seq u en ces10. D ata from  th e  F1 em bryos w as in d e p en ­
d e n t o f th e  d irection  o f th e  cross and  w as th e re fo re  poo led , b, The h istogram  
show s th e  app ro x im ate  d is tribu tion  o f TgfbT^~  le thal p h eno types  on th e  
th re e  gen e tic  backgrounds. The d a ta  is based  on th e  p e rce n tag e  to ta l p re n a ­
ta l le thality  (Fig. 1), and  th e  p e rce n tag e  p re-o rganogenesis  d e a th  (a), w ith  
th e  assum ption  th a t  all p ren a ta l loss of F1 and  NIH em bryos is d u e  to  yolk sac 
insufficiency. This assum ption  is statistically  consisten t w ith  th e  d a ta , 
a lth o u g h  a small p re -o rg an o g en esis  loss o f F1 or NIH em bryos ca n n o t be 
excluded. The d a ta  su g g es t th a t  th e re  a re  tw o  critical s tages  o f p ren a ta l 
le thality, p re -o rg an o g en esis  an d  m id -gesta tion , leading  to  th re e  classes of 
Tgfb1~'~ lethality; Class A, loss p re-o rganogenesis ; Class B, m id -gesta tion  loss; 
Class C, p ost-na ta l d ea th .
p rio r to  9.5 dpc, b u t bo th  backgrounds displayed lethal yolk sac 
defects in a p o rtio n  o f  the  T g fb r 1'  conceptuses (Fig. 2). O n  each 
background , the  estim ate  o f  prenata l loss m ade at b ir th  (F ig .l)  
was co n sisten t w ith  the  sum  o f  em bryos having lethal yolk sac 
defects o r estim ated  to  have died before 9.5 dpc (Fig. 2a). T here­
fore, T g fb l '1'  le tha lity  cou ld  be categorized  in to  th ree  d is tin c t 
classes: i) p re -o rg an o g en esis  loss (Class A, on  a C 57B L /6J/01a
N /N  N /C  C /C  N o. o f  A n im a ls
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background), ii) postnata l death (Class C, predom inantlv  on an 
N IH /O la background) and iii) m id-gestation yolk sac failure ''Class 
B, predom inan tly  in FI (N IH /O la  x  C57BL/6J/01a) conceptuses). 
Each p h en o ty p e  is d e te rm in ed  by genetic  background , out the 
three genetic backgrounds stud ied  (N IH /O la, C57BL/6J/01a and 
F I) show some overlap o f  phenotypes (Fig. 2b). This data would be 
consistent with a single codom inant m odifier gene, with threshold 
effects13 or incom plete penetrance, determ ining the Tgfbl lethal 
phenotype. It is also consistent with o u r previous findings of -50% 
prenatal lethality on a m ixed genetic background3 (see Methods).
Due to the co d om inan t behaviour o f the m odifier gene( s), the 
m ost inform ative cross for genetic linkage analysis was considered 
to be an FI intercross. W ith the prem ise that C57BL/6J/01a alleles 
would be underrepresented in class C animals, a prim ary genome- 
w ide search  for m a jo r m o d ifie r  genes th a t  in fluence  Tgfb l ' /_ 
em b ry o n ic  survival was in itia te d  using  50 p o ly m o rp h ic  DNA 
m arkers on 50 Tgfbl~f~ neonates from  an FI intercross (equiva­
lent to 100 m eioses). Survival to  b ir th  was utilised as the criteri­
on  for linkage analysis, as this was an unam biguous phenotype, 
and  prov ided  large a m o u n ts  o f  DNA for genom e analysis. The 
quantities o f DNA available from  class A and B embryos w tie con­
sidered im practical for genom e scanning  purposes. The e con­
s id e ra t io n s  o u tw e ig h e d  th e  fac t th a t  - 6 0 %  o f  F2 T g fb l '1'  
conceptuses were lost in utero, and therefore not available for geno­
type analysis (Fig. 1).
It has been estim ated  that a sim ple m onogenic tra it ca;i easily 
be m apped w ith 40 inform ative m eioses using m arkers at 20 cM 
intervals14. In the curren t study, we estim ate that we have scanned 
75%  o f  the  au to so m al genom e fo r a m ajo r m od ifie r gene with 
power =  80% using a stringent significance test (P  = 0.001 Mod­
ifier genes located in proxim al m ouse ch rom osom e 7 would not 
be identified during  ou r search, as Tgfbl m aps to this regionb  and 
m ost mice were hom ozygous 129/Sv here11 (data not shown).
Four regions o f the genom e showed suggestive linkage (P < 0-*1-"1’ 
ref. 16) in the first screen (D 3M it6 , D5Mit267/268, D 5M itl88  and
Fig. 3 M ap of ch rom osom e 5 show ing  th e  location  o f th e  m ajor m o d if ie r  
g en e  and  th e  proxim ity o f Fgfr3 an d  116. The position  of th e  inform al ve Mit 
m arkers used fo r m app ing  a re  show n to  th e  righ t o f th e  chrom osom e, a n d  
th e  m ap d istances (cM) a re  ind icated  b e tw e e n  each  pair o f m arkers tnot 
d raw n to  scale). M ap d istances w ere  ca lcu la ted  from  th e  d a ta  using MAP- 
MAKER32. N ote th a t  D 5M it268  w as previously incorrectly m apped  (Research 
Genetics), its tru e  m ap location  being  b e tw e en  D5M it76  and  D5Mit2 :?■ Tl)e 
g en o ty p e  num bers (CC : CN : NN) o f th e  F2 n eo n a te s  fo r each  Mit marker is 
show n to  th e  righ t o f th e  figure . N ote th a t  8/80 Tgfb1~h  mice are homozy­
gous CC over th e  region  con ta in ing  th e  m ajor m odifier gene .
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Table 1 • Genome screen for modifiers of the  Tgfb1~l~ 
phenotype
Ch. Marker cM ^value
n = 4 7 -5 0
1 M it318 17
Mit 76 33
Mit 387 66
Mit 403 98
2 Mit 83 17
Mit 38 45
3 Mit 6 18 0.021
Mit 106 41
4 Mit 192 9
Mit 178 27
Mit 175 42
Mit 170 63
5 Mit 49 0.1185
Mit 251 18.6a 0.0445
Mit 76 8 .0a 0.0100
Mit 268 3.3a 0.0021
Mit 75 1.3a
Mit 267 3.3a 0.0021
Mit 80 3.0a 0.0048
Mit 233 7.4a 0 .0264
Mit 197 5.2a 0.0246
Mit 7 8 .6a 0.0111
Mit 188 15.2a 0.0084
Mit 161 2 .5a 0.015
aPai1 17.3a 0.12
6 Mit 74 11
Mit 213 30
Mit 25 50
7 Mit 284 44
8 Mit 190 22
Mit 9 36
Mit 166 57
9 Mit 286 17
Mit 16 57
Mit 150 59
aTBRII 62
Mit 18 67
10 Mit 20 23
Mit 95 50
11 Mit 5 37
Mit 258 67
12 NDS 11 7 0.0069
Mit 46 17 0.0069
Mit 68 28 0 .47
Mit 8 60 0 .47
13 Mit 63 20
Mit 290 46
14 Mit 140 16
Mit 141 19
Mit 239 46
Mit 35 49
15 Mit 220 17
Mit 159 46
16 Mit 181 4
Mit 59 26
Mit 114 35
17 Mit 43 1
Mit 16 7
Mit 21 20
Mit 93 41
18 Mit 150 17
19 Mit 31 13
Mit 19 28
Mit 103 40
n =  80
0.056
0.00011
0.000014
0 .000088
0.00039
0.0088
0.0088
0.052
0.052
list o f th e  dinucleotide repeat markers and restriction fragm ent length polymor- 
hism (RFLPs) used in th e  primary gen om e screen. In total, 60 o f 150 a inu deotid e  
Jpeat markers w ere found to  be inform ative b etw een  C57BL/6J/Ola and NIH/Ola.
9 of these, togeth er with a RFLP in Tgfbr2 (ref. 19) w ere used for the first round 
lenome screen. The m ost significant linkage was observed using a single marker on  
hromosome 5, D5M it80 (P =  0.0048), w ith tw o  further loci on chrom osom es 3 and 
2 also showing suggestive linkage (P<0.05). An additional 11 dinucleotide repeat 
barkers and an RFLP for Planhl (M.B., unpublished) w ere used to  provide a more 
etailed linkage map on chrom osom e 5 (see also Fig. 3). This gave strongest link- 
ige with D5M it268  (P = 0.002). A further 30 Tgfb1~^ F2 mice w ere genotyped for 
elected markers on chrom osom es 3, 5 and 12, to  confirm or dismiss linkage, 
olumn 3 denotes chromosomal position (cM) o f each Mit marker (Research 
ienetics), with the exception o f chrom osom e 5*, w here markers w ere reassigned  
ositions according to  our own data using MAPMAKER32. Column 4 lists P values 
0.05 in th e  first round genom e screen. All markers w ere used to  screen all 50 
ice, but only those with P < 0.05 are listed. Column 5 lists P values o f selected  
barkers which w ere used to  screen 80 animals, n, number o f animals.
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D12Mit46; Table 1). To confirm or dismiss linkage at each of 
these four loci, an additional 30 neonatal T g f b l intercross 
DNA samples were analysed for markers on chromosome 3, 5 
and 12. P values at the loci on chromosomes 3 and 12 remained 
only suggestive (-0.05). It is most likely that these are false pos­
itives. In contrast, the support for linkage was strengthened at 
D5Mit268, surpassing the stringent linkage criteria proposed by 
Lander and Kruglyak16 (P < 5 X  10-5). To evaluate the inde­
pendent support for a second modifier gene on chromosome 5 
(D5Mitl88), it is necessary to account for the linked major mod­
ifier defined by D5Mit268. Thus we calculated the conditional 
genotype frequencies that are expected at D5Mitl88. Assuming 
a map distance of 43.4 cM separating the two markers (Table 1, 
Fig. 3), the expected genotype frequencies a r e ^ f  = 33%, fNC 
= 49% and fcc  = 18%. The observed frequencies of 39% : 46%
: 15% are not significantly different from those expected (P =
0.5).
We used the approach o f Risch and colleagues17 to gain 
insight into the contribution of the chromosome 5 modifier 
gene to the overall genetic variability segregating in the FI inter­
cross. It is convenient to define the genotypic risk ratio (GRR) as 
the ratio of survival in the F2 generation, compared to that of 
the NIFI/Ola (NN) parental strain. From the data shown in Fig.
1, the overall GRRF2 in the F2 generation is therefore equal to 
37.6%/82% = 46%. The GRRF2 contributed by a specific mod­
ifier gene can be estimated from the strength o f linkage to a 
marker. An estimate of the GRRF2, assuming that there is no 
recombination between the marker and the modifier gene, is 
equal to (1 +/cc(/nn+/cn(/nn)/4 (ref. 17; M.F. unpublished). By 
substituting the observed genotype frequencies for D5Mit268, 
we estimate the GRRF2 for the chromosome 5 major modifier 
gene to be 54%. Risch e ta l17 proposed two multilocus genetic 
models, an additive model in which the effects at one modifier 
gene may substitute for another and a multiplicative, epistatic 
model of gene interaction. Under an additive model, where the 
overall GRRF2 (expressed as 1/GRRF2-1) is a sum of contribu­
tions from individual modifier genes, the chromosome 5 mod- 
ifer gene explains 72% o f the overall GRRF2. Under a 
multiplicative model, where the overall GRRF2 is the product of 
contributions from modifier genes, the chromosome 5 modi­
fier explains 79% of the overall GRRF2. We therefore conclude 
that the chromosome 5 modifier locus accounts for about three- 
quarters o f the variability in the lethal embryonic phenotype 
and that one or more minor loci account for the rest.
The nature of the gene product encoded by the chromosome 
5 modifier locus remains to be identified. From the distribu­
tion of prenatal lethal phenotypes, it would appear that there 
are two prenatal events (pre-organogenesis and mid-gestation) 
which are critically dependent on both TGFpl and the modifi­
er gene. The modifier locus (which accounts for 3/4 of the genet­
ic effect), when homozygous for C57BL6/J/01a, confers a higher 
requirement for TGFpi during development and thus TGFpi- 
deficient embryos die pre-organogenesis. The NIH/Ola allele 
reduces the embryo’s dependence on TGFpl, thus heterozygous 
animals survive until mid-gestation and animals homozygous 
NIH/Ola at the modifier locus even survive beyond birth (Figs
1,2). Polymorphic forms of the gene product might determine 
the embryo’s ability to respond to limiting quantitites of mater­
nal TGFpi (ref. 12) or might permit redundancy by utilization 
of other TGFP ligands of alternative developmental pathways. 
Many obvious candidate genes have been excluded by this study, 
including Tgfb2 (ref. 14), Tgfb3 (ref. 14), Igf2r17, Tgfbr2 (ref. 
18), En^°, Planhl (M.B. unpublished), although two good can­
didates Fgfr3 (refs 21-23) and 116 (refs. 24,25) map close to this 
modifier (Fig. 3).
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The existence of modifier genes which influence the phenotyp­
ic outcome of gene knock out mice is now well established26-30. 
Several studies have demonstrated variable prenatal lethal phe­
notypes which are genetic background-dependent26-29. Further­
more, localization of genetic modifiers of postnatal phenotypes 
of spontaneous and targeted mutations have been reported29,31. 
However, the current study demonstrates the feasibility of using 
genetic material from postnatal animals to investigate genetic inter­
actions which occur during very early mammalian embryogenesis. 
This approach overcomes the constraints of working with small 
amounts of embryonic DNA, which could be contaminated by 
maternal tissue. The genetic approach to the identification and 
eventual cloning of genetic modifiers adds another dimension to 
the analysis of prenatal lethal knock outs, thus advancing knowl­
edge of genetic interactions which occur during early mammalian 
development in vivo.
Methods
Animals. The Tgfbl null allele was originally generated on a 129/Sv genet­
ic background11. In an earlier study from our laboratory, the mice were 
bred through two generations onto a C57BL/6J genetic background and 
crossed once to NIH/Ola. T g f b l conceptuses derived from intercrossing 
these Tgfbl+/~ mice were found to have one of two lethal phenotypes; mid­
gestation loss due to defects in yolk sac vasculogenesis and 
haematopoiesis3, or death at three weeks postpartum due to multisystemic 
inflammation10,11. For the purposes of this study, the null allele was bred 
through four generations onto either inbred NIH/Ola or inbred 
C57BL/6J/01a, obtained from Harlan Olac Ltd., UK. Thus the animals 
were, on average, 93.75% pure.
For genomic screening purposes, FI intercrosses between essentially 
genetically identical mice were set up ((Tgfbl+I~; NIH/Ola x 
C57BL/6J/01a) x (Tgfbl+I~’, NIH/Ola x C57BL/6J/01a)) and the F2 pups 
culled soon after birth (see below). As the mice were 6.25% impure, each 
parental pair was genotyped with each microsatellite to ensure that both 
parents were heterozygous at that locus prior to genotyping the offspring. 
This analysis confirmed the expectation11,15 that proximal chromosome 7 
would be predominantly homozyogous 129/Sv in the Tgfbl-1- animals.
Analysis of embryos. Embryos were collected from natural timed matings 
of Tgfbl+I~ animals of different genetic backgrounds. Noon on the day of 
the vaginal plug was regarded as 0.5 dpc. Embryos were dissected from the 
uterus into PB1 medium (Gibco BRL) and scored for morphological 
abnormalities. DNA was then extracted and the embryos were genotyped 
retrospectively.
Genotyping and microsatellite analysis. For the purpose of breeding, 
genomic DNA was extracted from tail biopsies of anaesthetised 3-week- 
old mice. For screening purposes, genomic DNA was isolated from the 
tails of neonates culled prior to the stage of postnatal death which results 
from lack of TGF|3l10,11. Animals were screened for Tgfbl genotype as 
described3, using, simultaneously the three oligonucleotide primer sets in 
a 20 pi reaction volume containing lx  PCR buffer (Cambio); 1.5 mM 
MgCl2; 5 mM dNTPs; 150-200 ng DNA and 1 U Tfl polymerase (Cambio).
Dinucleotide repeat primers for genomic mapping were either a gift 
from John Todd, purchased from Research Genetics, or synthesized on an 
Applied Biosystems 391 DNA synthesiser. The polymerase chain reaction 
(PCR) was performed according to manufacturer’s recommendations. 
Primer sets (150) were screened to search for polymorphisms between 
C57BL/6J/01a and NIH/Ola. Only 60 primer sets were polymorphic, and 
most size differentials were so small (1-8 nucleotides) that the polymor­
phisms could only be resolved by 8% acrylamide gel electrophoresis. DNA
was visualized by silver staining; the gel was fixed in 10% ethanol 0 So 
acetic acid for 15 min; stained in 0.1% silver nitrate; washed in H n. ° 
developed for 20 min in 1.5% NaOH, 0.1% formaldehyde.
Southern blot analysis. Southern blotting was performed as described^ 
using Quikhyb™ (Stratagene). ’
Genome screen. A genome wide screen was undertaken on newbor 
Tgfbl-1- pups (class C) from an FI Tgfbl+I~ intercross, to search for m o d  
ifier genes which determine the likelihood of prenatal lethality on the dif 
ferent genetic backgrounds. The decision to use Tgfbl-1- neonates (clas 
C) was due to the limiting quantities of DNA which could be obtained 
from class A or B embryos. The premise was that the C57BL/6J/Oia allele 
of the modifier gene(s) predisposes to prenatal lethality, and would thus be 
underrepresented in class C animals, based on the observation that there 
is complete prenatal loss of C57BL/6J/01a embryos, -70% prenatal loss of 
FI embryos, but only -20  % loss of NIH/Ola embryos (Fig. 1). If a single 
codominant gene was entirely responsible for this genetic effect, one 
would expect that, by birth, the genotype frequency at that locus would 
deviate from mendelian expectations and would be 0 CC: 0.75 CN : l.o 
NN (0 x 1: 0.3 x 2 : 0.8 x l, see Fig. 1). The frequencies of the three geno­
types fcc, fCN and f ^  detected by each marker were compared with those 
expected for an independently segregating locus (0.25 : 0.5 : 0.25); the sig­
nificance of any difference was assessed by using a %2 test (with 2 degrees 
of freedom).
As there was no control group for genotype analysis (class A and B 
embryos were not genotyped) the possibility existed that linkage (at 
D5Mit268) could be artefactual due, for example, to strain-specific segre­
gation distortion on chromosome 5. This possibility was excluded by analy­
sis of 50 Tgfbl+I+ animals born from the same F2 litters. The distribution 
of D5Mit268 alleles in these wild-type mice was the expected 1 : 2 :1 .
Calculation of conditional genotype frequencies. /cc = gcc
(l-2 r+ r2)+gCN (r-r2)+gNNr2. /CN = 2gcc (r-r2)+gCN (l-2r+2r2)+2 gNN 
(r-r2)- /nn = gccr2+gCN (r-r2)+gNN (l-2 r+ r2) where fcc, fCN and fm  are 
the expected genotype frequencies at a linked locus (D5Mitl88) and gcc, 
gCN and g j^  are the observed genotype frequencies at the modifier gene 
(D5Mit268). r = recombination fraction between the two modifier genes. 
Note that when r = 0, f cc  = gcc, /CN = gCN, fm  = gNN; when r = 0.5, fcc = 
V ^ y f c  N =  1 / 2 , ^ =  1/4.
Estimation of genotype frequencies on the mixed genetic background. In
our earlier study3, the mixed genetic background was roughly 1/8 129/Sv; 
3/8 C57BL/6J; 1/2 NIH/Ola. Of the Tgfbr1- embryos examined, only -1/7 
((3/8)2) would have been homozygous C57BL/6J at any single locus, that 
is, 1/28 (1/7 x 1/4) of each litter. Thus class A conceptuses would easily 
have gone undetected in the analysis. The majority of embryos would have 
been heterozygous CN (-50%) or homozygous NN (-25%) at any one 
locus, thus accounting for the observation of -50%  prenatal lethality due 
to yolk sac deficiencies3.
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APPENDIX 1.
Graphs 6a-10b - Morphological Scores of TGFpl+/- Intercross Litters at 
9.5dpc.
At 9.5dpc >100 TGFpi knockout conceptuses from the NIH, C57, 129 and reciprocal 
FI genetic backgrounds were dissected free from the maternal tissue, morphologically 
scored and genotyped for TGFpi by PCR of genomic DNA. The morphological scoring 
was based on two scores: Score 1 was an additive score giving a precise developmental 
staging of the conceptus using landmarks, whereas score 2 was a quantitative and 
qualitative assessment of the specific abnormalities suffered by the conceptus. Both 
scores, for each TGFpi genotypic class, on each genetic background studied are 
presented in the following box and whisker graphs. The data is laid out as follows; the 
box represents the 1st to 3rd quartiles, the line in the centre of the box is the median value 
and the whiskers cover the remaining data. Stars represent individual pieces of outlying 
data.
It is clear that on each genetic background score 1 does not vary greatly between 
genotypic class or genetic backgrounds. However, the magnitiude of score 2 is clearly 
related to the genotype of the concepus; i.e. little or no defects were seen in TGFpi+/+ 
conceptuses; any abnormalities observed were typically non-specific, for example - slight 
developmental retardation rather than defects characteristic of the TGFp 1 knockout mid­
gestation phenotype. A large range of severity of defects were observed in TGFpl+/- 
conceptuses. This is in concordance with the disparity of onset and severity of the mid­
gestation phenotype in the heterozygotes. As expected, on each genetic background, the 
largest proportion of severe defects befell the TGFpi-/- conceptuses. These defects 
mainly comprised abnormalities of the extra-embryonic vasculature and haematopoiesis.
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Graphs 6a and b. Box and W hisker Plots of M orphological Scores 1 and 2
in NIH Conceptuses o f Each Genotypic Class at 9.5dpc.
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Graphs 7a and b. Box and W hisker Plots of M orphological Scores 1 and 2
in C57 Conceptuses o f Each Genotypic Class at 9.5dpc.
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Graphs 8a and b. Box and W hisker Plots of M orphological Scores 1 and 2
in 129 Conceptuses o f Each Genotypic Class at 9.5dpc.
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Graphs 9a and b. Box and W hisker Plots of M orphological Scores 1 and 2
in NIH x C57 Conceptuses o f Each Genotypic Class at 9.5dpc.
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Graphs 10a and b. Box and W hisker Plots o f M orphological Scores 1 and
2 in C57 x N1H Conceptuses of Each Genotypic Class at 9.5dpc.
